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ABSTRACT 
 
Spatial and temporal control of protein synthesis in response to activity is required for 
neuronal function and plasticity. mRNA structure and sequence provide a powerful platform for 
such regulation, but how such information is utilized in neurons is incompletely understood. In 
my thesis, I explore how functional elements within 5’leaders (traditionally termed 5’UTR or 
untranslated region) of mRNAs act as cis-regulatory elements to influence basal and activity-
dependent translation in neurons.   
First, I identified a specific role for upstream open reading frames (uORFs) in regulating 
mRNA translation during neuronal differentiation. uORFs are regions within the 5’ leader that 
undergo translation. Using ribosome profiling (RP), an emerging next-generation sequencing 
technique which utilizes a modified RNA-sequencing library preparation to detect regions of 
mRNA occupied by actively translating ribosomes, I identified thousands of uORFs in human 
neuroblastoma cells. A portion of these uORFs demonstrated clear usage shifts with 
differentiation. Highly conserved uORFs exhibited increased GC content and were associated 
with cumulatively repressed CDSs. Importantly, changes in the translational efficiency of these 
conserved uORFs across differentiation were inversely correlated with CDS translation on these 
same transcripts. These data demonstrate uORF usage is common in neuroblastoma cells and that 
specific uORFs act as regulators of cell state-specific translation in neuronal differentiation.  
Next, I investigated the function of CGG repeats in the 5’ leader of FMR1. All humans 
have a conserved CGG-trinucleotide repeat (typically 20-45 repeats) in FMR1 that can become 
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unstable and expand intergenerationally.  Large expansions (>200 CGG repeats) cause Fragile X 
Syndrome, a common cause of intellectual disability, by silencing FMR1, leading to loss of the 
fragile X protein, FMRP. Intermediate (55-200 CGGs) expansions, in contrast, are transcribed 
and cause an age-related neurodegenerative condition known as Fragile-X Associated 
Tremor/Ataxia Syndrome (FXTAS). Our lab discovered that this repeat facilitates Repeat 
Associated Non-AUG translation (RANT), whereby ribosomes initiate at non-AUG codons 
upstream of the repeat to produce toxic homopolymeric proteins that drive pathogenesis in 
FXTAS. FMR1 avidly supports RANT at normal repeat sizes, suggesting that it might serve as a 
regulatory uORF to control FMRP synthesis. To address this, I expressed nanoluciferase 
reporters in rat hippocampal neurons. Using this strategy, I found that RANT exhibits a strong 
negative effect on FMRP synthesis at both normal and expanded repeats. FMRP is a key synaptic 
protein that is rapidly synthesized in response to mGluR activity. Importantly, preventing RANT 
or removing the repeat itself blocked this mGluR-induced response. This suggests that FMR1 
relies on these two elements to appropriately scale synaptic FMRP synthesis.  
Using non-cleaving antisense oligonucleotides (ASOs) that target the RANT initiation 
sites, I found that blocking RANT could decrease toxic protein production and prevent neuronal 
death. In a line of iPSC-derived neurons from a patient with a large CGG repeat (>200) that still 
generates FMR1 mRNA but has deficits in FMRP, treatment with the ASO increased 
endogenous FMRP expression by 50%. These findings define a native function for RANT and 
CGG repeats in regulating FMRP synthesis, and delineate RANT as a therapeutic target in 
Fragile X-associated disorders.	
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CHAPTER I 
The role of noncanonical mRNA translation in health and disease  
 
Introduction 
Gene expression in its simplest form relies on the process of DNA transcription to RNA, 
then translation of the RNA messenger into protein. This flow of information—termed the 
central dogma of molecular biology—provides an infrastructure for the process by which DNA 
is expressed as a functional protein or acts as a functional RNA element. However, it is a gross 
oversimplification. Every step in the pathway is highly regulated, with multiple modifiable 
factors that selectively influence protein generation. RNA sequence and secondary structure in 
particular acts as a powerful source of spatiotemporal regulation of gene expression. Moreover, 
every gene has the potential to reveal caveats to well-established doctrine.  
 
The scanning mechanism of eukaryotic translation initiation 
The scanning mechanism of translation initiation broadly refers to the process whereby 
the small ribosomal subunit with its associated factors binds to the modified guanosine cap 
(m7G) on the 5’ end of mRNA transcripts, then progresses in the 3’ direction to a start codon 
where it joins with the large subunit to initiate translation (Hinnebusch 2011, Hinnebusch, 
Ivanov et al. 2016). This process begins when a free 40S ribosomal subunit binds the ternary 
complex (TC), composed of Met-tRNAiMet bound to eIF2 (Figure1.1). eIF2 is comprised of three 
subunits. The γ subunit binds GTP, when GTP is hydrolyzed to GDP eIF2 cannot bind 
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Met-tRNAiMet. Phosphorylation of the α subunit of eIF2 inhibits the guanine exchange factor 
(GEF) eIF2B, which is responsible for adding GTP to eIF2. eIF4F is comprised of multiple 
initiation factors that bind to the m7G cap, this interacts with the polyadenosine binding protein 
(PABP) present on the 3’ end of the transcript, circularizing the mRNA(Hinnebusch 2011, 
Hinnebusch, Ivanov et al. 2016). Binding of the 40S subunit to the TC, along with eIF1, eIF1A, 
eIF3, and eIF5 forms the 43S preinitiation complex (PIC). The PIC is recruited to the transcript 
through interaction with the eIF4F complex, then begins scanning. Upon AUG start site 
recognition, eIF5 facilitates hydrolysis of the GTP bound to eIF2, initiation factors dissociate, 
and the 60S subunit binds forming the 80S ribosome with the Met-tRNAiMet positioned in the P 
site. Not every AUG codon within the 5’leader is utilized for initiation. Robust translation 
initiation depends not only on the perfect complementarity of the Met-tRNAiMet anticodon, but 
also the sequence directly surrounding (Thach, Dewey et al. 1966, Kozak 1981, Kozak 1984). 
The consensus or “Kozak” sequence, 5’-GCCGCC(A/G)CCAUGG-3’, marks the site of 
initiation(Kozak 1984, Kozak 1987). Endogenously occurring suboptimal AUGs in 5’ leaders are 
often bypassed by the PIC in a process termed “leaky scanning”. However, not all upstream 
AUGs are bypassed, striking a balance of translation on an individual transcript. Thus, the 
scanning model of translation initiation has its caveats, many of these are influenced by 
characteristics of 5’ leaders which will be further reviewed here. 
 
Ribosome profiling illustrates global protein synthesis 
Ribosome profiling (RP) in a next-generation sequencing method for locating translating 
ribosomes across the transcriptome (Ingolia, Ghaemmaghami et al. 2009). Cycloheximide is used 
to halt translating ribosomes on mRNA, RNase I is used to degrade unbound RNA, and a library  
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Figure 1.1: 
The scanning mechanism of eukaryotic translation initiation. I) An mRNA transcript is processed to have an 
m7G nucleoside at its most 5’ position and a polyadenylated tail associated with Poly(A) binding proteins. II) The 
eIF4F complex binds to the m7G cap. Poly(A) binding proteins interact with eIF4F which circularizes the transcript. 
III) eIF2 bound to GTP associates with Met-tRNAiMet to form the ternary complex. The ternary complex, eIF1, 
eIF1A, eIF3, eIF5, and the 40S ribosome come together to form the 43S preinitiation complex. IV) The preinitiation 
complex is recruited to the mRNA transcript through association with eIF4F. Then, the preinitiation complex and 
components of eIF4F scan the mRNA in the 5’ to 3’ direction in search of an optimal start site. To solidify start site 
recognition, eIF1 dissociates, and eIF5 facilitates the hydrolysis of eIF2 bound GTP to GDP (not shown). V) The 
60S subunit of the ribosome binds to the 40S subunit forming the 80S ribosome at the initiation site, facilitated by 
eIF5B. The eIF4F complex dissociates. When eIF5B hydrolyzes its GTP to GDP, eIF1A dissociates (not shown), 
and the 80S ribosome can form its first peptide bond. Inset: eIF2B stimulates GTP binding to eIF2, leaving eIF2 in 
its functional state to go on to form a ternary complex. eIF2 bound to GDP can be phosphorylated on the α subunit, 
making it a competitive inhibitor of eIF2B. 
 
is made from the ribosome protected footprints (RPF), each of which is approximately 28 
nucleotides (Ingolia 2010, Ingolia, Brar et al. 2012). Assessing global ribosome occupancy with  
RP has granted a new level of insight into the guiding principles of mRNA translation. Utilizing 
RP to investigate mRNA translation in Saccharomyces cerevisiae affirmed that ribosome 
profiling can recapitulate classic biochemical studies (Ingolia, Ghaemmaghami et al. 2009). 
Permutations of RP have also been highly informative. TCP-seq, or translation complex profile 
sequencing, utilizes formaldehyde crosslinking and a broader range of footprint sizes to select for 
intermediates in the initiation pathway (Shirokikh, Archer et al. 2017). This technique shows 
promise for identifying comprehensive principles that guide mRNA-translation machinery 
interactions (Archer, Shirokikh et al. 2016). At the core of the analysis of ribosome profiling 
studies is the calculation of translational efficiency (TE) by taking the ratio of RPF and mRNA 
abundance (Ingolia, Ghaemmaghami et al. 2009). RP is able to resolve active translation across 
transcripts with peaks in read density showing the highest three-nucleotide periodicity in the 
native frame(Ingolia, Ghaemmaghami et al. 2009). Interestingly, the earliest studies employing 
RP showed pervasive 5’leader translation and NCC initiation (NCC) (Ingolia, Ghaemmaghami et 
al. 2009, Ingolia, Lareau et al. 2011). RP studies will be further discussed in the following text.  
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The 5’ Untranslated Region regulates mRNA translation 
A potential role for the 5’ leader in regulation of translation initiation was recognized 
early following establishment of the cognate start codon and its location near the 5’ end of 
mRNA(Nirenberg and Leder 1964, Sundararajan and Thach 1966, Thach, Dewey et al. 1966, 
Bretscher 1968, Steitz 1969, Chang, Temple et al. 1977, Efstratiadis, Kafatos et al. 1977). The 
first fully sequenced human 5’ leaders were present in the alpha- and beta- globin transcripts 
(Baralle 1977, Chang, Temple et al. 1977). The presence of secondary structure in the regions 
sequenced was noted, with a highly stable hairpin formed in both transcripts(Chang, Temple et 
al. 1977). While the exact influence of the 5’ leader on peptide synthesis was unknown, the 
authors purported a likely interaction between this structured region and the ribosome.  
In the decade that followed, there was a push to identify regions responsible for initiation 
complex binding (Sherman, Stewart et al. 1980, Kozak 1981, Kozak 1986). Abolishing 
secondary structure in the 5’ leader of a reporter mRNA with denaturation or inosine 
monophosphate incorporation lead to further migration of the 40S ribosome past 5’ proximal 
AUG and a decrease in translation efficiency at this site, thereby supporting the role for a 
structured 5’ leader in influencing translation initiation(Kozak 1980).  Another study in 
Saccharomyces cerevisiae hinted that the AUG sequence is not an all or nothing requirement for 
initiation. In-frame AUGs were cloned in various locations upstream of the main start site which 
was mutated to preclude initiation(Sherman, Stewart et al. 1980). In doing so expression of the 
protein of interest varied, but this was not fully understood until the nucleotides flanking the 
AUG were identified as key modulators of 80S initiation(Kozak 1981).  
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Upon identification of the full Kozak sequence and substantial evidence for the scanning 
model of translation initiation, the possible roles for the 5’ leader sequence in influencing 
initiating ribosomes became clearer(Kozak 1981). Insertion of out-of-frame AUG codons 
upstream of the main initiation site AUG in preproinsulin coding sequence was an early indicator 
that translation in the 5’ leader can influence downstream translation(Kozak 1984). More optimal 
start sites inserted upstream of the main AUG were shown to be more highly repressive. In 
addition, if the reading frame derived from the AUG insertion was overlapping the main CDS 
(Figure 1.2) the level of repression was higher than if the in-frame termination codon was in the  
 
Figure 1.2:  
 
uORF architecture is dictated by reading frame and start site. A) A uORF with an initiation site and stop codon 
upstream of the main CDS is fully contained in the 5’ leader. B) A uORF that starts out of frame with the CDS can 
terminate within the CDS, forming an overlapping uORF. C) A uORF that initiates in frame with the CDS and does 
not encounter a termination site in the 5’ leader, will produce an N-terminal extension to the CDS protein.  
 
5’ leader. It was also described that if the ORF made from the upstream AUG terminated 
upstream of the preproinsulin CDS, preproinsulin was still made lending evidence to the theory 
that ribosomes can reinitiate. Further clarification on reinitiation has suggested that 40S 
ribosomes can remain engaged after translation, rebind the TC, and reengage with a downstream 
start site(Kozak 2002). This is influenced by length of the upstream coding region and the 
Overlapping uORF
uORF
N-terminal Extension
CDS
AAAAA
AAAAA
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CDS
CDS
A.
B.
C.
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distance between its termination codon and the next start site (Kozak 1987, Kozak 2002). The 
effect of secondary structure on start site recognition was recognized when a stable hairpin 
structure was inserted upstream of the AUG, dramatically decreasing the overall yield of the 
measured protein(Kozak 1986). Leader length was also shown to affect initiation, with longer 
unstructured regions upstream a stem-loop structure increasing the efficiency of translation of the 
reporter(Kozak 1988). Importantly, positioning a hairpin structure just downstream of an NCC, 
increased the likelihood of initiation at that site with GUG as the most efficient initiator of the 
codons tested (Kozak 1989, Kozak 1990). Many of these early studies preempted a large body of 
research illustrating the effect that endogenously occurring ORFs residing in the 5’ leader of key 
genes can have on translation. 
 
eIf1 and eIF5 are key to start site choice 
Two factors—eIF1 and eIF5—influence start site choice (Kozak 1986, Hinnebusch 
2011). eIF1 is termed the “gatekeeper” of start site choice, as it must dissociate from the PIC 
where it resides so that initiation can proceed (Hinnebusch 2011). Thus, blocking the 
dissociation eIF1 in mammalian cells in the appropriate mRNA context can increase initiation at 
near-cognate start sites and suboptimal AUGs, (Valasek, Nielsen et al. 2004, Hinnebusch 2011). 
eIF1 interacts directly with the 40S subunit in coordination with eIF1A to assist in binding the 
TC, but also promotes an “open” or scanning conformation of the PIC(Passmore, Schmeing et al. 
2007). Once, eIF1 dissociates, the TC is more firmly bound placing the initiator tRNA more 
optimally for AUG-anticodon binding(Maag, Fekete et al. 2005, Nanda, Cheung et al. 2009). In 
yeast, the Sui1— mutation in eIF1 reduces the interaction between eIF1 and the 40S subunit and 
increases initiation at non-AUG start sites (Cheung, Maag et al. 2007). eIF5 is a GTPase 
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accelerating protein (GAP) that stimulates the hydrolysis of GTP bound to eIF2 upon start site 
recognition. When eIF1 is bound, it is thought to block the GAP function of eIF5(Unbehaun, 
Borukhov et al. 2004). eIF5 is believed to promote dissociation of eIF1 through interactions of 
their N-terminal domains, and thus promote initiation(Hinnebusch 2011). In yeast, eIF5 
overexpression  increases initiation at the near-cognate AUU codon, which is believed to 
primarily occur due to altered interactions with eIF1 (Nanda, Cheung et al. 2009).  In human 
cells, eIF5 overexpression also increased initiation at suboptimal AUGs and near cognate 
codons(Loughran, Sachs et al. 2012). Interestingly, both eIF1 and eIF5 utilize start site context as 
a form of autoregulation. The AUG of eIF1 itself is in poor context, in mammals when eIF1 
levels are high, eIF1 inhibits its own synthesis (Ivanov, Firth et al. 2011). When eIF1 function is 
compromised in yeast, such as in the Sui— mutation, initiation at its suboptimal AUG is 
increased (Martin-Marcos, Cheung et al. 2011). eIF5 takes advantage of initiation at an 
inhibitory suboptimal AUG upstream of its main start site, so when eIF5 levels are high 
increased initiation at this upstream site inhibits further scanning to main CDS AUG of eIF5, 
creating a negative feedback loop(Loughran, Sachs et al. 2012). These two antagonistic factors 
for translation initiation highlight how important proper coordination is to start site recognition.  
 
Upstream ORFs influence main ORF translation 
A uORF can implement a regulatory role on its resident transcript through three 
overarching mechanisms: 1) through sequence-dependent interactions with the translation 
machinery, 2) through cis- and trans-interactions with uORF-derived peptides, and 3) through 
influencing RNA stability.  
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uORFs can influence CDS translation through sequence-dependent interactions 
Studies on the yeast transcriptional activator Gcn4 provided the first evidence that uORFs 
present in the 5’ leader of a eukaryotic transcript can influence main protein 
synthesis(Hinnebusch 1984, Thireos, Penn et al. 1984, Mueller and Hinnebusch 1986, 
Tzamarias, Alexandraki et al. 1986). GCN4 bears 4 non-overlapping AUG-initiated uORFs 
(Figure 1.3). Initially, point mutations of these AUGs were shown to variably increase GCN4  
 
Figure 1.3:  
 
GCN4 and ATF4 are transcripts regulated by uORF activity. GCN4 contains four uORFs in its 5’ leader. In 
yeast, Gcn4 protein production is regulated by its 5’ leader which modulates the availability of initiating ribosomes 
and protects the transcript from the stress-induced translational blockade. The 5’ leader of ATF4 bears one short 
uORF and one overlapping uORF. Like GCN4, these features boost the production of ATF4 in response to stress.  
 
production(Mueller and Hinnebusch 1986). Delving deeper into their function, the presence of 
these uORFs allow for the proper translational response of GCN4 to amino acid starvation. 
Under normal conditions, the availability of the ternary complex is non-limiting. uORF1 is 
translated first, then the ribosome reinitiates at the following 3 uORFs. Removal of uORF1 
actually decreases Gcn4 protein(Mueller and Hinnebusch 1986). This is likely due to increased 
initiation at the downstream uORFs. Following translation of uORF4, the ribosome dissociates 
and cannot reinitiate translation at the main initiator AUG of GCN4 (Hinnebusch, Ivanov et al. 
2016). Thus, basal levels of Gcn4 are low. This changes under conditions of stress. During 
amino acid starvation, the kinase Gcn2 phosphorylates serine 51 of the α subunit of eIF2. 
ATF4:
GCN4:
AAAAA
GCN4 CDS
AAAAA
ATF4 CDS
1 2
21 3 4
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Phosphorylation of eIF2α turns eIF2 into a competitive inhibitor of the GEF, eIF2B. eIF2B is 
responsible for the GDP bound to eIF2 to GTP. Thus, fully assembled ternary complexes are 
limiting. This changes the translation of the ORFs present on the GCN4 transcript (Hinnebusch 
1997). While uORF1 is still translated under stress, a loss of available ternary complexes is 
thought to preclude scanning 40S ribosomal re-initiation at the following three uORFs. By the 
time the scanning ribosome reaches the AUG of the main ORF, it has re-acquired bound the 
ternary complex and can initiate translation (Hinnebusch 1997). Gcn4 protein is thus present at 
increased amounts during amino acid starvation, and can act to increase transcription of genes 
involved in amino acid biosynthesis. 
GCN4 is the premier example of antithetical protein synthesis among stress-induced 
translational arrest, however cellular response to stress is known to affect a number of uORF-
containing transcripts(Young and Wek 2016). The Integrated Stress Response (ISR) is activated 
by specific stimuli, namely ER stress, viral infection, heme deprivation, and amino acid 
deprivation(Pakos-Zebrucka, Koryga et al. 2016). These stimuli each act on a specific eIF2α 
kinase leading to an increase in eIF2α phosphorylation, and a global decrease in protein 
synthesis(Harding, Novoa et al. 2000, Harding, Zhang et al. 2003, Pakos-Zebrucka, Koryga et al. 
2016). Despite a global translational arrest, a subset of transcripts show a paradoxical increase in 
translation. These transcripts distinctly contain uORFs, many of the gene products are associated 
with cellular response to mitigate stress and maintain homeostasis. ATF4 is the prototypical 
mammalian transcript modulated by uORF translation(Harding, Novoa et al. 2000, Vattem and 
Wek 2004). Like GCN4, ATF4 is a transcription factor responsible for activating transcription of 
stress response factors. It has two uORFs, the second of which overlaps the CDS (Figure 1.3). 
Studies have shown that uORF1, the most 5’ proximal uORF, is translated under normal 
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conditions followed by reinitiation at uORF2(Vattem and Wek 2004). As uORF2 is overlapping, 
this diverts ribosomes from translating the ATF4 ORF. Under ER stress or amino acid starvation, 
when eIF2α phosphorylation is upregulated, uORF2 is bypassed after uORF1 is translated. Thus, 
more 43S complexes reach the AUG of ATF4. Overall, delayed re-initiation leads to a general 
increase in the main protein product. A similar mechanism has been described for ATF5(Zhou, 
Palam et al. 2008). GADD34 and CHOP also encode stress response factors under similar 
conditions, and contain uORFs in their 5’ leaders(Lee, Cevallos et al. 2009, Palam, Baird et al. 
2011).  
Starck et al. (2016) suggested that some uORFs exhibit enhanced translation during stress 
through use of alternative ternary complexes or non-canonical initiation factors such as 
eIF2A(Starck, Tsai et al. 2016). This was illustrated through analysis of BiP, an ER chaperone, 
with two NCC initiated uORFs; the first initiates at a UUG and the second initiates at a CUG, 
and overlaps the CDS. eIF2A knock-down decreased translation of the second uORF, and was 
necessary for the maintenance of BiP levels after stress induction with thapsigargin(Starck, Tsai 
et al. 2016). Importantly, a role for eIF2A has been explored for Leu-tRNA initiated translation 
at CUG codons in MHC class I molecules from mouse antigen producing cells and at a CUG 
initiated N-terminal extension to PTEN in human and mouse(Starck, Jiang et al. 2012, Liang, He 
et al. 2014). These studies highlight a role for alternative translation factors in production of 
uORFs with NCC start sites. 
 
uORF-derived peptides can influence CDS translation through cis- and trans-interactions with 
ribosomes 
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The AMD1 mRNA transcript exhibits an interesting mechanism of noncanonical 
translation regulation that relies on the identity of the nascent peptide. A uORF present in the 
transcript encodes a hexapeptide that stalls its translating ribosomes at its termination site (Hill 
and Morris 1993, Law, Raney et al. 2001). Interestingly, the half-life of ribosomal stalling is 
proportional to the concentration of polyamines present and directly affects translation of the 
downstream ORF in cells(Law, Raney et al. 2001). These data point to a role for translation of 
uORF peptides working in cis to impede ribosome function. A separate mechanism whereby the 
synthesized uORF peptide can act to regulate downstream translation was described in the β2 
adrenergic receptor mRNA (Parola and Kobilka 1994). In this case it is postulated that the 
uORF-derived peptide can interfere with mRNA and ribosome interactions after being fully 
synthesized. When a fusion peptide derived from this sequence is added to an in vitro translation 
reaction, production of the main ORF is impaired (Parola and Kobilka 1994). Similar 
mechanisms have been suggested to regulate translation on the CHOP and V1bR (vasopressin 
V1b receptor) mRNA transcripts (Jousse, Bruhat et al. 2001, Rabadan-Diehl, Martinez et al. 
2007). Taken together, these data point to a distinct mechanism for translation regulation by 
uORFs. 
 
Translation of uORFs can influence mRNA stability 
Another means by which a uORF can exert a regulatory role on transcripts is through 
influencing mRNA stability. The principles for this mechanism are best understood in the 
context of nonsense mediated decay (NMD). NMD occurs in the wake of the ribosome 
encountering a premature termination codon, making the potential for 5’ leader translation an 
apparent trigger for this quality control measure. If a premature termination codon (PTC) resides 
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within 50-55 nucleotides to the 5’ end of an exon-junction site, this can trigger endonucleolytic 
cleavage and degradation of the transcript (Popp and Maquat 2013). This is believed to occur 
through interactions with the macromolecular exon-junction complex (EJC) and proteins 
associated with the terminating ribosome, namely UPF1 whose hyperphosphorylation as a 
consequence of encountering an EJC recruits decay factors(Le Hir, Izaurralde et al. 2000, 
Lejeune, Li et al. 2003, Popp and Maquat 2013). This process is thought to only come into effect 
during the first round of translation, which displaces EJCs for subsequent translation(Ishigaki, Li 
et al. 2001, Popp and Maquat 2013). The presence of a uORF is one of the top predictors of 
whether a transcript is an NMD target (Colombo, Karousis et al. 2017). Intriguingly, the 
transcripts of several NMD factors—UPF2, SMG1, SMG5, SMG6, SMG7—bear uORFs that are 
thought to make them substrates of this form of RNA decay themselves (Huang, Lou et al. 2011, 
Yepiskoposyan, Aeschimann et al. 2011). It is believed that this is one mechanism of 
autoregulation by which NMD maintains its balance—by a negative feedback loop to prevent 
over activity of RNA decay.  
 
Ribosome Profiling reveals widespread prevalence of uORFs 
As uORFs were initially described on only a case to case basis, the extent to which they 
are translated truly came to light through RP studies. Ingolia et al. (2009) described a significant 
enrichment of ribosomes in 5’ leaders in Saccharomyces cerevisiae, with a subset showing 
translation comparable to coding regions(Ingolia, Ghaemmaghami et al. 2009). 153 5’ leaders 
were deemed to contain a robustly translated AUG driven uORF, including a set of known 
uORFs. Interestingly, a separate set of 143 uORFs with initiation in the absence of an AUG 
codon were also identified. This was soon followed by research in mouse embryonic stem cells 
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(mESC), showing that ribosome occupancy in 5’ leaders is also detected in mammalian cells 
(Ingolia, Lareau et al. 2011). By using harringtonine, a drug that stops ribosomes at the site of 
initiation, it was suggested that less than 50% of all translation initiation sites are encoded by an 
AUG, with near cognate codons making up the vast majority of the rest (Ingolia, Lareau et al. 
2011). However, it is important to acknowledge that this number is somewhat misleading, as the 
most robust initiation sites- both for uORFs and for annotated start sites- were still AUG. 
However, the sheer number of uORFs (initial estimates were in the thousands) and the finding 
that they often used NCC initiation sites spurred further studies into this phenomenon (Brar and 
Weissman 2015, Kearse and Wilusz 2017). 
As a proof of principle, ribosome profiling of HEK293T cells treated with tunicamycin, a 
potent activator of ER stress, delineated the translational changes associated with the ISR 
(Sidrauski, McGeachy et al. 2015). This study confirmed upregulation of CHOP, GADD34, 
ATF4, and ATF5 translation upon stress, which was abrogated in response to ISRIB, an inhibitor 
of ISR(Sidrauski, McGeachy et al. 2015). Also identified in this analysis were several new 
transcripts with tunicamycin-induced upregulation of translation. Of these, SLC35A4 was shown 
to contain a novel uORF enriched in RPFs which has been shown to produce a functional peptide 
in human proteome analysis, illustrating that well established molecular pathways can be further 
clarified by ribosome profiling (Kim, Pinto et al. 2014, Sidrauski, McGeachy et al. 2015).  
Intriguingly, studies in multiple models have suggested that uORF translation can be 
conditionally regulated. uORF translation has been observed to shift during the yeast meiotic 
cycle and differentiation of mESCs. This shift was illustrated for both the GUG initiated uORF 
on CCNB2 and the AUG initiated uORF on ANAPC5(Ingolia, Lareau et al. 2011). A component 
of this may be attributed to expression of alternative 5’ leader sequences (through alternative 
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splicing) at different stages, which leads to the inclusion or exclusion of potential upstream start 
sites(Ingolia, Lareau et al. 2011, Brar, Yassour et al. 2012). Shifts in 5’ leader translation have 
also been described by RP studies on mitosis, neuronal differentiation of human ESCs, circadian 
oscillation, and organism development(Bazzini, Johnstone et al. 2014, Janich, Arpat et al. 2015, 
Johnstone, Bazzini et al. 2016, Blair, Hockemeyer et al. 2017, Blank, Perez et al. 2017, Sendoel, 
Dunn et al. 2017).  
 
Using Ribosome Profiling to decipher the global effect of uORFs 
The overall repressiveness of upstream translation on main CDS translation can be 
assessed through ribosome profiling. A positive correlation between 5’ leader coverage and main 
ORF TE was reported on transcripts with RP specified uORFs in Saccharomyces 
cerevisiae(Brar, Yassour et al. 2012). This was confirmed in human, mouse, and zebrafish 
datasets(Chew, Pauli et al. 2016). This purports that in order to detect these lower frequency 
events on transcripts, translation of the entire transcript needs to be higher overall. However, the 
translational efficiency of CDS coding regions in uORF-bearing transcripts are decreased 
relative to transcripts lacking a uORF(Chew, Pauli et al. 2016, Johnstone, Bazzini et al. 2016). 
Interestingly, there may be a dose-dependent effect where an increasing number of uORFs are 
associated with a decrease in the overall CDS TE(Chew, Pauli et al. 2016, Johnstone, Bazzini et 
al. 2016). The extent to which 5’ leader translation is actually responsible for the decrease in 
CDS TE remains controversial. For example, inducing oxidative stress in yeast with hydrogen 
peroxide treatment lead to a significant enrichment of overall ribosome density in 5’ leaders of 
1,800 transcripts(Gerashchenko, Lobanov et al. 2012). Interestingly, the majority of the 5’ leader 
regions exhibiting an increase in ribosome occupancy were devoid of AUG codons. This 
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conditional change in 5’ leader density was then compared to the change of CDS translation of 
those affected transcripts, showing no real directional correlation between the 
two(Gerashchenko, Lobanov et al. 2012). While a subset of transcripts do show an opposing 
change in main ORF translation when their uORFs are increasingly translated, the global 
contribution of uORF translation appears to be more indirect. Andreev et al. (2015) utilized 
HEK293T cells to investigate the translational effects of sodium arsenite, which leads to 
oxidative stress and eIF2α phosphorylation (Andreev, O'Connor et al. 2015). They confirmed a 
decrease in global protein synthesis with ATF4, ATF5, and SLC35A4 showing a paradoxical 
increase in RPF coverage. Additionally, reporter studies combined with RP demonstrated that a 
subset of transcripts with uORFs show only a slight decrease in translation relative to the global 
decrease, suggesting that uORFs can confer partial resistance to eIF2 repression(Andreev, 
O'Connor et al. 2015). This work was insightful because it suggested that uORF regulation of 
CDS translation can be subtle in its impact.  
Additionally, the start codon utilized by uORFs may be important to analyzing their 
overarching role. Spealman et al. (2017) identified AUG and NCC-initiated uORFs in three yeast 
strains. While main ORFs on transcripts with AUG-initiated uORFs had significantly decreased 
TE, ORFs on transcripts with NCC-initiated uORFs had increased translation(Spealman, Naik et 
al. 2017) . Sendoel et al. (2017) investigated which translation factors can promote a shift to 
more upstream translation during tumor initiation (Sendoel, Dunn et al. 2017). This study 
showed that mRNA translation during tumor induction was independent of the canonical eIF2 
ternary complex. Interestingly, most of the uORFs detected were believed to be NCC initiated, 
and 13 were found to produce stable peptides. Mindful of the role of eIF2A in promoting uORF 
translation, they determined a role for this factor in regulating protein synthesis during the 
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formation of tumors (Starck, Tsai et al. 2016, Sendoel, Dunn et al. 2017). Importantly, when 
eIF2A dependence is furthered by stress induction and the phosphorylation of eIF2α, they 
detected increased protein products by mass spectrometry from transcripts with eIF2A-targeted 
uORFs(Sendoel, Dunn et al. 2017). This highlights a positive correlation between uORF and 
main ORF translation, when the uORFs are mostly non-AUG initiated. The role for eIF1 was 
also examined globally by ribosome profiling, and revealed how translational machinery can add 
to the levels of uORF regulation by affecting start site stringency(Fijalkowska, Verbruggen et al. 
2017). During eIF1 knockdown, increased translation at uORFs with NCC start sites was 
associated with a lower relative CDS TE, conversely AUG initiated uORFs exhibited a decreased 
TE while their associated CDS increased in translation (Fijalkowska, Verbruggen et al. 2017). 
Taken together, these studies purport a complex role for uORFs in CDS regulation, and suggest 
that cell type and cellular conditions may change the relationship of a uORF to its associated 
transcript.  
Experiments in mouse embryonic fibroblasts revealed that ribosome profiling can be used 
to dissect the role of uORFs in affecting RNA stability. RP was used to identify actively 
translated uORFs in cells that had been treated with shRNA to knockdown UPF1 and prevent 
NMD (Hurt, Robertson et al. 2013). Only uORFs contained fully within the 5’ leader were used 
in the analysis, those that overlap the CDS were excluded. Transcripts with actively translated 
uORFs showed a cumulative increase in abundance in the UPF1 knockdown cells verses control, 
suggesting that these transcripts are de-repressed when NMD is precluded(Hurt, Robertson et al. 
2013). A similar result was suggested in uORF- and overlapping uORF-bearing transcripts in 
zebrafish, which cumulatively show decreased RNA abundance relative to transcripts without 
these features(Johnstone, Bazzini et al. 2016).  
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Transcript leaders influence uORF translation 
Alternative transcript leaders impart an important level of regulation that dictates the 
potential role of a uORF on a transcript. The inclusion of a translation start site or the placement 
of the next in frame stop codon may be dictated by alternative splicing in the 5’ leader as well as 
alternative transcription start sites. TIF-seq uses a modified library preparation and deep 
sequencing to identify the most 5’ and 3’ end of capped and polyadenylated mRNA 
transcripts(Pelechano, Wei et al. 2013). The implementation of TIF-seq in Saccharomyces 
cerevisiae revealed significant isoform heterogeneity with 80% of transcripts having a median of 
10 major isoforms. Interestingly, of the 1,191 transcripts with uORFs identified, 703 had 
multiple isoforms where the uORF was excluded which may contribute to overall downstream 
CDS translation levels(Pelechano, Wei et al. 2013). Arribere et al. (2013) performed a modified 
library prep for identification of transcript leaders and deep sequencing on mRNA that sediment 
with different fractions of a polysome gradient(Arribere and Gilbert 2013). Gradient fractions 
represent a range of mRNA translation from low (unbound by ribosomes) to high (bound by 
polysomes. When analysis was limited to transcripts with AUG initiated uORFs, these were 
enriched outside of the polysome fractions suggesting lower translation(Arribere and Gilbert 
2013). However, this was not observed for transcripts bearing uORFs with a NCC initiation site 
supporting the idea of distinct roles associated with these two categories of uORFs.  
 
Detection of uORF-derived peptides 
Active translation as characterized by ribosome profiling has revealed an abundance of 
noncanonical ORFs. Detection of stable products synthesized from these regions has been less 
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robust even for the well-defined uORF on GCN4 (Zhang and Hinnebusch 2011). To detect 
proteome-wide short ORF-encoded peptides, one study inspected all peptides larger than 8 
amino acids detected by LC-MS/MS in human K562 cells(Slavoff, Mitchell et al. 2013). Tryptic 
peptides—independent of annotated protein derivatives—were mapped to RNA-sequencing data, 
and counted if they could be mapped to a discrete, unannotated region of RNA with a potential 
ORF less than 450 nucleotides in length. 90 short ORF-encoded peptides were identified, 40% of 
which were predicted to reside in a 5’ leader(Slavoff, Mitchell et al. 2013). Only 43% of the 
entire set was expected to initiate at an AUG, lending credence to the potential production of 
stable peptides from NCC start sites. Another study took a different approach by enriching for 
the N-terminus of proteins using terminal amine isotopic labeling of substrates (TAILS) with 
LC-MS/MS in HEK293 cells(Na, Barbhuiya et al. 2017). This method identified 90 peptides 
derived from 5’ leaders, 69% were N-terminal extensions and 31% were derived from uORFs. 
Of the peptides detected, only 2% of N-terminal extensions and 11% of uORFs were expected to 
utilize an AUG start codon. However, nearly all of these initiated using a methionine amino acid 
in the first position (Na, Barbhuiya et al. 2017). These two studies highlight how proteomics can 
be utilized to investigate synthesis of 5’ leader derived products. However, it is key to note that 
uORF translation occurs at lower frequency than CDS translation, and shorter peptides may not 
remain stable for detection by mass spectrometry.  
 
uORFs in the nervous system 
Learning and memory requires dynamic changes in synaptic structure and function in 
response to extracellular stimuli. Many of these changes rely on translation of mRNA transcripts 
localized to synapses (Santini and Klann 2014). In particular, synaptic potentiation requires 
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precise spatial and temporal control by key translation factors. Hippocampal dependent learning 
requires synapses to undergo a form of plasticity elicited by group I metabotropic receptor 
(mGluR) activation termed long-term depression (LTD), which is a downscaling of synaptic 
strength dependent on new protein synthesis (Santini and Klann 2014). Pharmacological 
stimulation of group I mGluRs and induction of LTD increases eIF2α phosphorylation(Di Prisco, 
Huang et al. 2014). LTD can also be induced by salubrinol, which pharmacologically prevents 
the dephosphorylation of eIF2α (Di Prisco, Huang et al. 2014). Intruigingly, uORFs are more 
readily translated after pharmacological mGluR activation. A key neuronal transcript, OPHN1, 
contains uORFs that regulate its expression, and OPHN1 was required for proper LTD (REF). 
eIF2α phosphorylation has also been shown to play a role in a distinct form of synaptic 
potentiation, long term potentiation (LTP), in response to persistent cocaine injections in mice 
(Huang, Placzek et al. 2016). Additionally, multiple uORFs are suspected to reside in the 
transcript of protein kinase Mζ, a key factor in LTP maintenance (Ling, Benardo et al. 2002, Bal, 
Susorov et al. 2016). These data suggest that in the nervous system, a niche of uORF-containing 
transcripts may play a role in responding to the ever-changing microenvironment of individual 
neurons.  
 
Nucleotide Repeat Disorders 
Microsatellites are repetitive DNA elements that exist across the genome. These elements 
are inherently polymorphic in nature due to instability leading to expansion or contraction that 
can occur both somatically and intergenerationally (Lopez Castel, Cleary et al. 2010, McMurray 
2010). The expansion of diverse sequences in coding and noncoding regions of genes is a 
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common cause of neurodegenerative disorders from ALS to myotonic dystrophy, all associated 
with a diverse set of outcomes (Paulson 2018).  
Disease causing repetitive elements are traditionally categorized into three groups: 
dominantly inherited repeats within protein coding sequences, dominantly inherited repeat 
expansions outside of known protein coding sequences, and recessive or X-linked repeat 
expansions that impact the expression of the genes in which they reside.  Most of the repeats 
present within protein coding exons are trinucleotide CAG repeats encoding for glutamine. 
These polyglutamine diseases include Huntington’s Disease, spinal and bulbar muscular atrophy 
(SBMA), and several spinocerebellar ataxias (SCA). The mechanism thought to drive pathology 
in these dominantly inherited diseases is translation of the CAG repeat into an expanded 
polyglutamine tract. The resulting Polyglutamine-containing proteins aggregate and place a 
proteotoxic burden on cells (La Spada, Wilson et al. 1991, Trottier, Devys et al. 1995, Trottier, 
Lutz et al. 1995, Bates 1996, Paulson 2018). However, these dominantly inherited diseases are 
clinically diverse, suggesting a specific interaction between the polyglutamine expansion and the 
genes/proteinsin which these mutations arise.  
Nucleotide repeat expansion mutations can also result in RNA mediated toxicity, with 
DM1 as the stand-out example. In DM1, a CTG repeat resides in the 3’ UTR of the DMPK gene. 
This mutation does not meaningfully alter the abundance of DMPK, rather it causes RNA foci 
formation and sequestration of key proteins (Pettersson, Aagaard et al. 2015). Specifically, 
Muscleblind-like (MBNL) proteins, an important family of splicing factors, binds avidly to 
double-stranded CUG repeats. This sequesters these proteins into RNA foci and precludes them 
from performing their normal functions. In the case of MBNL sequestration, this leads to 
accumulation of misspliced transcripts normally regulated by MBNL (Miller, Urbinati et al. 
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2000, Mankodi, Urbinati et al. 2001, Jiang, Mankodi et al. 2004). Patients with DM1 experience 
progressive weakness and myotonia, and this can be recapitulated in mice by either 
overexpressing the CUG repeat out of its native gene context or by knocking out MBNL1 
(Paulson 2018). Moreover, overexpression of MBNL1 is sufficient to suppress CUG repeat 
associated phenotypes in muscle (Kanadia, Shin et al. 2006). 
Nucleotide repeat expansions can also elicit a loss of function in the genes in which they 
reside.  Friedreich’s ataxia results from a GAA repeat expansion in an intron of the FRDA gene 
which encodes frataxin. Friedreich’s ataxia is the most common autosomal recessive ataxia, 
characterized by early onset ataxia with sensory loss, aggressive scoliosis, and 
cardiomyopathy(Paulson 2018). In Friedreich’s ataxia, GAA repeat expansions lead to a change 
in the epigenetics of the FRDA locus that strongly suppresses the mRNA transcription 
(Campuzano, Montermini et al. 1996). This leads to a partial, but not complete loss of FRDA 
mRNA and Frataxin protein. This results from loss of function of frataxin, leading to impaired 
mitochondrial function and Iron homeostasis (Akbar and Ashizawa 2015). Unlike the dominant 
disorders described above, Friedreich’s ataxia requires expansion or mutations in both FRDA 
alleles, and the size of the repeat correlates inversely with the degree of mRNA expression and 
the severity of the clinical phenotype (Castaldo, Pinelli et al. 2008). 
 
The Genetic basis of Fragile X Syndrome and Fragile X-associated Disorders 
The gene FMR1 contains a polymorphic CGG repeat in its 5’ leader. This repeat is 
conserved among mammals, and increases in size in higher order primates(Eichler, Kunst et al. 
1995). In humans, this CGG element can expand to intermediate or “premutation” lengths of 
between 55 and 200 repeats. When this occurs, there is an enhancement in FMR1 transcription, 
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but inefficient Fragile X protein (FMRP) production (Tassone, Hagerman et al. 2000). Clinically, 
this results in the neurodegenerative disorder Fragile X-associated Tremor/Ataxia Syndrome 
(FXTAS) (Hagerman 2013). FXTAS occurs in ~1:5000 men over the age of 50 and in a lower 
percentage of female premutation carriers. In addition, premutation sized repeat expansions also 
cause premature ovarian failure, or Fragile X-associated Premature Ovarian Insufficiency 
(FXPOI), which is the most common genetic cause of early menopause. In both cases, the repeat 
is thought to elicit disease primarily through a gain-of-function mechanism, as manipulating 
FMRP expression is unable to modulate phenotypes associated with the repeat in model systems 
(Arocena, Iwahashi et al. 2005, Jin, Duan et al. 2007, Hashem, Galloway et al. 2009, Lu, Lin et 
al. 2012). 
In contrast to FXTAS and FXPOI, Fragile X Syndrome (FXS) results from expansion of 
CGG repeats in FMR1 to greater than 200 CGGs. This leads to hypermethylation of the promoter 
region and the CGG repeats leads to heterochromatization of the FMR1 locus. Akin to the 
scenario that occurs in Freidriech’s Ataxia, this epigenetic change leads to a partial or complete 
transcriptional shut off of the FMR1 locus (Wang, Berry-Kravis et al. 2010). The end result is 
loss of FMRP. FXS is the most common known monogenic cause of autism and intellectual 
disability. Patients also have increased rates of attention deficit hyperactivity disorder (ADHD) 
and epilepsy. FXS affects upwards of 1:5000 males and 1:4000-1:8000 females worldwide 
(Hagerman, Berry-Kravis et al. 2017).   
The threshold at which DNA methylation and transcriptional silencing of the FMR1 locus 
occurs has recently been questioned based on studies in patient derived induced pluripotent stem 
cells and human embryonic stem cells (Sciascia and Usdin , Avitzour, Mor-Shaked et al. 2014). 
Data in these lines suggest that repeats between 400 and 200 repeats becomes incompletely	
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methylated at the FMR1 locus (Sciascia and Usdin). While larger repeats are associated with 
silencing chromatin modifications, lines that retract in repeat size loose these modifications. This 
is important because the absolute cutoff of repeat size for disease phenotype is not the complete 
picture of patients with Fragile X disorders. The FMR1 locus exhibits significant mosaicism in 
terms of both repeat length and methylation status within individuals with FXS. Mosaicism 
occurs in ~40% of Fragile X cases, and is associated with an increase in both FMR1 mRNA and 
FMRP (Nolin, Glicksman et al. 1994, Jacquemont, Birnbaum et al. 2011, Pretto, Yrigollen et al. 
2014). Generally, FMRP levels positively correlate with IQ, and percent methylation is inversely 
correlated with IQ (Pretto, Yrigollen et al. 2014). While this would suggest that mosaic 
individuals have a more favorable prognosis, case studies reveal a range of severity in these 
cases from unaffected to full Fragile X Syndrome (Wohrle, Salat et al. 1998, Santa Maria, Pugin 
et al. 2014, Basuta, Schneider et al. 2015).  
FXTAS and FXS are traditionally viewed as clinically separate disorders. FXS patients 
begin displaying abnormalities during infancy, and by the age of two they exhibit delayed 
development of language, hyperactivity, and sensitivity to sensory stimulation (Hagerman, 
Berry-Kravis et al. 2017). Patients may have distinguishing physical features such as large ears 
and a long face. FXS patients may have a number of different behavioral and cognitive issues 
such as attention-deficit/hyperactivity disorder (ADHD), learning disabilities, intellectual 
disability, and/or autism.  
In contrast, FXTAS affects males with an average age of onset of 60.6 years of age. 
Patients with FXTAS may exhibit intention tremor, parkinsonism, cerebellar ataxia, and 
cognitive decline (Hagerman and Hagerman 2016).  Imaging studies reveal white matter 
abnormalities, as well as a reduction in volume of the brain stem and cerebellum (Hashimoto, 
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Javan et al. 2011, Hashimoto, Srivastava et al. 2011). Neurons exhibit the formation of both 
RNA foci and ubiquitinated inclusions in the brains of patients (Renoux and Todd 2012).   
Most premutation repeat carriers have a normal neurodevelopmental trajectory in 
childhood and early adulthood. However, early in life, some premutation carriers experience 
symptoms ranging from migraines, to insomnia and anxiety and in rare cases autism and learning 
disabilities (Hagerman 2013). Similarly, most patients with FXS do not develop this late-onset 
motoric difficulties or premature ovarian failure as in FXPOI, although they do have increased 
rates of movement disorders and stereotypies (Wheeler, Bailey et al. 2014).  The mechanisms 
underlying the differential phenotypes of neurodegeneration in FXTAS and neurodevelopmental 
abnormalities in FXS will be further discussed in the following sections. 
 
Molecular mechanisms associated with Fragile X-associated disorders 
FMRP is expressed throughout the body, however its expression is highest in brain and 
testis. In the mouse brain, FMRP is expressed in neurons throughout development and adulthood, 
and is present in glia early but is largely absent from these cells in the adult brain (Gholizadeh, 
Halder et al. 2015). Most studies of Fragile X Syndrome in mice have relied on an FMR1 knock-
out model, as hypermethylation and transcriptional silencing in the setting of expanded repeats is 
not recapitulated in mice with 300+ CGG repeats. Knock-out mice exhibit a range of phenotypes 
such as increased locomotion, learning difficulties, seizure sensitivity, and anxiety in behavioral 
assays (Hagerman, Berry-Kravis et al. 2017). There have been many avenues of research into the 
molecular consequences of this loss of FMRP, but the two areas of consensus are impairments in 
glutamatergic and GABAergic signaling.  
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The first evidence of glutamatergic signaling impairment came from electrophysiological 
studies in the Fragile X knock-out model. Hippocampal recordings from these mice showed 
enhanced mGluR-induce long-term depression (LTD), a form of plasticity that relies on post-
synaptic protein synthesis (Huber, Gallagher et al. 2002). In addition, morphological analysis of 
knock-out neurons revealed dendritic spine abnormalities including increased length and density, 
suggesting impaired maturation (Irwin, Patel et al. 2001, Nimchinsky, Oberlander et al. 2001). 
This spine morphology abnormality and enhanced LTD is likely due to changes in dendritic 
protein synthesis in FXS model mice. FMRP is an RNA binding protein that associates with and 
stall ribosomes on its associated transcripts (Brown, Jin et al. 2001, Darnell, Van Driesche et al. 
2011). In the absence of FMRP, it is thought that three signaling cascades converge to enhance 
global dendritic protein synthesis (Richter, Bassell et al. 2015). These three cascades, mediated 
through PI3K, ERK, and mTORC1, are all triggered by mGluR stimulation, and all converge on 
translation initiation machinery to promote protein synthesis. Drugs targeting any of these 
pathways rescues several phenotypes in the FMR1 knock-out mice (Dolen, Osterweil et al. 2007, 
Michalon, Sidorov et al. 2012, Gross, Chang et al. 2015, Gross, Raj et al. 2015, Richter, Bassell 
et al. 2015). 
FMRP is also thought to regulate its own translation. Upon mGluR stimulation, FMRP is 
rapidly degraded, allowing for activity dependent translation of the transcripts now freed from its 
repression. However, the FMR1 mRNA is present in dendrites and mGluR activation also 
triggers local synthesis of FMRP (Weiler, Irwin et al. 1997, Todd, Mack et al. 2003). It is 
thought that newly synthesized FMRP can then rebind to transcripts to turn off translation (Hou, 
Antion et al. 2006, Nalavadi, Muddashetty et al. 2012). Without FMRP, transcripts undergo 
higher basal levels of translation, but also exhibit a loss of mGluR stimulation-dependent 
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translation. The end result is that, in the absence of FMRP, mGluR stimulation leads to enhanced 
LTD that no longer requires temporally associated protein synthesis (Huber, Gallagher et al. 
2002, Bear, Huber et al. 2004).  
While the downstream effects of glutamatergic signaling are upregulated, GABAergic 
signaling is decreased in FMR1 knock-out mice, and GABAergic agonists rescue many 
behavioral phenotypes in these mice (Hagerman, Berry-Kravis et al. 2017). Based on these 
studies, the altered synaptic physiology described is thought to underlie the cognitive and 
behavioral deficits associated with FXS. Drugs targeting both glutamatergic and GABAergic 
signaling have been the subject of several clinical trials. However, these trials have thus far 
failed to meet their primary endpoints in patients, despite some subjective improvements in 
behaviors in FXS children (Erickson, Davenport et al. 2017). This highlights the importance of 
continued mechanistic research into the causes of FXS. Importantly, these disappointing 
outcomes purport that novel models of FXS may be necessary to ensure that findings are more 
translatable, and that targeting the proximal event in pathogenesis, loss of the FMRP, may be 
needed to achieve phenotypic correction in humans.  
 
RAN Translation and Neurodegeneration 
Microsatellites are capable of forming stable structures in RNA. While this can confer a 
toxic gain of function through direct binding with proteins(Todd and Paulson 2010, Renoux and 
Todd 2012), it was recently discovered to also support a newly recognized mechanism of 
translational initiation. This process is termed repeat associated non-AUG (RAN) translation, 
whereby toxic homopolymeric peptides are synthesized in the absence of an AUG start codon, in 
the presence of an expanded microsatellite (Kearse and Todd 2014, Green, Linsalata et al. 2016).  
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This was discovered by Zu et al. (2011) through work on the spinocerebellar ataxia 8 (SCA8) 
gene transcript, ATXN8, which contains a CTG repeat in in its 3’ UTR that is transcribed into 
both sense and antisense transcripts (Zu, Gibbens et al. 2011). The antisense transcript from 
ATXN8 (ATXN8OS) contains a short AUG-driven ORF encompassing the CAG repeat. The 
surprise came when removal of the AUG or placement of stop codons just upstream of the repeat 
did not preclude synthesis of the product polyglutamine product. In contrast,  translation 
persisted in all three reading frames of the repeat producing polyalanine and polyserine products 
in addition to a non-AUG initiated polyglutamine protein (Zu, Gibbens et al. 2011). The 
polyglutamine product was found to accumulate in cerebellar Purkinje cells of SCA8 patients. 
Central to this work was the finding that RAN translation of all three products increased with 
repeat size, and that replacement of the CAG repeat with CAA prevented RAN translation in all 
three frames (Zu, Gibbens et al. 2011).  Similarly, polyglutamine, polyalanine, and polyserine 
products were detected in the context of the antisense DM1 transcript (in the CAG orientation), 
where deletion of the only in-frame AUG (for polyserine) did not remove the signal. 
Polyglutamine aggregates were detected in myoblasts, skeletal muscle, and blood of DM1 
patients (Zu, Gibbens et al. 2011). Since this initial finding, RAN translation has been described 
in a variety of other nucleotide repeat expansion disorders, including genes such as C9orf72 
(ALS/FTD) and HTT (Huntington’s Disease), along with several (but not all) of the 
spinocerebellar ataxia genes (Ash, Bieniek et al. 2013, Mori, Weng et al. 2013, Banez-Coronel, 
Ayhan et al. 2015, Green, Linsalata et al. 2016).  
The FMR1 CGG repeat was also found to support RAN translation in all three potential 
reading frames on the sense strand in the absence of an AUG (Todd, Oh et al. 2013, Krans, 
Kearse et al. 2016), albeit with differing efficiencies. RAN translation also occurs at CCG 
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repeats generated by antisense transcription through the beginning of the FMR1 gene (Krans, 
Kearse et al. 2016). Distinct from what was described in ATXN8, RAN translation in two of the 
three potential reading frames of the  5’ leader of FMR1 relies on initiation at NCC start codons 
just upstream of the repeat (Todd, Oh et al. 2013, Kearse, Green et al. 2016). On the sense 
strand, the 0-frame RAN initiation event uses a GUG initiation site, and the +1-frame uses both 
an ACG and a GUG for initiation (Figure 1.4) (Todd, Oh et al. 2013, Kearse, Green et al. 2016). 
Peaks upstream of the repeat were detected in RP datasets from mouse and man (Todd, Oh et al. 
2013). Interestingly, an earlier study found that the Drosophila homologue to FMR1, dFMR1, 
encodes for a functional N-terminal extension that initiates at a CUG start site (Beerman and 
Jongens 2011). In CGG RAN translation, the +2-frame does not appear to rely on a start codon 
upstream of the repeat, making it more akin to what is observed at CAG repeat expansions with 
initiation occuring within the repeat (Kearse, Green et al. 2016). Interestingly, both the +1-frame 
and +2-frame products increase as a function of increased repeat size, and 0-frame RAN 
translation is attenuated at normal and expanded repeat lengths (Todd, Oh et al. 2013, Kearse, 
Green et al. 2016). Kearse et al. (2016) showed that translation of RAN reporter transcripts 
requires a functional 5’ cap and interaction with the cap-binding protein eIF4E, and that blocking 
eIF4A, the helicase critical for PIC scanning, significantly impaired RAN translation(Kearse, 
Green et al. 2016). These data point to a canonical scanning mechanism of translation initiation 
at the CGG repeat, with a primary failure in start codon fidelity leading to RAN initiation. 
Intriguingly, under ER stress and phosphorylation of eIF2α, CGG RAN translation of the 
+1- and +2-frames increases despite the global decrease in translation (Green, Glineburg et al. 
2017). This increase was dependent on the presence of an NCC start site, and was also observed 
in the ALS/FTD GGGGCC repeat (Green, Glineburg et al. 2017, Cheng, Wang et al. 2018).  
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Figure 1.4:  
 
FMR1 RAN translation initiates at near cognate start sites, in all three frames. The +1-frame RAN peptide, 
FMRpolyG, is synthesized starting with an ACG or GTG codon. The 0-frame product, FMRpolyR, is an N-terminal 
extension that initiates at an ACG. The +2-frame initiates within the repeat, producing FMRpolyA.   
 
Importantly, expression of either expanded CGG or GGGGCC repeats induced stress granule 
formation in cells, which is dependent on eIF2α phosphorylation (Green, Glineburg et al. 2017, 
Cheng, Wang et al. 2018). Taken together, these data support the notion of a feed forward 
mechanism of toxicity whereby RAN translation is upregulated in the presence of stress, and also 
themselves can independently induce stress, creating a feed-forward loop. 
 Aggregates of the +1 CGG RAN peptide, FMRpolyG, occurs in mouse models of the 
disease and, importantly, in patients with FXTAS (Todd, Oh et al. 2013, Sellier, Buijsen et al. 
2017). FMRpolyG aggregates are also identified in ovarian stromal cells from FXPOI patients 
(Buijsen, Visser et al. 2016). In FXTAS and FXPOI patients, these aggregates are ubiquitinated. 
Driving expression of FMRpolyG causes impaired proteasome function in model systems (Oh, 
He et al. 2015). Nuclear lamina integrity is also affected in FMRpolyG expressing cells, and 
FMRpolyG has been shown to interact directly with the inner nuclear membrane protein Lap2ß 
(Sellier, Buijsen et al. 2017). In mice, whole body expression of the FMRpolyG transgene 
impacts motor function and survival. Driving expression of the transgene in neurons decreases 
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survival, and alters body composition. These data provide evidence for RAN-associated toxicity 
in FXTAS. 
Two other nucleotide repeat expansion disorders where RAN translation may contribute 
to overall pathology are Huntington’s Disease (HD) and C9Orf72 ALS/FTD. HD is a 
polyglutamine disease caused by CAG repeat expansions in the coding region of HTT, the 
Huntingtin gene. Patients generally exhibit involuntary movements and cognitive decline (1993, 
Dickey and La Spada 2017). Individuals with larger expanded repeats are prone to earlier onset 
HD, linking the severity of HD to a generational effect (Andrew, Goldberg et al. 1993, Paulson 
2018). While the polyglutamine containing protein defines the pathology of this disease, Banez-
Coronel and colleagues (2015) showed that it is not the only homopolymeric expansion protein 
derived from this locus. RAN translation was shown to occur in both the sense and antisense 
direction through the CAG/CTG repeat, despite its residence within a protein coding open 
reading frame. In addition to the polyglutamine product, both poly-serine and poly-alanine 
products (sense) as well as poly-leucine and poly-cysteine products (antisense) were detected 
(Banez-Coronel, Ayhan et al. 2015). Importantly, production of the polyglutamine product 
remains in the absence of AUG, although in the native sequence context this is confounded by 
the presence of both an AUG initiated uORF and a utilized downstream AUG codon also in the 
Polyglutamine frame. In addition to polyglutamine, the four other potential RAN peptides 
accumulate in patient brains, and are increased in abundance in early onset HD (Banez-Coronel, 
Ayhan et al. 2015). HD RAN peptides have been linked to nucleocytoplasmic export disruption 
in neurons (Grima, Daigle et al. 2017). 
ALS (amyotrophic lateral sclerosis) is the most common motor neuron disease, while 
FTD (frontotemporal lobe dementia) is a form of early dementia that generally appears in 
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individuals in their 50s and 60s(Renton, Majounie et al. 2011). Though FTD and ALS are two 
distinct diseases, there is overlap in the patient population. In 2011, expansion of the 
hexanucleotide repeat GGGGCC in the gene C9Orf72 was discovered to be the most common 
known mutation underlying both ALS and FTD (DeJesus-Hernandez, Mackenzie et al. 2011, 
Renton, Majounie et al. 2011). GGGGCC bearing transcripts are transcribed in the sense and 
antisense direction, and the repeat is present in an intron or promoter region of sense strand RNA 
transcripts. RAN translation through this repeat produces five potential dipeptide repeat tract 
proteins—poly-glycine/alanine, -glycine/arginine, -proline/alanine, -proline/arginine, and -
glycine/proline (Ash, Bieniek et al. 2013, Gendron, Bieniek et al. 2013, Mori, Weng et al. 2013, 
Zu, Liu et al. 2013, Green, Linsalata et al. 2016). C9orf72-associated RAN proteins accumulate 
in the brains of patients in aggregates distinct from the TDP-43 positive aggregates classically 
seen in ALS/FTD. Two modes of cellular toxicity linked to the production of the various 
GGGGCC RAN proteins are nucleolar stress and nucleocytoplasmic transport impairment (Wen, 
Tan et al. 2014, Zhang, Donnelly et al. 2015). Several studies have concluded that poly-
glycine/alanine is the most abundant of all GGGGCC RAN proteins followed by the other two 
glycine containing repeat proteins, and that each frame has a different length-dependency 
(Green, Linsalata et al. 2016). GGGGCC RAN translation from linear mRNA transcripts appears 
to mainly depend on cap-binding of eIF4E and a canonical scanning mechanism involving 
eIF4A, similar to what has been reported for CGG repeats (Green, Glineburg et al. 2017, Tabet, 
Schaeffer et al. 2018).  However, GGGGCC RAN can occur to at least some degree without a 
cap and on spliced introns (Cheng, Wang et al. 2018). At least two of the reading frames require 
a near-cognate CUG for initiation, as well as an AGG closer to the repeat (Green, Glineburg et 
al. 2017, Tabet, Schaeffer et al. 2018). The dependency on a single start site for multiple reading 
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frames suggests that frame-shifting may occur; this was previously reported at CAG repeats but 
which was ruled out as a major contributor to the plethora of RAN translation products 
associated this repeat (Zu et al, 2011). Thus, while many nucleotide repeat expansions appear to 
support RAN, the underlying mechanism appear to have significant differences—not only 
between repeats but even in different frames of the same repeat. With so many permutations, 
there is much more research to be done into this novel mechanism of translation, and how RAN 
peptides may lead to toxicity. 
 
Other potential pathogenic mechanisms in FXTAS 
As in myotonic dystrophy, CGG repeat RNA is capable of forming nuclear foci with 
specific RNA binding proteins. Significant efforts have been made to determine if RNA-
mediated toxicity is a source of dysfunction in FXTAS. Initial work focused on a disease 
mechanism very similar to myotonic dystrophy: RNA mediated sequestration of specific 
proteins. CGG repeats form highly structured and repetitive motifs in vitro that could serve as 
scaffolds for binding up RNA binding proteins at high levels, and preventing these proteins from 
functioning elsewhere in the cell (Renoux and Todd 2012). Initial efforts aimed at identifying 
which RNA binding protein is specifically associated with CGG repeats revealed two candidates: 
Pur-alpha and hnRNP A2/B1 (Jin, Duan et al. 2007, Sofola, Jin et al. 2007). Both proteins bound 
CGG repeats in vitro and both were found to modulate CGG repeat-associated toxicity in 
Drosophila. Moreover, mass spectrometry of isolated nuclear aggregates identified over 20 
enriched proteins including the RNA binding proteins MBNL1 and hnRNP A2/B1 (Iwahashi, 
Yasui et al. 2006). A separate group of investigators explored this question using a CGG repeat 
expressed in isolation in cells (Sellier, Rau et al. 2010). This repeat was very toxic and bound to 
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a large group of RNA binding proteins over time, including SAM-68, hnRNP A2/B1, and 
MBNL1. One protein complex in particular was found to associate with CGG repeats both 
directly, specifically and early after expression in cells: the DGCR8-DROSHA complex, which 
are components of the miRNA processing machinery (Sellier, Freyermuth et al. 2013). Activity 
of this complex is reduced in the presence of expanded CGG repeats, and microarray profiling of 
postmortem FXTAS patient brains revealed a global decrease in mature miRNAs (Sellier, 
Freyermuth et al. 2013). Overexpression of DGCR8 increased the viability of cells derived from 
a mouse model of FXTAS. This lends strong evidence to the role of RNA-mediated 
sequestration in driving toxicity in FXTAS.  
An alternative gain of function disease mechanism in FXTAS centers on transcription 
through the CGG repeat, and the propensity for R-loop formation during this process(Hagerman 
and Hagerman 2016). R-loops are nucleic acid structures formed by direct binding of newly 
synthesized RNA to the complimentary DNA at the site of transcription. These are vulnerable 
sites to DNA damage which can trigger the DNA Damage Response (DDR), a signaling pathway 
with a number of outcomes including apoptosis (Jackson and Bartek 2009). There are a number 
of neurodegenerative disorders that DDR is thought to underlie such as spinocerebellar ataxia 
with axonal neuropathy 1 and ataxia with oculomotor apraxia 1(Rass, Ahel et al. 2007). R-loops 
have been suggested to form in at least two other nucleotide repeat disorders, C9Orf72 ALS/FTD 
and Friedreich’s ataxia (Groh, Lufino et al. 2014, Reddy, Schmidt et al. 2014). In FXTAS, R-
loops form in patient cells with a modest effect of increased repeat size, and their formation is 
positively correlated with transcription levels (Groh, Lufino et al. 2014, Loomis, Sanz et al. 
2014). More research on this subject is needed to determine if there is a link between R-loops 
and neuron loss in FXTAS.  
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Some efforts have been made to delineate which of these processes is a driver of toxicity 
in FXTAS.  In Drosophila, sequence changes around the repeat that preclude RAN translation of 
FMRpolyG suppress toxicity whereas inclusion of an AUG codon above the repeat to enhance 
FMRpolyG production enhances toxicity (Todd et al, 2013). Recently, a transgenic mouse model 
of FXTAS was developed with 99 repeats upstream of GFP. In mice where the region 
encompassing the RAN start sites are deleted, survival is comparable to that of wild-type mice 
(Sellier, Buijsen et al. 2017). However, mice with 99 repeats and the full 5’ region show 
significantly decreased survival as well as accumulation of RAN translation products. These data 
suggest that RAN translation, but not RNA mediated toxicity is the driving factor in FXTAS. It 
is likely that not one but all of the proposed mechanisms described above contribute in some way 
to the toxicity that leads to neuronal death in FXTAS.  
 
uORFs as targets for gene therapy 
This diversity of potential disease mechanisms in FXTAS and Fragile X-associated 
disorders coupled with the importance of the product synthesized from FMR1 make developing a 
therapeutic strategy for FXTAS complicated. An ideal therapy would preclude RNA and RAN 
associated toxicity while sparing or enhancing FMRP synthesis.  uORFs serve to regulate protein 
synthesis, and as such are potential targets for manipulation of the main gene product. 5’ leader 
mutations that create or inhibit uORF function have been described in a number of diseases from 
Alzheimer’s Disease to cancer, and many have been postulated to affect main ORF synthesis 
(Barbosa, Peixeiro et al. 2013).  
Recently, an approach was described that utilized cleavage-resistant antisense 
oligonucleotides (ASO) to block uORF translation (Liang, Shen et al. 2016, Liang, Sun et al. 
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2017). In these studies, RNASEH1 was mainly used as the transcript target. When the ASO was 
positioned to target the AUG of the uORF with its three most 5’ bases, so that the ASO targeted 
the upstream AUG and the sequence directly upstream of that AUG, the greatest degree of 
increase in the main ORF was observed in cells. This is independent of mRNA changes. A lesser 
degree of de-repression was observed when moving the ASO so that it was targeting both 
regions upstream and downstream of the start site(Liang, Shen et al. 2016). Mismatches 
introduced into the ASO sequence also limited its function. Though the mechanism by which 
these ASOs function is still in its early phase of discovery, they are believed to act by interfering 
with start site selection of the uORF by the PIC leading to resumption of scanning downstream to 
eventually initiate at the main AUG. Blocking cap-dependent initiation with a small molecule 
that inhibits the function of eIF4F, prevents the ASO-induced increase in downstream 
synthesis(Liang, Shen et al. 2016, Liang, Sun et al. 2017). The helicase DHX29 may play a role 
in resolving the ASO-RNA interaction to allow the PIC to continue scanning downstream of the 
binding site, perhaps via shunting (Liang, Shen et al. 2016).  A separate uORF was targeted on 
the mouse LRPPRC transcript and injected subcutaneously into mice. Detection of the protein in 
liver revealed a maximum ~82% increase in the protein, showing that this effect can be detected 
in vivo (Liang, Shen et al. 2016).   
Tiling stable stem loop regions within the 5’ leader of RNASEH1 with a similar ASO 
approach was also shown to increase downstream protein synthesis. One ASO, 761919, targeted 
a small stem loop leading to a 2-fold increase in RNase H1 protein(Liang, Sun et al. 2017). This 
was independent in changes in mRNA steady state levels, but increased the association with 
RNASEH1 transcript with polysomes indicative of more active translation. Similarly, an ASO 
targeting a stem loop in the 5’ leader of ACP1 increased protein production and increased the 
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association of two cap-dependent initiation factors—eIF4A and eIF2α—with reporter 
mRNA(Liang, Sun et al. 2017). These findings show that uORFs and inhibitory elements can be 
selectively targeted as a means of increasing translation of key proteins, and may be critical to 
developing therapeutics to treat a broad range of disorders. 
 
Perspective and Future Directions 
5’ leaders play important roles in regulating CDS translation across a variety of model 
systems and organisms.  This regulation must strike a delicate balance between insufficient and 
overzealous inhibition of downstream initiation and is dependent on multiple factors, including 
uORF translation, translation initiation factor and helicase availability and RNA structural 
elements. More recently, a focus on non-AUG initiated translation at repeat expansions and at 
uORFs has highlighted the potential roles of these processes in both cellular function and human 
disease. My thesis addresses the relationship between RAN translation, especially at CGG 
repeats, and the broader field of uORFs.  Specifically, I attempt to address the following 
questions:   
1) How common are uORFs in neurons or neuron-like cells?  
2) Do uORFs regulate CDS translation during neuronal differentiation? If so, how?  
3) Is there a non-pathologic function for CGG repeats and RAN translation?   
5) Can we use an ASOs or other methods to selectively block RAN and increase FMRP?  
6) Does preventing RAN rescue neurons from RAN-driven toxicity?  
 
In Chapter 2, I apply ribosome profiling to investigate the role of uORFs in a simplified 
model of neural differentiation. I performed ribosome profiling in both the wild-type and 
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differentiated cells. I found that uORFs are present on over 30% of transcripts, and that 
condition-dependent increases in uORF translation are associated with CDS repression. My data 
points to a mechanism for uORF-mediated inhibition which depends on the degree of translation 
through the uORF in order to scale its downstream repression. In Chapter 3, I investigate CGG 
RAN translation in the FMR1 5’ leader. I hypothesized that RAN translation regulates FMRP 
synthesis under conditions of neuronal activity. My data show that RAN translation inhibits 
FMRP basally, but is needed to allow for activity dependent modulation of FMRP synthesis. In 
the second half of Chapter 3, I took advantage of the ASO strategy described earlier to impede 
uORF translation by targeting the near-cognate start sites utilized for RAN translation. I show 
that targeting RAN in unaffected and patient cells lead to a >50% increase in FMRP abundance, 
and can rescue neurons from RAN-induced cell death. These data point to an endogenous role 
for RAN translation in regulating FMRP, and indicate that targeting RAN initiation may be a site 
for future therapeutic development.  
My thesis contributes to the overall knowledge on how 5’ leaders can modulate protein 
synthesis by establishing guiding principles on which uORFs can be repressive to CDS 
translation, and further clarifying the point that uORFs impart their regulatory role through a 
mechanism directly linked to their own translation. I then expanded our understanding on RAN 
translation and its role in balancing FMRP translation. I show that noncanonical uORFs can be 
taken advantage of as strategy to increase coding sequence translation, and I show that this can 
be potentially beneficial to the Fragile X Related disorders.  
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CHAPTER II 
Conditional translation of upstream open reading frames in a model of neuronal 
differentiation1 
 
Abstract 
Upstream open reading frames (uORFs) initiate translation within mRNA 5’ leaders. 
uORFs can both generate unannotated proteins and impact main coding sequence (CDS) 
translation from the transcripts in which they reside. Ribosome profiling (RP) studies suggest 
that translating ribosomes are pervasive within 5’ leaders across model systems. However, the 
significance of this observation remains unclear. To explore a role for uORF usage in neuronal 
differentiation, we performed RP on undifferentiated and differentiated neuroblastoma cells. 
Using a spectral coherence algorithm (SPECtre), we identify 3,508 uORFs in 31% of 
neuroblastoma transcripts. These uORFs predominantly utilize non-AUG initiation codons and 
exhibit translational efficiencies comparable to annotated coding regions. Among these, a highly 
conserved and consistently translated subset of uORFs is associated with repressed CDS 
translation. Intriguingly, these uORFs demonstrate directional changes in translation with 
differentiation that inversely correlate with cell-state shifts in CDS translation. These findings 
suggest that uORFs can provide a robust and state-dependent mechanism for CDS translation 
regulation during neuronal differentiation. 
																																																								1	This	chapter	will	be	submitted	for	publication	as: Rodriguez,	C.M.,	Chun,	S.Y.,	Mills,	R.E.,	Todd,	P.K. Conditional	translation	of	upstream	open	reading	frames	in	a	model	of	neuronal	differentiation.	
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Introduction 
Alterations in protein expression and abundance are required for successful and stable 
cellular differentiation (Hershey, Sonenberg et al. 2012). While changes in mRNA levels provide 
a partial view of networks driving such cellular changes, differences in translational efficiency 
act as an independent contributor to this process (Brar 2016). Determining ribosomal occupancy 
across the transcriptome through ribosomal profiling (RP) provides is a powerful tool for 
assessing the relationship between mRNA abundance and translational output (Ingolia, 
Ghaemmaghami et al. 2009). In particular, RP in cells and organisms has revealed a detailed 
picture of condition-specific changes in mRNA translation rates in multiple cellular processes 
from meiosis to development (Ingolia, Lareau et al. 2011, Brar, Yassour et al. 2012).  
The 5’ leader (traditionally referred to as the 5’ UTR) of mRNAs are one well-studied 
source of protein synthesis regulation (Kozak 1991, Calvo, Pagliarini et al. 2009, Sonenberg and 
Hinnebusch 2009, Hinnebusch, Ivanov et al. 2016). 5’ leaders can regulate the synthesis of the 
main coding sequence (CDS) product through a variety of mechanisms (Sonenberg and 
Hinnebusch 2009, Hinnebusch, Ivanov et al. 2016). RNA secondary structures can impede 
ribosomal scanning, which decreases access of assembled 40S ribosomal preinitiation complexes 
to CDS initiation sites. Translation can also initiate within 5’ leaders at upstream open reading 
frames (uORFS). In the case of uORFs that terminate after the CDS initiation site (overlapping 
uORFs or “oORFs”), initiation in the 5’ leader directly competes with CDS initiation for 
scanning 40S ribosomes and is thus predicted to be inhibitory on CDS translation. In contrast, 
uORFs that terminate within the 5’ leader and before the CDS initiation site (contained uORFs or 
“cORFs”), ribosomes can potentially reinitiate at the CDS. Thus, cORFs sometimes bypass other 
5’leader regulatory elements and can even provide stimulatory effects on CDS translation, but 
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may be repressive as well. uORF translation can also indirectly influence CDS translation by 
influencing mRNA stability (Rebbapragada and Lykke-Andersen 2009) or through interactions 
of newly synthesized uORF protein products with the translating ribosome (Parola and Kobilka 
1994, Rabadan-Diehl, Martinez et al. 2007). As such, the relationship of each uORF to the 
translation of its cognate CDS can be complex, which in turn makes it difficult to define their 
specific functions and regulation across the transcriptome based on position alone. 
Early ribosome profiling reports demonstrated the surprising finding that ribosome 
protected fragments (RPFs) are highly enriched within 5’ leader regions of mRNAs (Ingolia, 
Ghaemmaghami et al. 2009, Ingolia, Lareau et al. 2011, Brar, Yassour et al. 2012). Since these 
first reports, there have been several studies that investigated 5’ leader translation (Bazzini, 
Johnstone et al. 2014, Ingolia, Brar et al. 2014, Crappe, Ndah et al. 2015, Fields, Rodriguez et al. 
2015, Calviello, Mukherjee et al. 2016, Chun, Rodriguez et al. 2016). These studies revealed 
potential roles for uORFs in circadian clock regulation, organism development, and the cell cycle 
(Brar, Yassour et al. 2012, Janich, Arpat et al. 2015, Johnstone, Bazzini et al. 2016, Blank, Perez 
et al. 2017, Fujii, Shi et al. 2017). For example, AUG initiated uORFs were detected in the 
transcripts of key developmental signaling proteins during murine development (Fujii, Shi et al. 
2017). Homozygous deletion of an AUG initiated uORF in the 5’ leader of PTCH1—which 
encodes the major receptor for SHH signaling—disrupted differentiation of mouse embryonic 
stem cells into neural progenitors (Fujii, Shi et al. 2017). Interestingly, ribosome profiling at 
various time points throughout neuronal differentiation of human embryonic stem cells revealed 
shifts in 5’ leader coverage on a number of transcripts (Blair, Hockemeyer et al. 2017). However, 
these data were not systematically analyzed for active translation and characterization of uORFs, 
and relied solely of RPF reads as a measure translation of the whole 5’ leader. Additionally, few 
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studies to date have included non-AUG initiated uORFs in their analysis (Brar, Yassour et al. 
2012, Fijalkowska, Verbruggen et al. 2017, Spealman, Naik et al. 2017).  
Treatment of human neuroblastoma cells with retinoic acid triggers their exit from the 
cell cycle and their differentiation into a neuron-like cell type (Sidell 1982, Pahlman, Ruusala et 
al. 1984). While many studies have sought to understand genetic changes underlying this 
process, most have focused on transcript-level changes, with evaluation of shifts in protein 
abundance only studied on a case-by-case basis (Hanada, Krajewski et al. 1993, Kaplan, 
Matsumoto et al. 1993, Korecka, van Kesteren et al. 2013, Pezzini, Bettinetti et al. 2017). Here 
we used RP in this simple model system to study the role of uORF activity in regulating protein 
translation during neuronal differentiation. Using a spectral coherence algorithm (SPECtre) and 
stringent dataset filtering, we find that uORFs are present in 31.5% of mRNA transcripts (Chun, 
Rodriguez et al. 2016). The majority of these initiate at near-cognate codons, a subset of which 
were validated experimentally. By filtering our dataset further, we identified a subset of uORFs 
which demonstrate conditional expression and an inverse relationship with the translational 
efficiency of their cognate CDS across cell states. Taken together, our work expands on 
established observations by building a set of principles which can be used to determine the 
translatability of a 5’ leader and its potential for affecting CDS translation, while detailing the 
translational changes in a model of neuronal differentiation.  
 
Results 
SH-SY5Y cells are terminally differentiated into a neuronal cell population with RA 
We first confirmed the efficacy of RA treatment in differentiating SH-SY5Y cells. Cells 
were propagated to 80% confluency prior to 10µM RA treatment for six days (Figure 2.1A). RA  
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Figure 2.1: 
Retinoic acid treatment induces neuronal differentiation of SH-SY5Y cells. A) Schematic of experimental 
design and data acquisition work-flow. B) Immunocytochemistry performed on Non-Diff and RA-Diff SH-
SY5Y cells confirmed the shift to a neuronal phenotype with RA treatment. Immunocytochemistry was 
performed with antibodies against neurofilament (red) and β-actin (green). Nuclei were DAPI stained (blue). 
C) β-actin expression was decreased in RA-Diff cells. Individual cell fluorescence was quantified and 
represented as a corrected total cell fluorescence (CTCF) for β-actin; n=119 for Non-Diff and n=118 for RA-
Diff. D) Primary neurite length measured by neurofilament staining was increased by RA treatment; n=109 for 
Non-Diff and n=100 for RA-Diff. E) Western blot showing an increase in FMRP after RA treatment, 
quantified in F); n=4 for both conditions. For panels C), D), and F) Student’s t test, ****p≤0.0001. Graphs 
represent mean ± S.E.M. G) Differential mRNA abundance based on Non-Diff versus RA-Diff TPM. 
Transcripts were defined as significantly up-regulated (cyan) or down-regulated (gold) in the RA-Diff 
A.
grow cells to ~80% confluency
ribosome profilingmRNA seq
RA Differentiation (6 days)
B.
RA
 D
iff
Neurofilament β-Actin DAPI Composite
No
n-
Di
ff
+CHX or
+HARR/CHX experimentation
and
validation
AAAAA
AAAAA
AAAAA
0
50
100
150
200
Cy
top
las
mi
c β
-A
cti
n
****
C.
Pr
im
ar
y n
eu
rite
 le
ng
th 
(μ
m) ****
0
10
20
30
40
50
No
n-D
iff
RA
 Di
ff
WB:GAPDH
WB: FMRP
No
n-D
iff
RA
 Di
ff
****
0
100
200
300
FM
RP
:G
AP
DH
D. E. F.
Change with RA
differentiation:
+
+
+
UP
STATIC
DOWN
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
++++
+
+
+
+
+
+ +
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
++
+
+
+
+
+
++
+
+
+
+
+
++
+
+
++
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+ +
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+++
+
+
+
+ +
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
++ +
+
+
+ +
++
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
++ +
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
++
+
+ +
+
+
+ +
+
+
+
+ +
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
++
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
++
+
+
+ +
+
+
+
+
+
+
+
+
+
++ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ ++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
++
+
+
+
+
+
+
++ +
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+ +
+
+
++
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
++
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
++
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+ +
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+ +
+
++
+
+
+
+
+
++
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
++
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
++
+ +
+ +
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
++
+
+
+ +
+
+
+
+
+
+
+
+
+ +
+
+ +
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+ +
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+ +
+
+
+ +
+
+
+
+
+
+
+
+
++ ++
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-5
0
5
10
15
-5 0 5 10 15
Lo
g2
(R
A 
dif
f)
Log2(Non-diff)
mRNA
G.
-10*Log10(p-adjusted)
Mitotic cell
cycle process
Cell cycle 
process
Cell cycle
Mitotic cell
cycle
Nuclear
division
DO
W
N 
in 
RA
 D
iffe
re
nti
ate
d
0 20 40 60 80 100
H. I.
0 20 40 60 80 100
UP
 in
 R
A 
Di
ffe
re
nti
ate
d
-10*Log10(p-adjusted)
Signal 
transduction
Cell 
communication
Single organism 
signaling
Signaling
Response to 
stimulus
Biological ProcessBiological Process
No
n-D
iff
RA
 Di
ff
No
n-D
iff
RA
 Di
ff
		
61	
condition based on rank-change in abundance compared to the Non-Diff condition. Significantly enriched up-
regulated gene sets (biological process) in RA-Diff mRNAs (H) and down-regulated gene sets in RA-Diff 
mRNAs (I) based Benjamini-Hochberg multiple testing corrected p-values. Black vertical line denotes a 
corrected p-value cutoff of 0.05.  
 
treatment induces an exit from the cell cycle and a change in cellular morphology. Previous 
studies have used a similar protocol as a model for dopaminergic neuronal differentiation, 
although RA treatment is thought to generate a more immature neuron-like cell than what can be 
achieved from a neural progenitor (Sidell 1982, Pahlman, Ruusala et al. 1984, Kaplan, 
Matsumoto et al. 1993). Cytoskeletal alterations confirm a shift towards a more neuron-like state 
after 6 days of treatment. Cytoplasmic beta-actin immunofluorescence decreased and 
neurofilament labeled neurites increased in length in the differentiated cells (Figure 2.1B-D) 
(Micheva, Vallee et al. 1998, Cheever and Ervasti 2013). We also observed an increase in 
expression of FMRP, a protein involved in neuronal function and translational control that is 
highly expressed in neurons relative to other cell types and tissues (Figure 2.1E-F) (Hinds, 
Ashley et al. 1993).  
Global mRNA sequencing (mRNA-Seq) was performed to determine underlying 
transcriptional differences in undifferentiated (“Non-Diff”) or RA Differentiated (“RA-Diff”) 
cells (Figure 2.1G). Gene ontology analysis revealed downregulation of a network of transcripts 
associated with the biological processes of mitotically active cells in the RA-Diff cells (Figure 
2.1H). In contrast, transcripts comprising biological pathways associated with cell 
communication and stimulus response were upregulated in this condition (Figure 2.1I). GO 
analysis of transcript groups for “cellular compartment” and “molecular function” reveal similar 
changes associated with both conditions (Figure S2.1).  
 
Ribosome profiling detects conditionally regulated translation in neuronal differentiation 
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Figure 2.2: 
Retinoic acid treatment induces differential translation in SH-SY5Y neuroblastoma cells. A) Volcano 
plot of transcripts with differential translation by RPF counts in Non-Diff and RA-Diff cells. Significantly up-
regulated genes (cyan) and down-regulated genes (gold) in RA-Diff cells are defined by an absolute log2-
normalized fold-change cutoff of ±1 (vertical lines), and a multiple testing corrected p-value cutoff of 0.1 
(horizontal line). B) Volcano plot of transcripts with differential translational efficiency by Riborex analysis in 
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Non-Diff and RA-Diff cells. C) Changes in mRNA and RPF abundance across the two conditions was 
evaluated by pre-defined cutoffs of percent change in TPM, and the number of genes that changed as measured 
by one, both, or neither was counted. D) Gene sets (biological process) with significantly down-regulated RPF 
counts in RA-Diff cells. Genes upregulated in RA-Diff cells is shown in (E). The top five biological processes 
with significant change using a multiple testing corrected p-value cutoff of 0.05 (vertical line) are shown on 
the graph. F) Plot shows normalized mRNA reads (grey) and RPF (cyan/gold) over the 5’leader (thin line, 
left), CDS (thick line, middle), and 3’UTR (thin line, right). The axon guidance gene, PLXNA2, is 
representative of a transcript with higher translational efficiency and RPF in the RA-Diff condition. G) DAD1 
is an example of a transcript with consistent mRNA coverage, but an increase in RPFs in the RA-Diff 
condition. 
 
Ribosome profiling can resolve the exact regions of mRNA undergoing translation at 
nucleotide resolution across the transcriptome within a cell population (Ingolia, Ghaemmaghami 
et al. 2009). By comparing ribosomal occupancy within a given transcript in Non-Diff to RA-
Diff cells, we are able to gauge translational differences. This can be accomplished by directly 
measuring the number of ribosome protected fragments (RPFs) that map within a given 
transcript (Figure 2.2A) or RPF abundance can be normalized to mRNA expression in samples 
prepared in parallel as a measure of translational efficiency (TE) (Figure 2.2B). To discern the 
contribution of translation to this cell state shift, we compared the number of transcripts 
exhibiting a change at the level of mRNA (based on mRNA-seq), translation (based on RPF), or 
both across a range of percent changes. About half of all transcripts exhibit some change in one 
of these measures, although most exhibit less than a 50% shift. Intriguingly, the abundance of 
transcriptional and translational changes are comparable, suggesting that both contribute 
significantly to the morphological changes elicited by this shift in cell state (Figure 2.2C).  
To determine if the same classes of genes are impacted at the translational level as those 
which shift transcriptionally, we performed gene ontology analysis. GO analysis of transcripts 
with significantly decreased RPF coverage in the RA-Diff condition were largely associated with 
nuclear function and aligned well with changes at the transcriptome level (Figure 2.2D, Figure 
S2.2A-B). In contrast, transcripts with RPF reads significantly upregulated in the RA-Diff 
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condition revealed changes in pathways associated with development and differed significantly 
from changes detected by mRNA seq (Figure 2.2E, Figure S2.2C-D). Inspection of translational 
efficiency (TE) changes revealed some consistent and some distinct differentiation-associated 
changes (Figure S2.3). The discrepancies between the pathways changed by RPF or TE show 
how these two measures can produce different results. While many of the results align, those that 
do not indicate how translational output is influenced by transcript abundance. As one example, 
the PLXNA2 gene encodes a membrane-bound protein involved in nervous system development 
and axon guidance(Van Vactor and Lorenz 1999). Its mRNA coverage is upregulated upon 
differentiation; however, the increased expression is much greater at the RPF level (Figure 
2.2F), consistent with higher translational output of the functional protein. Other transcripts such 
as DAD1, a factor critical for N-terminal glycosylation with roles in apoptosis and the unfolded 
protein response, exhibit shifts solely at the level of translation (Figure 2.2G) (Kelleher and 
Gilmore 1997). 
 
Characterization and experimental validation of SPECtre-identified uORFs 
We next explored the potential roles of uORFs in RA-induced differentiation. To 
annotate uORF sequences within the 5’ leader of mRNA, we utilized the SPECtre algorithm for 
classifying active regions of translation (Chun, Rodriguez et al. 2016). SPECtre accounts for the 
fundamental attribute of an actively translating ribosome to shift position three nucleotides at a 
time as it synthesizes new peptides and the ability of ribosome profiling to resolve this behavior 
with peaks in read coverage. Our algorithm takes an unbiased approach to scoring all potential 
uORFs from start site to the next in-frame stop codon (Figure 2.3). For each potential uORF, the 
pattern of read coverage within this designated sequence is compared against the pattern of reads  
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Figure 2.3: 
Computational prediction and filtering of upstream-initiated open-reading frames. ORFs were predicted 
from AUG and non-AUG, near-cognate translation initiation sites in the 5’ leader of annotated protein-coding 
genes, and computationally extended to the first termination site encountered in the 5’ leader (upstream-
terminated ORFs) or CDS (overlapping ORFs). Predicted ORFs were then filtered according to a series of 
heuristic filters including: 1) minimum RPF coverage in the 5’ leader, 2) minimum mRNA-seq coverage in 
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CDS, 3) in-frame N-terminal extensions, 4) redundant isoforms, 5) minimum length with optimal RPF 
coverage, 6) sufficient SPECtre signal, and 7) removal of ambiguously annotated protein-coding transcripts. 
 
across all known protein-coding regions in the experimental library. This analysis results in a set 
of experimentally determined scores that are then subjected to a range of transcript-level filters.  
We established a translational threshold based on the distribution of scores in known 
coding genes to establish a minimum SPECtre score needed to classify a region as actively 
coding with a 5% FDR allowed. This results in a highly filtered set of 3,508 transcripts with 
4,954 unique uORFs (Figure 2.3). Of these transcripts, 1,599 contained overlapping upstream-
initiated ORFs (specified as oORFs), 1,438 uORFs fully contained in the 5’ leader (cORFs), and 
471 transcripts had two or more uORFs of either of these two categories (Figure 2.4A). The 
median distance of the uORF initiation site from the CDS is 99 nucleotides (Figure 2.4B). 
uORFs have a mean length of 78 nucleotides, but can span upwards of 500 nucleotides in length 
(Figure 2.4C).  
Previous work using harringtonine, a drug that stalls ribosomes at initiation sites, 
revealed a surprising occurrence of near-AUG codons enriched in ribosome peaks (Ingolia, 
Lareau et al. 2011). Though near-cognate initiation had been recognized previously, this hinted 
that there may be a greater number of initiation events at these codons than previously expected 
(Zitomer, Walthall et al. 1984, Peabody 1987, Kozak 1989, Peabody 1989, Mehdi, Ono et al. 
1990, Ingolia, Ghaemmaghami et al. 2009). When inspecting the translation start site of each 
SPECtre-identified uORF, we too see a number of non-canonical initiation events. Translation 
start sites were plotted to show the relative contribution of each in the final dataset (Figure 
2.4D). AUG initiation sites were accounted for by two different methods: they were either 
directly identified by SPECtre, or factored into the total count if they were present within 30 
nucleotides upstream or downstream of the start of the SPECtre signal without an intervening  
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Figure 2.4: 
Characterization and validation of predicted uORFs. A) The number of genes with at least one predicted ORF 
(bar plot) in the 5’ leader of evaluated protein-coding genes. The number of genes with a predicted ORF terminated 
upstream in the 5’ leader only (left circle), terminated in the CDS only (right circle), or with both a predicted 
upstream- and CDS-terminated ORF (overlap). B) Distribution of predicted ORF translation initiation position 
relative to the annotated protein-coding CDS start site in Non-Diff specific genes (gold), RA-Diff specific genes 
(cyan), and in aggregate (gray). C) Distribution of predicted ORF lengths in Non-Diff specific genes (gold), RA-Diff 
specific genes (cyan), and in aggregate (gray). D) Distribution of uORF translation start sites (TSS). AUG represents 
all AUGs predicted by SPECtre, or upstream/downstream 30-nt from the SPECtre predicted start site if no 
A. B. C.
CDS
uORF Initation to Annotated TIS uORF Length
Nu
mb
er
 of
 G
en
es
No uORF
One or more
TSS
AAG
ACG
AGG
AUA
AUC
AUG
AUU
CUG
GUG
UUG Nanoluciferase5’ leader w/ uORF
GGG X
5’ 3’3xFLAG
in frame with uORF
E.
ARF4
LYRM4
PCBD1
LAMB1
HAND2
AUG
CUG
AGG
ATT
AUG
uORF 
gene
Predicted
start
F.
Nanoluciferase
GGG X
5’ 3’3xFLAG
uORF-nLuc Reporter:
GGG-nLuc Reporter:
AR
F4
DA
D1
PS
AP
LY
RM
4
PC
BD
1
5’ leader-nLuc-3xFLAG
1
10
102
103
-10
log
(u
OR
F:
GG
G-
nL
uc
)
LA
MB
1
HA
ND
2
D.
7.5%
7.4%
21.5%
8.6%
5.7%
2.7%
12.6%
7.5%
21.4%
5.0%
0
200
400
600
800
0 100 200 300 400 500
0
100
200
300
400
500
−500 −400 −300 −200 −100 0
Length
Co
un
t
Distance
Co
un
t
0
2000
4000
6000
8000
10000
3508
7637
15991438 471
median = −99 nt median = 78 nt
G. I.
−12
−8
−4
0
4
−12 −8 −4 0 4
RA
-D
iff
Non-Diff
SPECtre Signal
20
10
0
75
Re
ad
s
mRNA
RPF
Non-Diff: ARF4 (ENST00000303436)
AUG STOP
−268 +0 +807 +1660
uORF
20
10
0
75
Re
ad
s
mRNA
RPF
RA-Diff: ARF4 (ENST00000303436)
37.5
37.5
H.
In
-fr
am
e
+1
 f.
s.
0
25
50
75
100
125
****
nL
uc
 A
cti
vit
y
5’ leader-nLuc-3xFLAG
PC
BD
1
uORF signal up in:
RA-Diff
Both
Non-Diff
oORFcORF
uORFs
		
68	
intervening stop codon is present. Near-cognate start codons are utilized in the majority of uORFs, while AUG is the 
single most common start site. E) Schematic of the uORF nanoluciferase (nLuc) reporters used in this study. GGG-
nLuc serves as a negative control, as its AUG initiation start codon is mutated to a GGG codon. This reporter 
supports very little translation. A table of the predicted start sites for each uORF reporter. F) nLuc assays performed 
in SH-SY5Y cells confirmed expression of these uORFs (teal). 5’ leaders not included in the high-confidence 
dataset (black) are below the GGG-nLuc reporter activity and considered not translated. All values are normalized to 
the GGG-nLuc control performed in parallel during experimentation, data for individual reporters was collected in 
triplicate in multiple experiments. Student’s t test, all teal uORFs in panel. F) have a p value ≤0.0001, and all black 
uORFs have a p value <0.05. Graph represents mean ± S.E.M. G) Plots show mRNA reads (grey) and RPF counts 
(cyan/gold) for ARF4. The annotated uORF is characterized by the presence of consistent RPF coverage in the 5’ 
leader. H) Frameshifting the uORF relative to nLuc decreases translation of the reporter. The reporter was cloned so 
that the nLuc tag was frameshifted (f.s.) out of frame with the predicted uORF and the CDS start site. n=3, Student’s 
t test, ****p≤0.0001. Graph represents mean ± S.E.M. I) K-means clustering analysis of log2(uORF SPECtre Score) 
in Non-Diff and RA-Diff cells, reveals differentiation-associated shifts. Three clusters of CDS regulation emerge: 
those CDS that are up-regulated in RA-Diff cells (cyan), up-regulated in Non-Diff cells (gold), and CDS with no 
change in translational potential (gray).  
 
stop site. Due to the high potential translatability of ORFs with AUG start codons, these were all 
annotated as AUG start sites. This constitutes 21.5% of the initiation sites used. In comparison, 
we detected 21.4% of uORFs use CUG as their initiation codon, consistent with previous reports 
(Peabody 1987, Ingolia, Lareau et al. 2011).  
Detection of uORF derived peptides by mass spectrometry has proven difficult, likely 
due to a range of complications from sample preparation, bias in annotation algorithms, as well 
as intrinsic factors that make these peptides difficult to detect (Bazzini, Johnstone et al. 2014, 
Chugunova, Navalayeu et al. 2018). Several methods have been developed to enhance the 
detection of small peptides, each with variable yields (Slavoff, Mitchell et al. 2013, Bazzini, 
Johnstone et al. 2014, Na, Barbhuiya et al. 2018). Though techniques for detecting 5’ leader-
derived peptides are progressing. For example, by enriching for the N-terminus of proteins using 
terminal amine isotopic labeling of substrates (TAILS) with LC-MS/MS in HEK293 cells, 90 
uORF peptides were detected, and about two-thirds of these were supported by ribosome 
profiling data (Na, Barbhuiya et al. 2018).  
As many factors can hinder detection of a stable peptide, we sought to identify active 
translation of uORFs in our dataset through nanoluciferase (nLuc) assays. To verify that SPECtre 
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identified uORFs were expressed in SH-SY5Y cells, candidates were cloned for nLuc assays. 
The complete 5’ leader upstream of the start site through the entire predicted coding region of the 
uORF was placed upstream of an nLuc tag without an AUG start codon mutated (Figure 2.4E). 
GGG-nLuc alone was used as a negative control, as GGG is not predicted to support translation 
initiation (Kearse, Green et al. 2016). SPECtre identified uORFs resided in the 5’ leader of 5 
genes: ARF4, LYRM4, PCBD1, LAMB1, and HAND2. Three of these transcripts have uORFs 
with near-cognate start sites, ARF4 and HAND2 utilize an AUG (Figure 2.4E). Reporters were 
co-transfected into SH-SY5Y cells with pGL4.13 which encodes firefly luciferase (FFluc) as a 
transfection control. DAD1 and PSAP serve as negative controls, as their 5’ leaders were filtered 
out early on in our analysis. All 5 of our predicted uORFs showed a significant level of 
translation above GGG-nLuc (Figure 2.4F). RPF and mRNA coverage of ARF4 reveals 
significant coverage across the uORF in the Non-Diff state (Figure 2.4G). One key feature of 
SPECtre is its ability to discriminate reading frame (Chun, Rodriguez et al. 2016). While we 
have shown that 5’ leaders can be translated, we wanted to investigate whether genes identified 
by SPECtre supported spurious translation or if these sequences were specific to initiation in one 
reading frame. To evaluate this, we mutated the reporter for PCBD so that the predicted uORF 
was out of frame. Placing nLuc out of frame resulted in a significant drop in signal (Figure 
2.4H), revealing that the ribosome discerns coding regions based on specific sequence context, 
and that a 5’ leader can support a discrete translation event.  
We next sought to determine whether SH-SY5Y differentiation can affect uORF SPECtre 
score. We performed k-means clustering using the SPECtre score of uORFs in the Non-Diff and 
RA-Diff datasets (Figure 2.4I). This revealed that uORFs either group based on the cell-state 
(blue and gold) or show consistent scores in both states (grey). These clusters are not predictive 
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of a directional change in CDS translation (Figure S2.4). While SPECtre score is not a direct 
measure of translational efficiency, it is a measure of robust translation, thus this result suggests 
that expression of uORFs may be a regulated process. In fact, we observe a positive correlation 
between CDS TE and uORF TE in this dataset (Figure S2.5), which is consistent with a number 
of previous RP studies (Brar, Yassour et al. 2012, Chew, Pauli et al. 2016). This positive 
relationship does not preclude the potential for a uORF to act as a repressor, although it suggests 
that other regulatory measures can act upstream to dictate the role of uORFs such as pre-
initiation complex binding. Further analysis is needed to resolve the intricacies of this 
relationship.  
 
Constrained analysis of the uORF dataset reveals that conserved uORFs may be more inhibitory 
To further analyze the overall oORFs and cORFs, we constrained our analysis to those 
that meet a higher translational threshold in at least one of the replicates from each condition. 
Thus, including only highly translated uORFs. This is key because we have included non-AUG 
initiated uORFs in our dataset, which in principle have lower potential for translation, and 
because of this may contribute a higher level of variability to our analysis. Additionally, after 
observing the positive correlation between CDS TE and uORF TE (Figure S2.5), we believed it 
was important to limit our analyses to a stricter dataset in order to parse out a relationship 
between these two regions. In filtering down our dataset, we obtained 158 oORFs and 137 
cORFs that initiate at both AUG and near-cognate codons (Figure 2.5A, Figure S2.6). These 
cORFs and oORFs have comparable translational efficiencies (Figure S2.7). We analyzed the 
conservation of this set of uORFs divided into subsets based on initiation codon. uORFs were 
analyzed at the codon level (comprised of only the 5’ leader region for oORFs) compared to all  
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Figure 2.5: 
Constrained analysis of the uORF dataset reveals a repressive effect of highly conserved uORFs. SPECtre 
identified uORFs were further filtered to include only uORFs that have coverage in all four Non-Diff and RA-Diff 
libraries. A) This produces a dataset of 158 oORFs, which overlap the CDS, and 137 cORFs, which are fully 
contained in the 5’ leader. B) Conservation analysis of annotated 5’ leaders in all three reading frames (orange), 
annotated CDS regions over all three frames (grey), predicted AUG-initiated uORFs (dark blue), and predicted non-
AUG uORFs (light blue). C) Average GC nucleotide content is shown for 5’ leader regions (orange), CDSs (grey), 
AUG uORFs (dark blue), and non-AUG uORFs (light blue). For oORFs, only the 5’ leader region of the oORF is 
included. 5’ leaders are significantly more GC rich than both AUG uORFs and non-AUG uORFs, p= 5.72e-12 and 
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1.54e-07, respectively. Non-AUG uORFs are significantly more GC rich than CDSs and AUG uORFs, p=7.92e-18 
and 2.16e-06. D) Empirical cumulative distribution of TE in all CDSs (black) verses CDSs from transcripts with two 
subsets of uORFs: those with an AUG initiation site (red) and those with a non-AUG initiation site (Blue). 
Distributions are significantly different with p-values annotated on graph. E) Empirical cumulative distribution of 
TE in all CDSs (black) verses CDSs from transcripts with two subsets of non-AUG uORFs: those in the highest 
quartile of conservation (Conserved, red) and those in the lowest quartile of conservation (Non-Conserved, Blue). 
Distributions are significantly different with p-values annotated on graph. F) Average TE for AUG uORFs and non-
AUG uORFs reveals no difference between the two subtypes. G) Analysis GC content of non-AUG uORFs shows 
an increase in GC content of the conserved group relative to the non-conserved group. All verses conserved: 
p=5.89e-08, all verses non-conserved: p=2.54e-06, conserved verses non-conserved: p=1.62e-18. H) cORFs and 
oORFs identified in our dataset differentially impact the distribution of normalized protein abundance compared to 
transcripts lacking uORFs using a mass spectrometry dataset derived from human lymphoblastoid cell lines (Battle, 
Khan et al. 2015). All 3 groups are significantly different from one another. 
 
5’ leader sequences, 3’UTRs, and annotated CDSs. Both non-AUG and AUG uORFs exhibit a 
range of conservation, with a significant portion showing conservation levels that are comparable 
to CDSs (Figure 2.5B).  
Next, we investigated the sequence context for which AUG and non-AUG uORFs were 
derived by determining their GC content, which is generally higher in 5’ leaders than CDSs and 
which serves as a proxy for increased RNA structure due to the enhanced strength of GC 
hydrogen bonding compared to AU pairs (Banerjee 1980). Interestingly, we do observe a 
decrease in GC content in both AUG and non-AUG uORFs closer to what is observed for CDSs, 
suggesting that less stable secondary structure is necessary for robust translation of these 5’ 
leader regions (Figure 2.5C) (Kozak 1980, Kozak 1986). However, we do observe a significant 
increase in the GC content of non-AUG uORFs relative to AUG uORFs. This indicates that there 
may be a balance of secondary structure necessary to observe initiation at a near-cognate start 
site where too much is preclusive of translation but a slight increase relative to CDSs and AUG 
uORFs is necessary for near-cognate initiation. This is consistent with biochemical findings that 
the presence of a structured region can increase sub-optimal start site selection due to stalling of 
scanning ribosomes (Kozak 1990).  
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To investigate the role uORFs have on impacting downstream translation, we compared 
the cumulative distribution of CDSs without a predicted uORF to CDSs in our transcripts of 
interest. First, we investigated all uORFs regardless of conservation, but stratified into two 
groups: AUG initiated and non-AUG initiated. This analysis replicated past findings that AUG 
initiated uORFs are associated with less translation from their cognate CDSs, although this effect 
was mild (Figure 2.5D). In contrast, CDSs downstream of non-AUG initiated uORFs showed a 
comparable distribution to the control set. As the role of non-AUG uORFs has not been well 
elucidated, we wondered if there was an attribute of non-AUG uORFs that can delineate their 
role in affecting CDS translation. Recognizing the range of conservation, we next explored 
whether conservation carries with it any function or sequence specific features. We further 
divided the non-AUG uORFs into two groups: those in the top quartile of conservation 
(conserved) and those in the bottom quartile of conservation (non-conserved). For the top 
quartile of conserved transcripts, the presence of non-AUG uORFs was significantly, but 
modestly associated with CDS repression (Figure 2.5E). In contrast, non-AUG initiated uORFs 
in the lowest quartile of conservation were associated with highly translated CDSs, suggesting 
that there is a component of a uORF’s regulatory role tied to sequence conservation. This is not 
due to TE levels of the conserved verses non-conserved, non-AUG uORFs (Figure 2.5F). 
Interestingly, the conserved group is associated with higher GC content, consistent with the 
finding that 5’ leader secondary structure is a predictor of CDS repression and that these features 
are conserved (Pelletier and Sonenberg 1985, Chew, Pauli et al. 2016). These data depict the 
dichotomy between AUG and non-AUG uORFs, but emphasize a potential role of both for 
regulating downstream translation. 
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Figure 2.6: 
Retinoic Acid induced differentiation elicits transcript-level reciprocal shifts in uORF and CDS translation 
rates. A) CDSs with oORFs that exhibited the largest increase in TE in the RA differentiated state in the Non-Diff 
state) exhibit a significant decrease in oORF TE in the RA-Diff state by paired analysis. B) CDSs that exhibit the 
largest decrease in TE with RA treatment exhibit an increase in oORF TE with RA treatment by paired analysis. C) 
CDSs with oORFs that exhibited the largest increase in TE in the RA differentiated state exhibit an decrease in 
cORF TE with RA differentiation by paired analysis. D) CDSs that exhibit the largest decrease in TE with RA 
treatment do not exhibit a significant reciprocal increase in cORF translation after RA treatment. For A-D, 
Transcripts with uORFs were separated into quartiles based on their degree and direction of change in TE ratio with 
differentiation. Gold lines represent a nominal decrease in uORF TE with RA treatment. Blue lines represent a 
nominal increase in uORF TE with RA treatment. E) Plots show mRNA reads (grey) and RPF counts (cyan/gold) for 
GLO1. Bar graphs of the average CDS TE or uORF TE across both replicates illustrate the inverse relationship of 
translation through these two regions. F) A sample of oORF-containing ribosomal protein transcripts show both an 
inverse and positive correlation between translation of the CDS and oORF, the full set is listed in Figure S2.9.  
 
To provide further validation for our results, we cross-referenced our results with a 
quantitative SILAC mass spectrometry dataset derived from 62 lines of human lymphoblastoid 
cells (Battle, Khan et al. 2015). After restricting our analysis to transcripts with stable RNA 
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levels in the top 75% of expression (RPKM) as provided by RNA-sequencing data for all lines, 
we obtained ~1500 transcripts with mass spectrometry data (Pickrell, Marioni et al. 2010). 50 of 
these transcripts reside in the constrained dataset of 295 uORF-containing transcripts described 
above and 540 transcripts are in the full set of 4,954 transcripts with a predicted uORF, leaving 
~1000 transcripts without translation in the 5’ leader (None). CDS translation (SILAC:mRNA) 
of the 50 transcripts from the restricted set (cORF and oORF) was analyzed against CDS 
translation of the group of transcripts with no uORF (None). This revealed a slight decrement in 
normalized protein abundance of CDSs downstream of a cORF and a sizable reduction in 
normalized protein abundance of CDSs downstream of an oORF, relative to CDSs without 5’ 
leader translation (Figure 2.5H). Though these data are derived from a cell-type other than SH-
SY5Ys, this reveals a possible mechanism of translation repression dependent upon the context 
of uORF translation with oORFs having the potential for greater repression than a cORF. This is 
supported by past studies as cORFs have the ability to reinitiate if termination occurs at an 
optimal distance from the CDS, whereas the translation of oORFs directs ribosomes downstream 
of the CDS initiation site (Kozak 1987, Hinnebusch, Ivanov et al. 2016).  
 
Conditional fluctuations in uORF translation inversely correlate with CDS translation 
uORFs generally inhibit the downstream translation of their cognate CDS. In certain 
cases, such as cellular stress, the use of specific uORFs is regulated in response to the stimulus in 
a manner that changes the associated CDS translation. One well studied case is ATF4, a gene 
with two uORFs. Translation of the second uORF is inhibitory to translation of the main ATF4 
protein (Harding, Zhang et al. 2003, Vattem and Wek 2004). However, under conditions where 
fully assembled ternary complexes are limiting (due to eIF2α phosphorylation), this second 
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uORF is bypassed, leading to an activation of ATF4 translation (Vattem and Wek 2004). This 
balance between translation within the 5’ leader and translation within the CDS results in an 
inverse relationship between the two.  
RA treatment of SH-SY5Y cells induces potent changes in protein synthesis mediated in 
part at the level of translational control. We therefore evaluated the relationship between shifts in 
uORF translation and CDS translation with RA-induced cellular differentiation using the 
constrained dataset from Figure 2.5. To discern the comprehensive relationship between 
translation of these two regions, we first analyzed the relationship of conditional translation of 
oORFs between the two conditions (RA-Diff:Non-Diff) against the same ratio for CDS 
translation (Figure S2.8A). The same analysis was done for cORFs (Figure S2.8B). Condition-
dependent uORF changes and CDS changes were positively correlated. Though this is consistent 
with previous RP reports on uORFs, classical biochemical studies would suggest that an inverse 
relationship should be observed (Hinnebusch 1997). We wondered if there was a subset of 
transcripts that might show an inverse relationship in response to differentiation. Thus, we 
limited our analysis to transcripts with the largest shifts in CDS translation. Paired analysis was 
performed on individual transcripts in the top quartile of differentiation-dependent changes in 
CDS translation. oORF-bearing transcripts that show their lowest level of CDS translation in the 
Non-Diff state exhibited their highest level of oORF translation in this condition (Figure 2.6A). 
The opposite was true for oORF-bearing transcripts that where repressed in the RA-Diff 
condition (Figure 2.6B). This pattern was also detected for transcripts with cORFs with CDS  
translation repressed in the Non-Diff state (Figure 2.6C). One exception to this finding are 
transcripts with cORFs that are repressed in the RA Diff state (Figure 2.6D). The reason for this 
is unclear, but over half of the transcripts in this particular group do show the relationship 
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described above. Overall, the trend determined through this analysis suggests that highly 
repressed CDS translation is largely accompanied by an oppositional shift in uORF translation. 
This inverse relationship is further evidenced on the novel uORF-baring transcript, GLO1 
(Figure 2.6E). GLO1 is an enzyme central to the glyoxalase system, which detoxifies byproducts 
of cellular metabolism, and is central to neuronal repair in response to injury (Pieroh, 
Birkenmeier et al. 2014).The oORF on GLO1 is increased in TE in the Non-Diff condition, while 
the CDS is decreased in TE. The inverse is evident in the RA-Diff state. Interestingly, in 
transcripts with oORFs, there is an enrichment for ribosomal proteins (Figure 2.6F, Figure 
S2.9). These 19 oORF-bearing transcripts exhibit both an inverse and positive oORF to CDS 
relationship; whereas of the 4 ribosomal protein transcripts that contain cORFs, all show a 
positive correlation between translation in these two regions. However, in 20 of the 23 
transcripts, the CDS is more highly translated in the Non-Diff state. This pattern may be 
indicative of state-dependent regulation associated with the specific molecular functions of 
ribosomal proteins, and oORFs may play a role in modulating their expression.  
 
Conclusions 
As ribosome profiling studies and analyses continually arise, we are still deciphering the 
overarching role of uORFs in regulating translation across the transcriptome. While there is a 
clear repressive effect of translation within the 5’ leader of specific transcripts, the data derived 
from ribosome profiling experiments are less conclusive. Several studies have concluded a 
cumulatively repressed CDS TE on transcripts with an AUG-initiated uORF (Chew, Pauli et al. 
2016, Johnstone, Bazzini et al. 2016). Some have suggested divergent roles for AUG-driven 
uORFs and uORFs with near-cognate start sites in regulating CDS translation (Fijalkowska, 
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Verbruggen et al. 2017, Spealman, Naik et al. 2017). Other studies have shown a positive 
correlation between CDS translation and uORF translation (Brar, Yassour et al. 2012, Chew, 
Pauli et al. 2016). The reason for this variability may be due to the differences in criteria used to 
identify active translation in 5’ leaders. In addition, there may be a component of uORF 
regulation that is cell type- and condition-specific.  
In this study, we show that SPECtre and stringent filtering can be used to categorize a set 
of uORFs translated in SH-SY5Y cells. By including near-cognate start codons in our analysis, 
we show that uORFs that utilize near-cognate start sites can be highly translated and are more 
prevalent in our highest confidence dataset than AUG-driven uORFs. Moreover, we confirmed 
that expression of uORFs that initiate at near-cognate start codons can be validated in cells. In 
aggregate, we confirm what others have described—AUG initiated uORFs are associated with a 
repressed CDS (Chew, Pauli et al. 2016, Johnstone, Bazzini et al. 2016, Spealman, Naik et al. 
2017). However, here we find a divergent role for non-AUG uORFs based on conservation and 
their level of translational activity. Highly conserved uORFs are present upstream of 
cumulatively repressed CDSs whereas lowly conserved uORFs reside upstream of efficiently 
translated CDSs. This is particularly interesting because both sets of uORFs utilize 
predominantly near-cognate start codons. RP reports showing CDS repression by uORFs 
commonly restrict their analysis to AUG initiation (Bazzini, Johnstone et al. 2014, Chew, Pauli 
et al. 2016, Johnstone, Bazzini et al. 2016).  
In yeast studies, groups have suggested that near-cognate initiation in 5’ leaders is 
positively correlated with CDS translation, showing no apparent repressive role or repression in 
only a subset of transcripts (Brar, Yassour et al. 2012, Spealman, Naik et al. 2017). However, 
one RP study did suggest a repressive role for non-AUG uORFs under conditions of decreased 
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start site stringency. This study utilized a knockdown of eIF1, the “gatekeeper” of start-site 
selection, which favors AUG initiation (Valasek, Nielsen et al. 2004, Nanda, Cheung et al. 
2009). RP of eIF1 knockdown in human epithelial cells showed an increase in translation of non-
AUG uORFs relative to their CDSs, but only of uORF/CDS pairs that were regulated by the 
knockdown (Fijalkowska, Verbruggen et al. 2017). Our data extend on this by describing that 
near-cognate initiation may have a role under normal cellular conditions, where endogenous 
translation machinery has not been manipulated. Stratifying our analysis by conservation was 
key to identifying this result. We show that conserved non-AUG uORFs are mildly repressive in 
aggregate; we suspect that using SPECtre and strict criteria to identify robust translation helped 
to clarify this finding. This is consistent with findings that features of AUG-initiated uORF-
mediated translation are conserved (Chew, Pauli et al. 2016).  
When investigating conditional shifts in translation, an overarching role for uORFs has 
not been well established. A report using peroxide treatment to induce stress in Saccharomyces 
cerevisiae observed no obvious relationship between an increase in RPFs in the 5’ leader and 
CDS translation across conditions (Gerashchenko, Lobanov et al. 2012). Several more reports 
have suggested a positive relationship between uORF translation and CDS translation, explaining 
this by the low frequency of uORF translation and a reliance on whole transcript activity to 
increase in order to detect such a low event (Brar, Yassour et al. 2012, Jang, Lahens et al. 2015, 
Chew, Pauli et al. 2016). In principle, this is likely the overarching relationship, as this is what 
we observe in our full dataset. It is likely that translation of 5’ leaders and CDSs can increase 
concomitantly as a by-product of increased ribosomal-mRNA interaction. The scanning model of 
translation initiation would predict that an increase in suboptimal codon selection would increase 
as the number of preinitiation complexes increase on a transcript (Mehdi, Ono et al. 1990, 
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Hinnebusch, Ivanov et al. 2016). Additionally, transcription can work upstream to dictate the 
role of a uORF. Alternative transcription start sites have been a proposed mechanism by which a 
given uORF is excluded from the main transcript isoform (Pelechano, Wei et al. 2013, Spealman, 
Naik et al. 2017). Still, both cistrons on a transcript can increase similarly as transcription 
increases. Constraining our analysis to uORFs easily detected in both conditions likely 
eliminated some of the noise created by the mechanisms mentioned above. In our study, paired 
analysis of a this highly filtered set of oORFs showed robust directionality and an inverse 
correlation with their associated, translationally repressed CDS. This relationship was not as 
strong for cORFs. Regardless, these findings suggests that the pattern of repression represented 
in classically studied uORF-bearing transcripts—like ATF4 and GCN4—appears in transcripts 
associated with RA induced cellular differentiation (Hinnebusch 1984, Thireos, Penn et al. 1984, 
Harding, Novoa et al. 2000, Vattem and Wek 2004).   
Future work will be needed to understand both the relationships of these uORF regulated 
genes to each other and the mechanisms by which their uORF activities are altered. One set of 
genes that is particularly enriched in our dataset are ribosomal protein encoding transcripts that 
contains oORFs. While ribosomes were once thought to play a passive role in the selection of 
mRNA transcripts, many recent studies have suggested that specialized ribosomes can contribute 
to the overall proteome through sequence-specific interactions (Xue and Barna 2012). For 
example, RPL38 specifically interacts with HOX mRNAs because of structures in their 5’ 
leaders, these encode key transcription factors required for proper development (Xue, Tian et al. 
2015). Thus, the make-up of ribosomal proteins within a cell can influence the cell 
phenotypically. Further evidence for specialized ribosomes is illustrated in the tissue-specificity 
of ribosomal proteins (Kondrashov, Pusic et al. 2011, Guimaraes and Zavolan 2016). We see a 
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negative relationship between oORFs present on RPL30, RPL9, RPS16, RPS24, and RPS18 
transcripts and the CDSs for these genes, which may contribute to their expression level changes 
in differentiation. 
The data presented in this study are important for demonstrating that robustly translated 
and conserved uORFs carry the potential to act as regulated repressors CDS translation. 
Importantly, many of these regulatory uORFs initiate in the absence of an AUG start codon. 
Scaled translation of uORFs may thus serve as an important regulatory mechanism for 
translation of a set of transcripts whose proteins are conditionally expressed in response to 
neuronal differentiation. 
 
Methods: Cell culture and Experimentation 
SH-SY5Y cell maintenance and differentiation 
SH-SY5Y cells were grown in DMEM:F12 media (Invitrogen) supplemented with 10% 
FBS, .01mg mL-1 Gentamicin and .25ug mL-1 Amphoreticin B. Cells were plated on 150mm 
plates that were either coated with .1mg/mL poly-D lysine (Millipore) for differentiation or 
uncoated. Cells were allowed to propagate to 80% confluency for 1-2 days prior to lysing for 
ribosome profiling or induction of differentiation. SH-SY5Y cells were differentiated for 6 days 
in 10µM retinoic acid (all-trans, Sigma), with media changed every 24 hours.  
 
Construction of the Ribosome Profiling libraries 
Ribosome profiling libraries were prepared as in Ingolia et al., 2010 and Ingolia et al., 
2012. Cells were washed with ice cold PBS with CHX at 100ug mL-1. Plates were immediately 
flash frozen in liquid nitrogen, moved to dry ice, and lysed (in the presence of CHX) to prevent 
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ribosome loading and runoff. Additional lysates were processed in parallel for poly(A) mRNA 
purification and mRNA-sequencing library preparation. Polysomes were isolated from the 
ribosome footprinting lysates on a 1M sucrose gradient with high speed centrifugation using a 
70.1Ti rotor (Beckman) at 55,000 r.p.m. for 4 hrs at 4°C. rRNA was eliminated prior to linker 
ligation using Ribo-Zero Gold rRNA Removal Kit (Illumina). Ribosome Profiling libraries were 
barcoded and multiplexed with 2-4 libraries per lane, and sequenced on a HiSeq 2000 (Illumina) 
using 50 cycles of single end reads. mRNA libraries were multiplexed on a single lane. All 
sequencing was conducted at the University of Michigan DNA Sequencing Core.  
 
Plasmid Construction 
pcDNA 3.1 plasmid was modified to encode NanoLuc and GGG-NanoLuc as previously 
published CITE. gBlocks® (IDT) were ordered of the 5’ leader sequence to the last codon before 
the in-frame stop of selected genes flanked by restriction sites. These were restriction cloned 
upstream of GGG-nLuc using PacI and XhoI (NEB) with 12 nucleotides between the start of the 
5’ leader and the T7 promoter sequence to reduce spurious initiation in sequences specific to the 
plasmid. Frameshifts were accomplished by PCR cloning with primers that inserted one or two 
nucleotides between the uORF and the nanoluciferase sequence. PCR products were cloned in 
place of nanoluciferase in the original uORF plasmid using XbaI and SacII (NEB). Restriction 
digest and Sanger Sequencing were used to confirm plasmid sequence.  
 
SH-SY5Y Transfection and Nanoluciferase Assay 
SH-SY5Y cells were seeded on 6-well culture plates at 3 x105 cells per well. 24 hours 
post seeding, each well was transfected using 7.5µL FUGENE HD (Promega) and 1.25µg 
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nanoluciferase reporter plasmid along with 1.25µg pGL4.13 (internal transfection control that 
encodes firefly luciferase [FFluc]) in 300 µL of OptiMEM (Invitrogen). Transfections of 
differentiated cells were performed on day 5 in RA supplemented media. Cultures were allowed 
to grow for 24 hours after transfection. Cells were lysed in 250µL Glo Lysis Buffer (Promega) 
for 5 minutes at room temperature. 50µL lysate was mixed with 50µL prepared Nano-GLO or 
ONE-Glo (Promega) for 2 minutes, and bioluminescence was detected using a GloMax® 96 
Microplate Luminometer. Nanoluciferase signal was normalized to FFluc signal in each sample. 
pcDNA 3.1 encoding nLuc the AUG start codon mutated to a GGG (GGG-nanoLuc) was run in 
parallel with each experimental nLuc plasmid and subjected to both conditions to serve as a 
control for normalization.  
 
Immunocytochemistry and microscopy 
Cells were fixed at 37°C with 4% PFA/4% sucrose in PBS with 1mM MgCl2 and .1mM 
CaCl2 (PBS-MC), permeabilized for 5 minutes in .1% Triton-X in PBS-MC, and blocked for 1 
hour with 5% bovine serum albumin in PBS-MC. Cells were incubated in blocking buffer and 
primary antibodies against β-actin (Santa Cruz Biotechnology, cat# sc-130656, 1:1000) and 
neurofilament (Abcam, Ab8135, 1:1000) for 1 hour at room temperature. Following 3x10 minute 
washes in PBS-MC, cells were incubated in PBS-MC with Alexa Flour 488 conjugated goat anti-
rabbit IgG and Alexa Flour 635 conjugated goat anti-mouse IgG to achieve secondary detection 
(Thermo Fisher, 1:1000). Cells were washed again, and placed in ProLongTM Gold antifade 
reagent with DAPI (Invitrogen).  
Imaging was performed on an inverted Olympus FV1000 laser-scanning confocal 
microscope using a 40x objective. Acquisition parameters were identical for each condition and 
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optimized to eliminate signal bleed-through between channels. Images were converted to 
average-intensity z-projections in ImageJ. Cytoplasmic β-actin was quantified by averaging the 
integrated density corrected for background signal of the cells in each condition. The length of 
one main neurofilament-labeled primary neurite per cell was determined in ImageJ and 
converted from pixels to µm, and averaged for each condition.  
 
Western Blotting 
Cells were maintained as described above. Cells were washed 2X in PBS, and RIPA 
buffer was added to a single well of a 12-well dish either at 80% confluency or after 6 days of 
retinoic acid differentiation. Cells were agitated for 40 minutes at 4°C to ensure complete lysis. 
Lysates were clarified by centrifugation, and the supernatant was mixed with reducing SDS 
sample buffer and boiled for 5 minutes at 90°C. Equal amounts of lysate were loaded on an SDS-
PAGE gel and subsequent western blotting was carried out with primary antibodies against 
FMRP (1:1000, cat# 6B8, BioLegend) or GAPDH (1:1000, cat# sc-32233, Santa Cruz 
Biotechnology)—in 5% (wt/vol) non-fat dry milk in TBS-T (NFDM). An HRP conjugated goat 
antibody to mouse IgG or to rabbit IgG was used for secondary detection (1:5000, Jackson 
ImmunoResearch Laboratories) in 5% NFDM.  
 
Methods: Analysis of ribosome profiling and mRNA-Seq datasets 
Alignment to the human genome and transcriptome (GRCh38 Ensembl version 78) 
Ribosome profiling and mRNA-Seq reads were trimmed of adapters, and then by quality 
using fasqt-mcf from the ea-utils package (Aronesty, 2011). Ribosome profiling and mRNA-Seq 
reads in FASTQ format were trimmed based on quality if four consecutive nucleotides were 
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observed with Phred scores of 10 or below. The minimum read length required after trimming was 
25 nucleotides.  
Trimmed sequences were then aligned to a ribosomal RNA sequence index using Bowtie 
v1.1.2 (Langmead, Trapnell et al. 2009) to deplete them of contaminant sequences. Alignment to 
the rRNA sequence contaminant index was performed using the following parameters: seed 
alignment length of 22 nucleotides, no mismatches in the seed alignment were allowed, with the 
unmapped reads written to a separate FASTQ file. 
bowtie -l 22 -n 0 -S --un /path/to/depleted_reads.fq \ 
  /path/to/rRNA_index \ 
  /path/to/trimmed_reads.fq 
Ribosome profiling and mRNA-Seq reads depleted of rRNA contaminant sequences were aligned 
to the human genome and transcriptome (Ensembl, version 78) using TopHat v.2.0.10 (Trapnell, 
Pachter et al. 2009). The trimmed and rRNA-deplete reads were aligned to the human genome and 
transcriptome with the parameters specifying standard Illumina reads, with un-gapped Bowtie 1 
alignment (using a seed alignment length of 22 nucleotides, with no mismatches in the seed 
alignment allowed), to annotated junctions only, using Solexa quality scores: 
 tophat2 -p 4 –bowtie1 \ 
–-no-novel-juncs \ 
--library-type fr-unstranded \ 
--solexa-quals \ 
-G /path/to/ensemble.gtf \ 
/path/to/bowtie_index \ 
/path/to/depleted_reads.fq 
 
Sequence alignment quality filtering and merging 
Ribosome profiling and mRNA-Seq reads aligned to the human genome and transcriptome 
by TopHat2 were output to BAM format, and then sorted by chromosomal coordinate. Reads were 
then filtered by mapping quality using SAMtools (Li, Handsaker et al. 2009); read alignments 
were required to have minimum mapping quality of 10, or higher, to be retained for subsequent 
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analyses. Unique read group identifiers were assigned to each technical and biological replicate, 
and then the alignments were merged by technical replicates and subsequently as biological 
replicates using Picard (http://broadinstitute.github.io/picard/). 
 
Metagene profile generation and alignment offset calculation 
 For counting reads over transcript isoforms, metagene profiles were generated from the 
Ensembl (version 78) transcript annotation database using Plastid (Dunn and Weissman 2016). A- 
and P-site offsets for harringtonine and cycloheximide ribosome profiling reads, respectively, were 
determined by pooling all reads that overlapped canonical AUG translation initiation start sites 
from annotated protein-coding genes. The most common (mode) distance from the 5’ ends of reads 
of a given length to the position of the AUG in those reads was accepted as the A- or P-site offset 
distance. 
 
Calculation of transcript abundance 
 Read counts over each transcript isoform, or region (5’UTR, CDS, and 3’UTR), were 
normalized by length, summed, and reported as transcripts per million (TPM) as described 
previously (Li and Dewey 2011). At the time of analysis, Cufflinks (Trapnell, Williams et al. 2010) 
was required for initial transcript quality control, and was run with the following parameters: 
 cufflinks -p 8 -o /path/to/output \ 
  -G /path/to/ensemble.gtf \ 
  /path/to/tophat/alignments 
 
SPECtre analysis of transcripts in non-differentiated and RA-differentiated libraries 
SPECtre profiling (Chun, et. al., 2016) measures the strength of the tri-nucleotide 
periodicity inherent to the alignment of ribosome protected fragments to protein-coding genes in 
		
87	
a reference transcriptome. SPECtre analysis was applied in two stages: 1) to score the translational 
potential of annotated transcripts to build a background protein-coding reference model, and 2) to 
score the translational potential of predicted upstream-initiation ORFs. In this way, the 
translational potential of predicted upstream and overlapping ORFs are score against a background 
model of translation derived from annotated protein-coding transcripts. Annotated protein-coding 
transcripts were profiled by SPECtre using the following parameters: 
python /path/to/SPECtre.py \ 
 --input /path/to/tophat/alignments \ 
 --output /path/to/output \ 
 --log /path/to/logfile \ 
 --gtf /path/to/ensemble.gtf \ 
 --fpkm /path/to/cufflinks/isoforms.fpkm_tracking \ 
 --len 30 \ 
 --fdr 0.05 \ 
 --min 3.0 \ 
 --nt 8 \ 
 --type mean \ 
 --target <chromosome_id> 
Where the minimum FPKM required for a transcript to be considered as translated for generation 
of the background model was specified as 3.0, and the length of the sliding SPECtre windows was 
set to encompass 30 nucleotides. The SPECtre score for a transcripts was defined as the mean of 
the scores over these sliding windows, and a 5% false discovery rate was established to set the 
minimum SPECtre translational score threshold. In addition, SPECtre profiling was split by 
chromosome to speed computation, and the results were merged afterwards using a custom Python 
script. Finally, prior to analysis of predicted upstream-initiated ORFs by SPECtre profiling, the 
minimum SPECtre translational threshold was re-calculated using TPM instead of FPKM using a 
minimum cutoff of 10 transcripts per million. 
 
Computational prediction of upstream-initiated open reading frames 
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 Open reading frames were computationally predicted from annotated 5’UTR sequences 
(Ensembl, version 78) using AUG, and near-cognate non-AUG translation initiation site 
sequences. Open reading frame sequences were generated based on these predicted initiation site 
sequences and read through to the first in-frame termination codon encountered in the annotated 
CDS. These predicted ORFs were then used to generate coordinates over which they would be 
profiled and scored by SPECtre. Identical parameters to the annotated transcript SPECtre 
analysis were employed for consistency across analyses: 
 python /path/to/SPECtre-uORFs.py \ 
  --input /path/to/alignments \ 
  --output /path/to/output \ 
  --results /path/to/spectre/transcript_results \ 
  --log /path/to/logfile \ 
  --fpkm /path/to/cufflinks/isoforms.fpkm_tracking \ 
  --len 30 \ 
  --fdr 0.05 \ 
  --min 3.0 \ 
  --nt 8 \ 
  --type mean \ 
  --target <chromosome_id> 
Three alternative inputs are required for the SPECtre analysis of predicted ORFs: 1) the 
annotated transcript GTF database was not required and removed, 2) the results of the annotated 
transcript analysis, and 3) a genomic sequence file in FASTA format. The results of the 
annotated transcript analysis were used to identify the set of transcripts from which to predict 
upstream-initiated ORFs, and the FASTA sequence file was used to generated the ORF 
sequences for output. 
 
Supplemental annotation of non-AUG translation initiation sites 
 Upstream sequences of predicted non-AUG translation initiation sites were examined for 
possible in-frame AUG initiation start sites; 5’UTR sequences of predicted non-AUG sites were 
extracted, and then searched for the presence of in-frame AUG sites. These non-AUG sites were 
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then re-annotated according to the proximity of upstream AUG initiation sites: those with an in-
frame AUG site within 30 nucleotides of the predicted TIS, and those with an in-frame AUG site 
in-frame, but beyond 30 nucleotides upstream of the predicted site. 
 
Kernel density estimation of differential uORF translation on CDS translational efficiency 
 To further differentiate those uORFs with differential translation and identify those that 
contribute to the regulation of downstream CDS, the log-change in predicted ORF TPM was 
compared against the log-change in downstream CDS TPM across the conditions. The differential 
translational identity of each predicted ORF was retained from the SPECtre clustering analysis, 
and kernel density estimation was performed using R. 
 
Calculation of translational efficiency 
 Ribosome profiling or mRNA-Seq reads were counted over each region (5’UTR, CDS, and 
3’UTR), transcript, or upstream-initiated ORF and then normalized to length and library size as 
transcripts per million (Li and Dewey 2011). To calculate translational efficiency over a region, 
transcript or upstream-initiated ORF, ribosome profiling TPM in each biological replicate across 
each condition was quantile normalized (Amaratunga, et. al., 2001) and then divided by the 
quantile normalized TPM in mRNA-Seq. Read and RPF counts from mRNA-Seq and ribosome 
profiling libraries does not include those that overlap the 5’UTR and 3’UTR. Furthermore, to limit 
the boundary effects due to translation initiation and termination, RPF and read counts do not 
include those whose A- or P-site adjusted position for harringtonine and cycloheximide libraries, 
respectively, overlap the first or last 15 nucleotides of an annotated CDS. 
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Differential expression analysis and gene set enrichment testing in mRNA-Seq 
As described previously, the read abundance over annotated protein-coding transcripts was 
calculated as TPM, then quantile normalized across conditions using the preprocessCore package 
(Bolstad, 2016) in R (R Core Team, 2017), and then ranked. The change in rank for each gene was 
calculated across the non-differentiated and RA-differentiated conditions, and the significance of 
the up- or down-regulation of these rang-changes across conditions was classified using an extreme 
outlier cutoff (Tukey 1949). Functional characterization of these significantly rank-changed genes 
across the non-differentiated and RA-differentiated conditions was analyzed using the goseq 
package (Young, Wakefield et al. 2010) in R, and corrected for multiple testing using Benjami-
Hochberg adjusted p-values. 
 
Differential translation analysis and gene set enrichment testing in ribosome profiling 
 Ribosome profiling read fragments were A- or P-site adjusted, and then counted over 
annotated protein-coding CDS regions in each biological replicate using the metagene profiles 
generated by Plastid (Dunn and Weissman 2016). As described previously, ribosome-protected 
fragments with A- or P-site adjusted positions that overlapped the first or last 15 nucleotides of the 
boundaries defined by the annotated CDS region were masked from the analysis. DESeq2 (Love, 
Huber et al. 2014) was used to identify those genes with differential translation across the two 
states of cellular differentiation. Genes were annotated as significantly up- or down-regulated 
using a Benjamini-Hochberg adjusted p-value cutoff of 0.1, and fold-change in counts greater than 
1, or less than 1, respectively. Functional characterization of these significantly up- and down-
regulated genes was analyzed by goseq using parameters specified previously. 
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Differential translational efficiency and gene set enrichment testing in ribosome profiling 
 For each biological replicate, ribosome profiling read fragments were A- or P-site adjusted, 
and then counted over annotated protein-coding CDS regions using the metagene profiles 
generated by Plastid. As above, read counts over the first and last 15 nucleotides of protein-coding 
CDS regions were masked for subsequent analyses. In addition, mRNA-Seq read counts were 
extracted from each condition, with the proximal and terminal 15 nucleotide ends of the CDS 
masked for consistency with the RPF counts. The DESeq2 wrapper for differential translational 
efficiency analysis, Riborex (Li, Wang et al. 2017), was used to identify those genes with 
significant changes in translational efficiency. Genes were annotated as significantly up- or down-
regulated using a Benjamini-Hochberg adjusted p-value cutoff of 0.1, and absolute fold-change of 
1. Functional characterization of the sets of genes enriched in each condition by translational 
efficiency was analyzed by goseq using parameters described previously. 
 
Rank-change in transcript abundance 
 In addition to significance cutoffs for up- and down-regulated regions or transcripts based 
on mRNA-Seq and ribosome profiling sequence alignments, global changes were assessed by 
percent change in abundance. TPM based on mRNA-Seq and RPF alignments were calculated, 
quantile normalized, and then compared by percent change in abundance across the non-
differentiated and RA-differentiated libraries. The number of genes with a change in TPM across 
the two conditions was evaluated at pre-defined percent-change cutoffs of 10%, 20%, 30%, 40% 
and 50%. 
 
Conservation analysis 
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 To assess the conservation of the various regions, transcripts and ORFs, the PhyloCSF 
scores (Lin, Jungreis et al. 2011) over each target region was extracted. For upstream-initiated 
ORFs, the PhyloCSF score was extracted according to its predicted phase. In order to de-convolute 
the contribution of regional conservation due to overlap with annotated CDS regions, predicted 
ORFs that did not initiate and terminate wholly upstream of a CDS were also scored according to 
the subset of their coordinates defined by the 5’UTR alone. The mean PhyloCSF over each of these 
regions and ORFs was calculated, and then mean-shifted to canonical (+0) reading frame of the 
annotated CDS for comparison. 
 
GC nucleotide content analysis 
 Similar to the conservation scores, the ratio of GC nucleotide content in each reading frame 
of 5’UTRs, CDS, and 3’UTRs was calculated. GC content over the predicted phase of each 
upstream-initiated was calculated, with the 5’UTR overlapping region of CDS-terminated 
upstream ORFs deconvoluted from the region overlapping the CDS as described above. 
 
Cluster analysis of differential uORF translation by SPECtre score 
 In order to identify subsets of upstream-initiated ORFs with differential translation in one 
state of cell differentiation compared to the other, the SPECtre score for each predicted ORF was 
calculated (described in Supplemental Materials and Methods). The SPECtre score of each 
predicted ORF was classified by k-means clustering in R to define sets of uORFs with differential 
translation in one of the conditions, and those with no difference in translational potential between 
the two conditions. 
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Additional filtering of candidate uORFs 
Additional replicate-based filtering was applied to the set of predicted uORFs to identify a 
set of highly confident candidates. As a form of internal validation, a predicted uORF was required 
to meet a minimal translational threshold in at least one of the technical replicate samples across 
both conditions. This threshold was determined on a conditional basis dependent on the 5% FDR 
cutoff required for translational activity according to the distribution of SPECtre scores in protein-
coding genes. 
 
Orthogonal proteomic validation of predicted uORFs 
To assess their biological reproducibility, predicted uORFs from ribosomal profiling of 
non-differentiated and RA-differentiated SH-SY5Y cells were cross-referenced against mRNA-
Seq and matched mass spectrometry data derived from the transcriptional and translational 
profiling of 62 AML samples (Battle, Khan et al. 2015). In order to mitigate the effects of 
transcriptional variation as a potential confounding variable, a common set of genes were 
identified that were consistently among the top 75% by transcript abundance across all 62 AML 
samples. The number of genes with a predicted uORF in this set of stably transcribed genes was 
identified. To assess the potential regulatory effect of predicted uORFs in this common set of 
genes, the mass spectrometry estimates of protein abundance were normalized by mRNA-Seq 
transcript abundance. Cumulative distribution plots and density histograms were generated from 
the normalized protein abundance estimates to assess the potential regulatory contribution of 
predicted uORFs against a background distribution of genes with no uORF predicted. 
 
Rank-change analysis of conditional translational repression by predicted uORFs 
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 To investigate potential conditional effects of predicted uORFs on the translational 
repression of annotated CDS regions, the ratio of CDS translational efficiency was calculated as 
the RA-differentiated replicate TE divided by the non-differentiated replicate TE. The RA-
differentiated to non-differentiated CDS TE ratios were then partitioned according to the average 
nucleotide conservation of the predicted uORF. The top 25% and bottom 25% of predicted cORFs 
by conservation were extracted, and the significance of their rank-change in TE differences across 
conditions was calculated using a Wilcoxon Rank-Sum test. The significance in rank-change 
difference of the top 25% and bottom 25% of predicted oORFs by conservation was assessed 
separately. 
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Figure S2.1: 
 
Extended Data for Figure 2.1, #1: Gene sets with significantly down-regulated mRNA transcripts in RA-Diff cells 
are shown in (A) and (B). Gene sets upregulated in RA-Diff cells are shown in (C) and (D). Genes sets for Cellular 
Compartment are shown in (A) and (C), and sets for Biological Process are shown in (B) and (D). The top five 
groups with significant change using a multiple testing corrected p-value cutoff of 0.05 (vertical line) are shown on 
the graph. 
 
 
 
Figure S2.2: 
 
Extended Data for Figure 2.2, #1: Gene sets with significantly down-regulated RPF counts in RA-Diff cells are 
shown in (A) and (B). Gene sets upregulated in RA-Diff cells are shown in (C) and (D). Genes sets for Cellular 
Compartment are shown in (A) and (C), and sets for Biological Process are shown in (B) and (D). The top five 
groups with significant change using a multiple testing corrected p-value cutoff of 0.05 (vertical line) are shown on 
the graph. 
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Figure S2.3: 
 
Extended Data for Figure 2.2, #2: Gene sets with significantly down-regulated translational efficiency in RA-Diff 
cells are shown in (A), (C) and (E). Gene sets upregulated in RA-Diff cells are shown in (B), (D), and (F). Genes 
sets for Molecular Function are shown in (A) and (B), sets for Cellular Compartment are shown in (C) and (D), and 
sets for Biological Process are shown in (E) and (F). The top five groups with significant change using a multiple 
testing corrected p-value cutoff of 0.05 (vertical line) are shown on the graph. 
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Figure S2.4: 
 
Extended Data for Figure 2.4, #1: uORFs cluster by SPECtre score conditionally, but clustering does not correlate 
with directional CDS changes. Kernel density estimation analysis of changes in TPM over annotated protein-coding 
CDS as a function of changes in TPM over predicted upstream-initiated ORFs. Cluster identity of predicted ORF 
changed in translational potential as scored by SPECtre is identical to panel A): predicted ORFs enriched for 
translation in RA-Diff cells (cyan), predicted ORFs with enriched translation in Non-Diff cells (gold), and those 
with static translation across the two conditions (black) are annotated to protein-coding CDS with higher RPF 
abundance in Non-Diff cells (above horizontal line), and those with higher RPF abundance in RA-Diff cells (below 
horizontal line). 
 
 
 
Figure S2.5: 
 
Extended Data for Figure 2.4, #2: Analysis of the full uORF-containing transcript set reveals a positive correlation 
of uORF TE and CDS TE. Pearson correlation, r=0.41. 
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Figure S2.6: 
 
Extended Data for Figure 2.5, #1: Distribution of cORF and oORF translation start sites (TSS) for the transcripts 
shown in Figure 5. 
 
 
 
 
 
Figure S2.7: 
 
Extended Data for Figure 2.5, #2: Average TE values for cORFs and oORFs in the Non-Diff (left) and RA-Diff 
(right) conditions reveals no significant difference between the two types of uORFs. 
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Figure S2.8: 
 
Extended Data for Figure 2.6, #1: A) Using the filtered dataset from Figure 5, analysis of the relationship between 
cORF and CDS translation (log10TE Non-Diff/RA-Diff) reveals that the translational efficiency of these two regions 
positively correlate in response to RA-Differentiation, R2=0.12. B) This is also seen for oORFs, R2=0.32. 
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Figure S2.9: 
 
Extended Data for Figure 2.6, #2: Full list of ribosomal transcripts enriched in the constrained dataset for oORFs. 
4 ribosomal transcripts contain cORFs and are listed as well. While most of these transcripts show a positive CDS 
TE:uORF TE relationship, 20 of the 23 are repressed in the Non-Diff state. 
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CHAPTER III 
RAN Translation regulates FMRP synthesis and can be selectively targeted in Fragile X 
Disorders 2 
 
Abstract 
CGG repeat expansions in FMR1 impair fragile X protein (FMRP) expression, resulting 
in autism and intellectual disability in Fragile X Syndrome. In contrast, repeat associated non-
AUG translation (RANT) from transcribed CGG repeat expansions produces toxic proteins that 
drive neurodegeneration in Fragile X-associated Tremor/Ataxia Syndrome (FXTAS). Here we 
describe fundamental roles for RANT at normal CGG repeat sizes in regulating FMRP synthesis. 
RANT impairs basal FMRP synthesis both in vitro and in neurons. This inhibition requires 
conserved near-AUG codons in the 5’ UTR. Activation of FMRP synthesis by mGluR agonists 
requires both RANT and the CGG repeat. Targeting RANT initiation sites with antisense 
oligonucleotides (ASOs) blocks RANT and prevents neuronal death. Moreover, ASO treatment 
of human Fragile X neurons enhances endogenous FMRP synthesis. These findings define a 
native function for RANT and CGG repeats in regulating FMRP synthesis and delineate RANT 
as a therapeutic target across all Fragile X spectrum disorders. 
 
 
																																																						
2 Most of this chapter was submitted for publication as: Rodriguez CM, Kearse MG, Haenfler JM, Flores BN, Lui Y, 
Wright SE, Ifrim MF, Glineburg MR, Jafar-Nejad, P, Sutton MA, Bassell GJ, Rigo F, Parent JM, Barmada SJ, Todd 
PK. RAN Translation regulates FMRP synthesis and can be targeted in Fragile X Disorders. 
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Introduction 
Fragile X Syndrome (FXS) is the leading monogenic cause of autism and intellectual 
disability (Hagerman et al., 2017). It results from large (>200) CGG nucleotide repeat 
expansions in the 5’ untranslated region (UTR) of the FMR1 gene present on the X chromosome 
FMRP plays a central role in regulating activity-dependent protein synthesis at synapses (Bhakar 
et al., 2012) . FMRP is an RNA-binding protein that interacts with ~4% of brain mRNAs, 
including an enriched fraction of synaptic transcripts from genes associated with autism (Ascano 
et al., 2012; Brown et al., 2001; Darnell et al., 2011). FMRP suppresses translation of target 
transcripts, either through direct interactions with targets or via association with translating 
ribosomes (Chen et al., 2014; Darnell et al., 2011; Feng et al., 1997). Upon activation of group I 
metabotropic glutamate receptors (mGluRs), FMRP is dephosphorylated and rapidly degraded, 
allowing for local translation of FMRP-associated mRNAs (Ceman et al., 2003; Hou et al., 2006; 
Nalavadi et al., 2012). FMR1 mRNA itself is rapidly translated in response to mGluR activation, 
creating a negative feedback loop that temporally limits activity-dependent translation (Hou et 
al., 2006; Todd et al., 2003; Weiler et al., 1997). This activity-dependent regulation of neuronal 
FMRP synthesis requires specific sequences in the 3’ UTR (Suhl et al., 2015). Whether the CGG 
repeat or FMR1 5’ UTR contribute to this regulation is unclear.  
In contrast to FXS, intermediate “premutation” sized CGG repeat expansions in the 
FMR1 locus elicit a clinically distinct neurological disorder: Fragile X-associated Tremor/Ataxia 
Syndrome (FXTAS). Repeats in patients with FXTAS range from 55-200. FXTAS is an age-
related neurodegenerative disease characterized by gait difficulties, action tremor, and dementia 
with executive dysfunction and, in some cases, Parkinsonism and peripheral neuropathy (Berry-
Kravis et al., 2007). This un-methylated premutation repeat enhances FMR1 transcription and 
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triggers formation of large ubiquitinated intranuclear neuronal inclusions in the brains of FXTAS 
patients (Greco et al., 2002; Tassone et al., 2007; Todd et al., 2010). Premutation repeats also 
cause Fragile X-associated premature ovarian insufficiency (FXPOI), the most common 
inherited cause of early menopause (Sullivan et al., 2011). Together with Fragile X Syndrome, 
these conditions and other CGG repeat-associated clinical phenotypes are collectively referred to 
as Fragile X spectrum disorders to capture the full range of potential pathology that results from 
CGG repeat expansions at this locus (Lozano et al., 2014).  
Transcribed CGG repeats likely elicit neurodegeneration through multiple mechanisms, 
including RNA-mediated sequestration of proteins, DNA damage response activation by R-loop 
formation, and mitochondrial dysfunction (Hagerman and Hagerman, 2016; Kong et al., 2017). 
Recently, focus has been placed on the ability of CGG repeats to support repeat-associated non-
AUG translation (RANT) in all three reading frames to produce toxic homopolymeric 
polyglycine (FMRPolyG), polyalanine (FMRpolyA), and polyarginine (FMRpolyR) proteins 
(Kearse et al., 2016; Todd et al., 2013). The most abundant RANT product, FMRpolyG, forms 
intranuclear neuronal inclusions in FXTAS patient brains and aggregates in FXPOI patient 
ovaries (Buijsen et al., 2016; Hukema et al., 2015; Sellier et al., 2017; Todd et al., 2013). 
Significant evidence suggests a direct role for FMRpolyG in disease pathogenesis. Enhancing 
FMRpolyG production exacerbates CGG repeat associated toxicity in cell and Drosophila model 
systems and impairs protein quality control pathways (Oh et al., 2015; Todd et al., 2013). In 
contrast, precluding FMRpolyG production markedly suppresses inclusion production in both 
mice and Drosophila models and is necessary for CGG repeats to elicit neurodegeneration in 
transgenic mice (Sellier et al., 2017; Todd et al., 2013).  
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RANT is a non-canonical form of translational initiation originally described at expanded CAG 
and CUG repeats in the context of the Spinocerebellar Ataxia 8 locus (Zu et al., 2011).  RANT 
has now been observed in seven repeat expansion disorders, including C9orf72-associated 
amyotrophic lateral sclerosis and frontotemporal dementia and Huntington’s disease (Ash et al., 
2013; Banez-Coronel et al., 2015; Cleary and Ranum, 2017; Mori et al., 2013; Zu et al., 2011). 
At CGG repeats, initiation of this non-canonical form of translation is a cap- and scanning-
dependent event that requires initiation factors eIF4E and eIF4A (Kearse et al., 2016). However, 
it specifically bypasses the requirement of an AUG start codon; instead, it relies on initiation 
predominantly at near-AUG codons that reside just 5’ to the repeat or, in one reading frame 
(FMRpolyA), within the repeat itself.  
While there is mounting evidence that RANT occurs at expanded repeats and can 
contribute to toxicity, potential roles for this alternative translational initiation mechanism in 
normal physiology are unexplored (Brar, 2016; Kearse and Wilusz, 2017). RANT of FMRpolyG 
occurs readily at the prominent repeat size in the human population (25-30 CGG repeats) (Kearse 
et al., 2016; Todd et al., 2013). Given its location within the FMR1 5’ UTR, we tested the 
hypothesis that RAN translation at CGG repeats regulates FMRP synthesis. Here we describe 
how RANT of both normal and expanded CGG repeats regulates basal and activity-dependent 
FMRP synthesis. This regulation occurs in both human cell lines and within neuronal processes 
where FMR1 is typically located, with specific requirements for both the CGG repeat and 
conserved non-AUG codons that allow for RANT initiation. Treatment with non-cleaving 
antisense oligonucleotides (ASOs) that sterically hinder RANT initiation suppresses 
neurotoxicity from repeats and to enhances endogenous FMRP synthesis in human induced 
pluripotent stem cell (iPSC)-derived neurons with a large unmethylated CGG repeat expansion. 
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Overall, these findings define a new non-pathogenic physiological role for RANT in regulating 
neuronal FMRP synthesis, and provide a novel therapeutic approach in multiple Fragile X 
spectrum disorders.  
 
Results 
RAN translation initiation at CGG repeats impairs FMRP synthesis 
We previously determined the sites of RANT initiation within the 5’ UTR of FMR1. 
Initiation in the 0-reading frame (relative to the AUG start codon of the FMRP open reading 
frame) upstream of the repeat would generate an N-terminally extended FMRP containing a 
polyarginine tract (FMRpolyR-FMRP). Initiation in this frame occurs at an ACG codon 60 
nucleotides upstream of the first CGG repeat codon. Generation of this product is suppressed at 
both normal and larger repeat sizes (Kearse et al., 2016), and is expressed at the lowest level of 
the three potential reading frames as measured by luciferase assays (Figure S3.1A, (Kearse et 
al., 2016)). The most abundant RAN product, FMRpolyG, initiates in the +1 reading frame at 
one of two near-cognate codons: an ACG codon at 35 nucleotides upstream of the CGG repeat 
and a GUG codon at 11 nucleotides upstream the CGG repeat to create an out-of-frame, 
overlapping upstream open reading frame (uORF) that ends after the AUG start codon of FMRP. 
Initiation in the +2 reading frame, FMRpolyA, occurs within the repeat itself at larger repeat 
sizes and terminates prior to the AUG start codon of FMRP, creating a uORF with the potential 
for re-initiation (Hinnebusch et al., 2016; Kearse et al., 2016).  
To determine whether CGG RANT might have a conserved function, we first explored 
the sequence conservation of the 5’ UTR. The CGG repeat element in the 5’ UTR of FMR1 is 
highly conserved among mammals and becomes expanded in primates (Eichler et al., 1995). 
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Outside of the repeat itself, the 5’ UTR of FMR1 in humans is almost invariant. A large-scale 
analysis of novel point mutations in FMR1 that might recapitulate FXS revealed no 
polymorphisms in the 5’ UTR outside of the repeat (Collins et al., 2010). Within mammals, all 
three RANT start sites are conserved in reading frame relative to the CGG repeat and to the 
AUG of the FMRP main open reading frame (ORF) to armadillos (Figure 3.1). The mean 
vertebrate phyloP score of the 0-frame ACG is 0.39, and for the ACG and GUG of the +1 frame 
the scores are 1.60 and 1.48, respectively. These values represent slower relative evolution of all 
three RANT start sites and a high level of conservation of the +1 start sites amongst vertebrates, 
and suggest a physiological, rather than pathophysiological, role for RANT(Pollard et al., 2010).  
 
 
Figure 3.1: 
RANT start sites are conserved among mammals. Interspecies conservation of near-cognate codon RANT start 
sites in the 0/native (arginine; green) and +1 (glycine; orange) reading frames of the 5’ UTR of FMR1. The CGG 
repeat is highlighted in blue. The AUG start codon for the FMRP open reading frame (yellow) is 69 nucleotides 
downstream of the repeat. All three initiation sites and their reading frames in reference to the repeat and the native 
frame FMRP start codon are conserved in mammals. 
 
 
Assays of global protein synthesis by ribosome profiling demonstrated that translation 
initiation at near-AUG codons within the 5’ UTR of mRNAs is quite common, with overlapping 
uORFs typically acting as negative regulators of translation from the main ORF (Brar et al., 
2012; Ingolia et al., 2012; Ingolia et al., 2011). In published datasets from both man and mouse, 
Armadillo (Dasypus novemcinctus)
 GGGCGGCGGGCCGACGGCGAGCGCGGGCGGCGGCGGTGACGGAGGCGCCGCTGCCAGGGGGCGTGCGGCAGCGCGGCGGCGGCGG...AUG*FMRP CDS
-------GAGCCGACGGAGAGCGCGGGCGG------TGACGGCGGCGCCGCTGCCGGGGGGCGTGCGGGAGCGCGGCGGCGGCGG...AUG*FMRP CDS
Chimpanzee (Pan troglodytes)
Wild boar (Sus scrofa)
GGGCGGCGGGCCGACGGCGAGCGCGGGCGGCGGCGGTGACGGAGGCGCCGCTGCCAGGGGGCGTGCGGCAGCGCGGCGGCGGCGG...AUG*FMRP CDS
GGGCGGCGGGCCGACGGCGAGCGCGGGCGGCGGCGGTGACGGAGGCGCCGCTGCCAGGGGGCGTGCGGCAGCGCGGCGGCGGCGG...AUG*FMRP CDS
GGGCGGCGGGCCGACGGCGAGCGCGGGCGGCGGCGGTGACGGAGGCGCCGCTGCCAGGGGGCGTGCGGCAGCGCGGCGGCGGCGG...AUG*FMRP CDS
GGGCGGTGAGCCGACGGCGAGCGCAGGCGGCGGCGGTGACGGCGGCGCCGCTGCCGGGGGGCGTGCGGCAGCGCGGCGGCGGCGG...AUG*FMRP CDS
.
. . ..
.
.
Homo Sapiens
Homo Sapiens
Homo Sapiens
Dog (Canis familiaris)
GGGCGGCGGGCCGACGGCGAGCGCGGGCGGCGGCGGTGACGGAGGCGCCGCTGCCAGGGGGCGTGCGGCAGCGCGGCGGCGGCGG...AUG*FMRP CDS
GGGCGGTGAGCCGACGGCGAGCGCGGGTGGCGGCGGTGACGGCGGCGCCGCTGCCGGGGGGCGTGCGGCCGCGCGGCGGCGGCGG...AUG*FMRP CDS
.....Homo Sapiens
Mouse (Mus musculus)
GGGCGGCGGG---------CCGACGGCGAGCGCGGGCGGCGGCGGTGACGGAGGCGCCGCTGCCAGGGGGCGTGCGGCAGCGCGGCGGCGGCGG...AUG*FMRP CDS
GGGCGGGCAGTGAAGCAAACGGACGGCGAGCGCGGGCGGTGGCAGTGACGGCGGCGCCGCTGCCGGGGGGCGTGCGGTAACGCGGCGGCGGCGG...AUG*FMRP CDS
.... .... . .Homo Sapiens
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we previously detected peaks on the two near-AUG codons in the +1 reading frame associated 
with initiation of FMRpolyG translation (Ingolia et al., 2012; Ingolia et al., 2011; Todd et al., 
2013). Re-analysis of these datasets identified a third uORF initiation site at the 0-frame ACG in 
mouse embryonic stem cells treated with harringtonine (a drug that stalls ribosomes at initiation 
sites), suggesting that this initiation event occurs in mice at normal repeat sizes (Ingolia et al., 
2011).  
To test the impact of these RAN events on FMRP synthesis, we generated two sets of 
reporters. The first set serves as a measure of FMRP synthesis with the full 5’ UTR and the first 
coding exon of FMRP fused to a modified nanoluciferase (nLuc) with a GGG in place of its start 
codon (Figure 3.2A). The second set serves as a measure of RANT with GGG-nLuc in the 0, +1 
or +2 frames of the full FMR1 5’ UTR (Kearse et al, 2016). Both reporter sets were modified to 
contain a range of CGG repeats from 0 to 100. Consistent with previous results (Chen et al., 
2003; Ludwig et al., 2011), increasing the number of CGG repeats in our FMRP reporter 
negatively impacts FMRP synthesis in in vitro translation assays using rabbit reticulocyte lysate 
(RRL) as measured by nLuc activity (Figure 3.2B). However, western blot analysis provides a 
more complete picture of how the CGG repeat impacts translation in the native frame. There are 
two species generated from the FMRP reporter: one at the expected molecular weight of 24.5kDa 
(lower band) and an upper band representing an N-terminal extension initiating upstream of the 
repeat. Expression of both wild-type FMRP and the N-terminal extension is inversely 
proportional to the CGG repeat size, with most of the detectable N-terminal extension absent at 
normal repeat sizes (28 CGGs) and beyond. Consistent with this, the N-terminal extension is less 
than 1% of the total measured FMRP reporter signal in HEK293 cells at normal and expanded 
repeat sizes, and is undetectable by western blot (Figure S3.1A).   
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Figure 3.2: 
RANT impacts the translational efficiency of FMRP in vitro. A) Schematic of FMRP and RAN nanoluciferase 
(nLuc) reporter. The AUG of the nLuc coding sequence (pink) is mutated to GGG and placed in-frame with the first 
coding exon of FMRP (yellow) downstream of the full 5’ UTR of FMR1 (green) to act as a reporter for FMRP 
((CGG)n FMRP-nLuc). Alternatively, GGG-nLuc was inserted into the 5’ UTR of FMR1 within different reading 
frames to serve as a reporter for RANT ((CGG)n RAN-nLuc). The reading frame for each RANT reporter is altered 
by inserting +1(FMRpolyG) or +2(FMRpolyA) nucleotide frameshifts between the repeat and nLuc. Repeat size and 
sites of RAN initiation codon mutations are indicated. A carboxyl-terminal 3xFLAG tag (gray) is included for 
antibody-based detection. B) Top: Western blot of in vitro translated (CGG)n FMRP-nLuc reporter mRNAs 
harboring different CGG repeat sizes. Bottom: Luciferase activity of in vitro translated FMRP-nLuc reporters with 
CGG repeat sizes. ‡‡: FMRP-nanoluciferase-3X FLAG protein. ‡: N-terminal extension of FMRP from initiation in 
the (polyarginine) 0-frame. The addition of increasing repeats leads to a significant reduction in FMRP until 45 
repeats where the FMRP levels remain steady as more repeats are added. C) Top: Western blot of the (CGG)n 
FMRP-nLuc reporters with 25 or 100 CGG repeats with mutation of either the 0 or +1 initiation sites in isolation or 
in combination. +1-AUG represents insertion of AUG in place of ACG RAN initiation codon in the +1-reading 
frame. Bottom: nLuc Assay of 25 and 100 repeat (CGG)n FMRP-nLuc reporters with indicated mutations. A 
synergistic increase in FMRP reporter product is seen when all three near-AUG start sites are mutated to block RAN 
initiation (0/+1-AAA). D) Left: Western blot of in vitro translated +1 (CGG)n RAN-nLuc reporters. Mutating the +0 
frame ACG initiation site (0-AAA) in +1 (CGG)n RAN-nLuc reporters increases translation in the +1 reading frame. 
Right: Luciferase activity of in vitro translated +1 (CGG)n RAN-nLuc reporters. E) 0-AAA and +1-AAA initiation 
codon mutations enhance RANT in the +2(FMRpolyA) reading frame by nLuc assay in vitro. These effects are 
synergistic at expanded repeat sizes. All nLuc assays were performed in triplicate in 3 or more independent 
experiments. One-way ANOVA was performed for panel C, and within repeat groups (25 or 100) for panels D, E, 
and F, **p>0.01, ****p<0.0001. All graphs represent mean +/- S.E.M. 
 
The near-cognate start sites utilized for 0-frame (ACG) and +1 frame RAN initiation 
(ACG and GUG) were mutated to determine whether they influence FMRP synthesis. The single 
0-frame start site was mutated to an AAA codon (0-AAA). The first +1 start site was also 
mutated to an AAA while the second was mutated to a TAG (+1-AAA). The 0/+1-AAA mutant 
has all three of these mutations to prevent RAN initiation in both reading frames. In vitro 
translation of the 0-AAA mutant FMRP reporter with no CGG repeats confirms that a large 
portion of the nanoluciferase signal is derived from an N-terminal extension to FMRP, and 
mutation of the 0-frame initiation site decreases its overall expression (Figure S3.1B). This 
suggests one reason for the CGG repeat is to direct initiation to the main, downstream AUG. 
Mutating the +1 frame start sites increases FMRP reporter synthesis in the absence of any repeat 
element. Mutating both reading frames (0/+1-AAA) also increases expression from the FMRP 
reporter, suggesting that removing the negative impact of the +1 reading frame is sufficient to 
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offset the loss of the N-terminal initiation event. This is visualized via western blot, where 
mutants with decreased signal in the N-terminal extension (upper band) have increase signal in 
the wild-type FMRP band (lower band). The continued presence of an N-terminal extension band 
in the absence of the 0-frame ACG codon suggests alternative non-AUG codons may be utilized 
in this in vitro system even when no repeat is present.  
To evaluate the impact of these initiation events in the presence of a repeat, we added 25 
or 100 CGG repeats to these mutant FMRP reporters and performed in vitro translation assays. 
Interestingly, the removal of 0-frame RAN translation increases FMRP translation in both 25 and 
100 repeats (Figure 3.2C). In isolation, the +1 reading frame has no effect on FMRP synthesis 
alone. However, mutating both reading frames (0/+1-AAA) leads to a synergistic increase in 
FMRP translation at both normal and expanded repeat sizes. These data implicate potential 
coordination between RANT in the two reading frames in modulating downstream translation of 
the FMRP open reading frame.  
As a second test of whether upstream initiation events can impair FMRP synthesis, we 
placed AUG codons in either the +1 or +2 reading frames. Both AUG codons severely decrease 
the signal from our FMRP reporters, with the +1 AUG mutations exhibiting greater inhibition of 
FMRP reporter synthesis than the +2 AUG and greater inhibition with larger repeats (Figure 
S3.1C). As a third test, we introduced stop codons in multiple reading frames either upstream or 
downstream of the CGG repeat in our FMRP reporters (Figure S3.1D). Stop sites were placed in 
all three reading frames upstream of the repeat (All STOP up) or all three reading frames 
downstream of the repeat (All STOP down). Placing stop codons in all three reading frames 
upstream of the CGG repeat significantly increased FMRP reporter expression. In contrast, 
placing stop sites downstream of the repeat in the three frames slightly decreased reporter protein 
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levels (Figure S3.1E). This may reflect loss of the contribution from the N-terminal extension 
that occurs in vitro. Overall, these studies are consistent with a direct role for RAN translation in 
negatively regulating FMRP production in vitro.  
To understand whether there is interplay between RANT reading frames, we utilized 
RANT specific reporters (Kearse et al, 2016) with RAN initiation sites mutated serially across 
reading frames in each reporter. Mutating the 0-frame ACG to an AAA leads to a significant 
increase in +1 frame RAN translation in both 25 and 100 CGG repeat-containing reporters 
(Figure 3.2D). Next, we introduced the 0-AAA, +1-AAA, 0/+1-AAA, or +1-AUG mutations to 
the +2 frame RAN reporters. Precluding RAN initiation in the 0- and +1-reading frames 
increases translation in the +2-reading frame at both normal and expanded repeats (Figures 
3.2E, Figure S3.1F). This effect was greatest for 0-AAA and 0/+1-AAA mutants, and was 
enhanced in the setting of expanded repeats. In contrast, driving translation in the +1 frame with 
an AUG upstream of the repeat markedly decreases production of the +2 product. In conjunction 
with previous data demonstrating that CGG RAN translation relies on the m7G cap, eIF4E, and 
the eIF4A helicase (Kearse et al., 2016; Ludwig et al., 2011), these experiments are 
predominantly consistent with a scanning mode of translational initiation for both RANT and 
FMRP. RAN initiation in each reading frame is inhibited by previous upstream initiation events 
and all events negatively regulate FMRP synthesis.  
 
RAN translation negatively regulates neuronal FMRP synthesis 
Our initial experiments assessing interplay between RAN translation and FMRP synthesis 
were conducted in a non-neuronal in vitro system without direct relevance to Fragile X spectrum 
disorders. To determine the effect of RAN translation on FMRP synthesis in a more relevant cell 
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type, FMRP reporters were transfected into mature rat hippocampal neurons. Unlike the in vitro 
condition, neither the 0-AAA nor the +1-AAA mutants alone led to a significant increase in 
FMRP (Figure 3.3A). However, the combined 0/+1-AAA mutant had a greater than two-fold 
enhancement in the FMRP reporter signal (Figure 3.3A). This was true at both normal and 
expanded repeats, as well as in the absence of any CGG repeats (Figure S3.2 A). Similar to the 
in vitro studies, placing an AUG start codon in the +1 frame upstream of the repeat decreased 
FMRP reporter abundance (Figure S3.2 B). 
To evaluate whether a human cell would also demonstrate this inhibitory effect of RANT 
on FMRP synthesis, we transfected SH-SY5Y human neuroblastoma cells with these same 
reporters (Figure 3.3B). As in neurons, mutations that precluded RANT in the 0- and +1 reading 
frames markedly enhanced FMRP reporter levels in SH-SY5Y cells. This was not due to altered 
RNA expression or stability from the different constructs, as RT-qPCR studies demonstrated no 
difference in mRNA abundance between control and 0/+1-AAA mutant reporters (Figure 3.3C). 
Our reporters do show an increase in mRNA abundance with a larger repeat, recapitulating past 
findings that larger repeats exhibit elevated transcription (Figure S3.2C) (Ofer et al., 2009; 
Tassone et al., 2007). To determine the spatial distribution and abundance of the reporter protein 
in transfected neurons, we performed immunocytochemistry in neurons transfected with the WT 
or 0/+1-AAA FMRP reporters (Figure 3.3D-E). As with the nLuc assay, we observed 
significantly increased signal in neurons with the 0/+1-AAA mutations. This effect was seen in 
both the soma and in dendritic processes where a portion of FMRP synthesis normally occurs 
(Figure 3.3F). 
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Figure 3.3:  
RAN translation impedes FMRP translation in neurons. A) nLuc assay in mature (DIV 13) rat hippocampal 
neurons shows synergistic increase in FMRP reporters when RAN translation is precluded in the two reading frames 
(0/+1-AAA). n>8 for each condition. B) nLuc Assay demonstrates enhanced FMRP reporter signal in (0/+1-AAA) 
mutants at normal and expanded repeats in human SH-SY5Y neuroblastoma cells expressing indicated reporters. 
n=3 for each condition. C) RT-qPCR of SH-SY5Y cells expressing indicated FMRP reporters show no change in 
steady state reporter mRNA levels between WT and 0/+1-AAA mutant reporters at either 25 or 100 CGG repeats. 
n=3 for each condition. D) Immunocytochemistry of FLAG tagged (green) reporters transfected into neurons co-
expressing mCherry to fill the cell. E) Straightened dendrites of the WT and 0/+1-AAA reporters with 25 repeats 
shows greater reporter signal in neuronal processes with the RAN mutant reporters. F) Reporter signal was 
calculated using the corrected total cell fluorescence (CTCF). n=17 for WT and 0/+1-AAA CGG25 reporters, n=23 
for the WT CGG100 reporter and n=21 for the 0/+1-AAA CGG100 reporter. All graphs represent mean +/- S.E.M. >3 
independent experiments for A-C. All individual replicates are internally normalized to a co-transfected pGL4.13 
(firefly luciferase) plasmid. Panel A utilizes a two-way ANOVA with multiple comparisons within repeat groups. 
Panels B, C, and E utilize a Student’s t-test, *p<0.05, ***p<0.001. All graphs represent mean +/- S.E.M. 
 
CGG RAN translation occurs locally in dendrites 
If RANT regulates local FMRP synthesis, then it should occur out in neuronal processes 
where a subset of FMR1 mRNA is translated. To test this directly, we generated a series of RAN 
translation specific reporters using a Venus fluorescent protein without an AUG start codon  
downstream of the 5’ UTR of FMR1 in the +1 RANT reading frame. RAN reporters along with 
positive (AUG-Venus) and negative (DAUG-Venus, no AUG start codon) controls for translation 
were individually co-transfected alongside the cell-filling mCherry into mature rat hippocampal 
neurons (Figure 3.4A). As expected, AUG-Venus shows high translation that is expressed 
throughout the entire cell, while removal of the AUG (DAUG-Venus) erases any signal from the 
Venus channel. In contrast, +1 RAN protein products of both 25 and 90 CGG repeats accumulate 
in aggregates in neuronal soma and dendrites, with higher steady state expression of reporters 
with larger repeats (Figure 3.4B).  
To decipher if RAN translation occurs in neuronal processes we performed single-
molecule imaging using a protocol specifically designed to detect translation events in distal 
apical dendrites (Ifrim et al., 2015). Event maps were derived using the +1 RAN-Venus reporters 
with 25 and 90 CGG repeats (Figure 3.4C). Dendrites were located using the pre-bleach Venus  
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Figure 3.4:   
RAN translation occurs in distal dendrites. A) Live imaging of mature rat hippocampal neurons co-
transfected with RANT specific Venus reporters and mCherry. Top left: Venus alone. Bottom left: Venus 
without an AUG start codon (∆AUG Venus). Top right: +1 (CGG)25 RAN-Venus. Bottom right: +1 (CGG)90 
RAN-Venus. Live imaging revealed aggregation of FMRpolyG at large (90) and small (25) repeat sizes in 
soma and processes. B) +1 RAN-Venus harboring expanded CGG (90) repeats are expressed more than 
reporters with normal length repeats. C, D) Single molecule imaging detects translation events in distal 
neuronal processes of neurons transfected with +1 (CGG)n RAN-Venus reporters with 25 (C) or 90 (D) 
repeats. E) Quantification of RANT events in processes demonstrates no significant difference between repeat 
sizes. n=3 individual distal dendrites per transfection. Student’s t-test, n.s.=not significant, ***p<0.001. All 
graphs represent mean +/- S.E.M. 
 
signal, and single molecule events were detected post-bleaching. Importantly, we readily 
detected isolated RANT events within dendrites at both normal and expanded repeat sizes in the 
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+1 reading frame. However, we observed no significant difference in translation rates between 
normal and expanded repeat sizes (Figure 3.4D). Given that there is both more transcript overall 
in neurons expressing the larger repeat and higher basal +1 RAN peptide abundance at larger 
repeats in these same neurons, as well as in other cell-based and in vitro assays (Kearse et al, 
2016), this finding of a similar dendritic synthesis rate suggests that RANT at normal repeat sizes 
may be favored in neuronal processes. 
 
CGG repeats and RAN translation are required for mGluR dependent FMRP synthesis 
Induction of lasting changes in synaptic function often requires localized activity-
dependent neuronal protein synthesis(Cajigas et al., 2010; Costa-Mattioli et al., 2009; Ho et al., 
2011). Activation of metabotropic glutamate receptors (mGluRs) triggers synaptic protein 
synthesis (Weiler and Greenough, 1993). This new protein synthesis is required for critical 
aspects of neurophysiology, including the maintenance of mGluR induced long-term depression 
(LTD) and mGLuR elicited epileptiform discharges (Huber et al., 2000; Merlin et al., 1998). 
FMRP plays an active role in regulating protein synthesis: its loss leads to increased basal 
protein synthesis in neurons and it is required for mGluR-triggered translation of FMRP target 
mRNAs (Osterweil et al., 2010; Qin et al., 2005; Tang et al., 2015; Todd et al., 2003). Consistent 
with this, loss of FMRP in rodents leads to enhanced mGluR-dependent LTD, as well as 
behavioral phenotypes including learning dysfunction, lowered seizure threshold, and enhanced 
anxiety and autistic behaviors (Dolen et al., 2007; Huber et al., 2002). These phenotypes can be 
largely corrected by genetic or pharmacologic attenuation of mGluR receptor signaling (Dolen et 
al., 2007). FMRP itself is degraded and then rapidly resynthesized in response to group I mGluR 
(mGluR1) receptor activation in neurons and synaptoneurosomes (Hou et al., 2006; Nalavadi et 
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al., 2012; Todd et al., 2003; Weiler et al., 1997). The loss and then return of FMRP coincides 
with a critical window for protein synthesis-dependent plasticity elicited by mGluR activation 
(Huber et al., 2000; Merlin et al., 1998), suggesting that it may provide negative feedback to  
temporally constrain local synthesis events in neurons (Bear et al., 2004; Todd and Malter, 
2002).  
To explore how RANT impacts activity-dependent FMRP synthesis, we evaluated the 
impact of mGluR activation on endogenous FMRP and our FMRP and RANT reporters. 
Consistent with published data(Todd et al., 2003), application of the mGluR1 agonist 
dihydrophenylglycine (DHPG, 50µM) to hippocampal rat neurons in culture significantly 
increased endogenous FMRP expression by 56% after 30 minutes of treatment (Figure 3.5A). 
FMRP and +1 RAN nanoluciferase reporters were modified with a C-terminal PEST degron 
sequence to stimulate reporter protein turnover, lowering the stable background of the reporter 
and allowing for enhanced detection of changes in expression over short timeframes (Figure 
3.5B). In addition, the 3’ UTR of FMR1 was included as previous work demonstrated that it was 
required for mGluR-dependent synthesis of FMRP (Suhl et al., 2015).  
First, we investigated whether our transfected reporters could recapitulate DHPG-induced 
changes in endogenous FMRP expression. FMRP-nLuc-3’ UTR reporters bearing either 20 or 90 
CGG repeats both exhibited a significant increase in activity after 30 minutes of DHPG 
treatment, similar to that observed with endogenous FMRP (Figure 3.5C). In contrast, reporters 
without the CGG repeat (CGG0) showed no response to DHPG, suggesting a specific role for the 
repeat element in mGluR-triggered FMRP translation. To understand this further, we first 
replaced the CGG repeat with a GAA25 repeat. This modification maintains the length of the 5’  
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mGluR dependent FMRP synthesis requires the CGG repeat and RAN translation. A) Left: Western blot 
of cultured rat hippocampal neurons treated with 50µm DHPG for the indicated times. Right: Quantification of 
western blots (normalized to GAPDH) shows an increase in endogenous FMRP at 30 minutes of treatment 
versus sham treated cells. B) Schematic of FMRP and +1 RAN reporter constructs modified to add a PEST 
degron sequence and the 3’ UTR of FMR1 to allow for appropriate mRNA trafficking. (C) NLuc assays in rat 
hippocampal neurons 30 minutes after mock or DHPG treatment. No DHPG response was seen in constructs 
lacking a CGG repeat ((CGG)0). Both 20 and 90 CGG repeat FMRP reporter constructs exhibited an increase 
in signal in response to DHPG. For all nLuc assays, each individual replicate is internally normalized to co-
transfected pGL4.13 (firefly luciferase). D) Replacing the CGG repeat with a (GAA)25 repeat prevents DHPG 
dependent increases in the FMRP reporter. E) RAN translation reporter (+1 (CGG)n RAN-nLuc) shows no 
response to DHPG at normal repeat sizes (20) and a significant decrease after DHPG treatment at expanded 
repeats (90). F) Mutations that prevent RANT initiation (0/+1-AAA) prevent the DHPG-induced response of 
FMRP reporters at both normal and expanded repeat sizes. G) Hybridization Chain Reaction (HCR) of nLuc 
mRNA combined with ICC to co-transfected mApple verifies dendritic export of reporter RNAs. H) 
Quantification of dendritic nLuc mRNA by HCR. FMRP reporters with 20 and 90 repeats exhibit enhanced 
dendritic mRNA abundance relative to AUG-Nanoluciferase-PEST-3xFLAG. Panels A, H: One-way ANOVA 
with correction for multiple comparisons, Panels C-F: Student’s t-test, *p<0.05, **p<0.01, ***p<0.001. All 
graphs represent mean +/- S.E.M. 
 
UTR, but removes the stable RNA secondary structure. In vitro, this change leads to a 4-fold 
increase in basal FMRP-nLuc signal (Figure S3.3A). Replacing the CGG repeat with GAA in  
neurons completely precludes increases in reporter expression induced by DHPG (Figure 3.5D), 
suggesting the structure or sequence of the CGG repeat itself is important to this regulatory 
process.  
We next evaluated the impact of mGluR activation on CGG RANT. RANT reporters for 
FMRPolyG (+1 CGG RAN-nLuc-3’ UTR) showed no change after DHPG treatment at normal 
repeat sizes. In contrast, there was a significant decrease in +1 (CGG)90 RAN-nLuc-3’ UTR 
expression after DHPG treatment (Figure 3.5E), suggesting that suppression of RANT anti-
correlates with FMRP synthesis. To test whether RANT is required for mGluR-induced FMRP 
synthesis more directly, we introduced 0/+1-AAA mutations into our FMRP reporters to 
preclude RAN initiation in these reading frames. Blocking RAN initiation prevented DHPG-
induced synthesis of the FMRP reporters (Figure 3.5F), establishing a function for RANT in 
regulating mGluR-dependent FMRP translation. Collectively, these data support a model 
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whereby the CGG repeat and RANT provide a balance of FMR1 translation events both basally 
and in response to neuronal activity.  
The transport of specific mRNAs into dendrites is required for local protein synthesis 
(Cajigas et al., 2010; Ho et al., 2011). Thus, we investigated the distribution of the reporter 
transcripts in transfected neurons. To accomplish this, we adapted a technique known as 
hybridization chain reaction (HCR) to specifically detect mRNAs containing the nLuc-3xFLAG 
sequence (Figure S3.3B) (Choi et al., 2016; Dirks and Pierce, 2004). Neurons co-expressing 
FMRP-nLuc-3’ UTR reporters and mApple were evaluated by co-HCR/ICC with Cy5-labeled 
RNA probes (Figure 3.5G). There is significant dendritic localization of reporters that include 
the regulatory regions of FMR1 compared to constructs lacking this sequence, independent of the 
presence of any repeat element (Figure 3.5H), consistent with previous results (Suhl et al., 
2015). There is a trending CGG repeat length-dependent increase in the abundance FMRP-nLuc-
3’ UTR reporter mRNAs in distal dendritic processes from 0 to 90 CGG repeats (Muslimov et 
al., 2011). However, this difference was largely explained by differences in relative transcription 
(Figure S3.2C). These data suggest that the absence of response to DHPG in CGG0-FMRP-
NLuc 3’ UTR reporters is unlikely to result from defects in mRNA localization.  
 
Impeding RAN initiation with an antisense oligonucleotide increases endogenous FMRP 
Overlapping uORFs typically function to suppress translation from the main ORF of the 
transcript in which they reside (Hinnebusch et al., 2016). The translation efficiency of the main 
ORF in a given transcript can be enhanced by sterically hindering translation initiation at 
upstream AUG start sites with antisense oligonucleotides (ASOs) (Liang et al., 2016; Liang et 
al., 2017). To evaluate whether a similar strategy could be used to target RANT we designed a  
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Fig 3.6:  
ASO targeting of RAN translation start sites increases FMRP expression in human cells. A) Schematic of 
non-cleaving, RANT blocking ASOs. Colored bars overlap the corresponding FMR1 5’ UTR sequence and 
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start sites; 0 frame ACG (orange), +1 frame ACG (purple), and +1 frame GUG (green). B) A significant 
increase in the FMRP reporter is detected by nLuc assay of HEK293 cells expressing CGG25 FMRP-nLuc-
3’UTR mRNA that were subsequently transfected with +1 RAN ASO (100nM). n=6 for two independent 
experiments performed in triplicate. C) Cells expressing the RAN translation reporter mRNA (+1 (CGG)25 
RAN-nLuc) were subsequently transfected with the indicated ASOs. The +1 RAN ASO and +1 RAN ASO-2, 
but not the Control ASO, significantly decreased the RAN reporter compared to control. n=5 for each 
condition. D) Top: FMRP expression assessed by western blot in HEK293 cells transfected with increasing 
concentrations of +1 RAN ASO for 24 hours. Bottom: +1 RAN ASO elicits a dose-dependent increase in 
endogenous FMRP expression. n=3 for each condition. E) RT-qPCR of HEK293 cells transfected with the +1 
RAN ASO shows no effect on endogenous FMR1 mRNA levels at the effective dose (100nM). n=3 for each 
condition. F) Treatment of HEK293 cells with +1 RAN ASO-2, which targets the GUG initiation site for +1 
RAN, also increases endogenous FMRP. n=4 for each condition. G) 0-frame ASO has no effect on FMRP 
expression in HEK293 cells. n=3 for each condition. For panel E, G, and H, One-way ANOVA with a Fisher’s 
LSD test for dose dependency, *p<0.05, **p<0.01, ****p<0.0001. For all other panels, Student’s t-test, 
**p<0.01. All graphs represent mean +/- S.E.M. 
 
series of modified ASOs targeting the near-AUG sites utilized for RANT in the 5’ UTR of 
FMR1. Six ASOs, harboring 2’-O-methyl modifications and phosphorothioate backbones, were 
designed to singly overlap with the three RAN start site targeted by the three most 5’ nucleotides  
of the ASO (Figures 3.6A, Figure S3.4A). We first tested these ASOs to determine their impact 
on expression of our FMRP and RANT reporters. HEK293 cells were transfected with  
capped and polyadenylated in vitro transcribed CGG25 FMRP-NL reporter mRNAs and the 
ASOs of interest. Treatment with an 18 nucleotide ASO targeting the first +1 reading frame start 
site (+1 RAN ASO) enhanced expression of FMRP as measured by nLuc assay (Figure 3.6B). 
We next determined whether this ASO directly targeted RANT in the +1 reading frame as 
predicted. Cells were transfected with both +1 CGG25 RAN-nLuc-3’ UTR reporter mRNA and 
+1 RAN ASO or an 18 nucleotide long ASO targeting the 0-frame RAN initiation site (0-frame 
ASO). The +1 RAN ASO caused a significant decrease in +1 CGG25 RAN reporter expression, 
while 0-frame ASO had no effect (Figure 3.6C).   
To determine the impact of these ASOs on endogenous FMRP expression, we titrated the 
amount of +1 RAN ASO transfected into HEK293 cells. 24 hours after transfection, the +1 RAN 
ASO elicited a dose dependent increase in endogenous FMRP expression, peaking at 189% when 
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treated with 100nM ASO compared to 0nM ASO treatment (Figure 3.6D-E). This occurred in 
the absence of changes in mRNA levels (Figure 3.6F). A similar effect on endogenous FMRP 
was observed in patient-derived fibroblasts transfected with +1 RAN ASO (Figure S3.4B), while 
the 16-nucleotide ASO targeting this ACG start site increased FMRP at lower doses in HEK293 
cells (Figure S3.4C). 
Treatment with an ASO targeting the GUG codon used in RANT in the +1 reading frame 
(+1 RAN ASO-2) was also effective, showing a significant increase in endogenous FMRP at 
100nM following 24-hour transfection (Figure 3.6G). However, neither the 16- nor 18-
nucleotide ASOs targeting the 0-frame (0 RAN ASO) had an impact on FMRP expression 
(Figures 3.6H, Figure S3.4D). Co-transfecting the +1 RAN ASO and 0 RAN ASO together led to 
no improvement above what was already seen with +1 RAN ASO alone (data not shown). As 
expected, transfection with a control “non-targeting” ASO had no impact on FMRP expression 
(Figure S3.4F). Interestingly, tiling the two +1 RANT initiation sites with the ASOs that singly 
increase FMRP synthesis actually decreased FMRP levels in a dose dependent manner when 
combined in cells (Figure S3.4E). This is likely due to an impact on the ability of the translation 
machinery to reinitiate scanning further down the mRNA transcript (Liang et al., 2017). 
 
ASO blockade of RAN translation suppresses CGG repeat induced neuronal death 
RANT in general and FMRpolyG production in particular are required for CGG repeat 
induced neurodegeneration in both fly and mouse models of FXTAS (Sellier et al., 2017; Todd et 
al., 2013). To test if the +1 RAN ASO also suppresses RANT in RNAs bearing a large repeat, we 
co-transfected HEK293 cells with both the ASOs specified and +1 (CGG)90 nLuc-3’ UTR and 
firefly luciferase reporters (Figure 3.7A). The +1 RAN ASO elicited a 55% reduction in 
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FMRpolyG production by luciferase assays, with no change elicited by a control ASO treatment. 
Similarly, this same ASO strongly suppressed FMRpolyG reporter protein levels by western blot  
 
Fig 3.7:   
RAN ASO suppresses CGG repeat toxicity. A) HEK293 cells expressing the indicated reporters were co-
transfected with control or +1 RAN ASOs. +1 RAN ASO (100nM) selectively suppressed RAN reporter 
expression by nLuc assay. B) Western blot demonstrates selective effect of +1 RAN ASO on +1 (CGG)100 
RAN-nLuc expression. n=3 for each condition for experiments using nLuc reporters, Student’s t-test, 
**p>0.01, ***p>0.001. Graphs represent mean +/- S.E.M. C) Rat neurons transfected with +1 (CGG)100 RAN-
GFP exhibit inclusions in transfected neurons. Scale bar in bottom right image represents 10µm. D) Survival 
analysis on rat cortical neurons transfected with the indicated constructs and ASOs tracked by longitudinal 
fluorescence microscopy. +1 (CGG)100 RAN-GFP expressing neurons exhibit significant toxicity compared to 
GFP expressing controls. Treatment with 1µM +1 RAN ASO, but not the control ASO, reduces CGG repeat 
associated toxicity in cells overexpressing +1 (CGG)100RAN-GFP. Survival is plotted as cumulative risk of 
death. n= number of neurons per condition. Cox proportional hazard analysis, n.s.=not significant, *p= 0.0286, 
***p<2e^-16. 
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(Figure 3.7B). These data show that the ASO that increases endogenous FMRP can also 
selectively engage the RNA target and block RANT of FMRpolyG from expanded repeats. 
To determine if this blockade of FMRpolyG synthesis modulates CGG repeat toxicity in 
neurons, we transfected primary neurons with +1 (CGG)100 RAN-GFP expression constructs, 
which has an analogous design to the previously mentioned nLuc and Venus reporters, and tested 
the efficacy of the +1 RAN ASO to ameliorate neuronal toxicity. Expanded repeat containing 
constructs, elicited large somatic and dendritic aggregates of FMRpolyG fused to GFP (Figure 
3.7C). To measure neuronal toxicity, we utilized automated longitudinal microscopy to track 
neuron death over 10 days on mixed primary rat cortical cultures. This system allows for 
accurate tracking of survival of hundreds of individual neurons over time, with differences in 
groups measured as a cumulative hazard of death (Flores et al., 2016). Neurons were transfected 
with mApple and either +1 (CGG)100 RAN-GFP or GFP. Transfected cells were visualized by 
fluorescence microscopy at regular intervals spanning 10 days, and neuronal survival at each 
time determined on a single-cell level by using mApple as a cell marker for neuronal viability. 
Neurons expressing CGG repeats demonstrated significant toxicity compared to neurons 
expressing GFP alone across multiple experiments (Figure 3.7D), consistent with previous 
studies demonstrating that expanded CGG repeats are sufficient to cause neurodegeneration 
(Sellier et al., 2017; Todd et al., 2013).  
To determine the efficacy of the RANT blocking-ASO to prevent cell death, transfected 
neurons were treated with either +1 RAN ASO or a control ASO. Parallel treatment with the RAN 
ASO had no toxic effect compared to the control ASO in GFP transfected neurons over the 
course of the experiment (Figure 3.7D). In contrast, treatment of +1 (CGG)100 RAN-GFP 
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expressing neurons with +1 RAN ASO significantly reduced toxicity compared to control ASO 
treated neurons (Figure 3.7D). Together with previous studies(Sellier et al., 2017, Todd et al., 
2013), these findings support a direct role for FMRpolyG production in CGG repeat-associated 
neuronal toxicity and suggest that targeting specific RANT may prevent repeat-mediated 
neurodegeneration. 
 
RAN targeting ASOs increase FMRP in Fragile X full mutation patient derived neurons 
The majority of FXS cases result primarily from hypermethylation of the CGG repeat and 
FMR1 promoter leading to heterochromatization of the FMR1 locus and transcriptional silencing. 
However, upwards of 40% of FXS patients exhibit incomplete methylation and some FMR1 
transcription, often associated with mosaicism in CGG repeat size (Jacquemont et al., 2011; 
Nolin et al., 1994; Tassone et al., 1999). FMRP expression in such cases typically remains quite 
low, presumably because of translational inefficiency elicited by the repeat expansion (Feng et 
al., 1995). Importantly, the relative FMRP expression levels in these cases inversely correlates 
with the severity of symptoms, suggesting that even subtle enhancements of FMRP expression 
can be clinically meaningful (Lozano et al., 2014; Tassone et al., 1999).  
To determine whether +1 RAN ASO treatment might enhance FMRP expression in the 
setting of a large CGG repeat expansion, we derived iPSCs from a previously established and 
characterized fibroblast line (TC43-97) with a fully unmethylated FMR1 promoter and ~250-600 
CGG repeats (Figures 3.8A, Figure S3.5A-B) (Burman et al., 1999). As iPSCs, the TC43-97 
line maintains FMR1 mRNA levels, but shows a significant decrease in FMRP expression 
relative to controls (Figure S3.5C-D). The iPSC TC43-97 line maintains an unmethylated repeat 
with a mosaic of repeat length between ~250-340 CGG repeats (not shown). Bisulfite qPCR 
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confirmed that the promoter remained unmethylated after iPSC derivation (Figure S3.5E). This 
new iPSC line allowed us to investigate how the +1 RAN ASO interacts with mRNA bearing a 
full FXS mutation and determine whether it can still impact FMRP expression in this more 
disease-relevant setting. 
 
 
Figure 3.8:   
RAN ASO increases FMRP expression in unmethylated Fragile X full mutation iPSCs. A) Schematic detailing 
iPSCs derived from control (30 CGG repeats) or patient (TC43-97) with unmethylated full mutation (250-340 CGG 
repeats). B) Western blot for FMRP in control and TC43-97 iPSCs transfected with indicated doses of +1 RAN ASO. 
C) Both iPSC lines exhibit a concentration dependent increase in FMRP by one-way ANOVA with a Fisher’s LSD 
test. *p<0.05, **p<0.01, ***p<0.001. n=6 for each condition in both iPSC lines. All graphs represent mean +/- 
S.E.M. 
 
First, we tested if the +1 RAN ASO could increase FMRP in control and TC43-97 iPSCs 
by transfecting increasing doses of the ASO. We observed a significant increase in endogenous 
FMRP at 100nM in both cell lines, while the TC43-97 iPSCs showed a significant increase even 
with 75nM of ASO (Figure 3.8B-C). This occurs in the absence of changes in FMR1 mRNA 
expression (Figure S3.6A). Next, iPSCs were differentiated into neural progenitors and then 
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differentiated for 5 weeks to produce neurons according to an established protocol (Figure 
S3.6A-B) (Shi et al., 2012). Neurons were treated for 24 hours with +1 RAN ASO, followed by a 
media change and 5 additional days of maintenance in culture (Figure 3.9A). Control human 
iPSC derived neurons with a normal repeat size responded to 150nM of +1 RAN ASO with a 
significant increase in FMRP by western blot analysis (Figure 3.9B-C). The full mutation FXS 
iPSC-derived TC43-97 neurons also responded to the ASO with a 62% increase in FMRP. This 
effect is specific to the +1 RAN ASO as control neurons treated with the control ASO showed no 
change in FMRP abundance.  
To confirm that this enhanced FMRP expression in the TC43-97 line was occurring in 
neurons, we conducted immunocytochemistry studies on TC43-97 iPSC-derived neurons to 
detect FMRP in cells that stain for the mature neuronal marker TUJ1 (Figure S3.6C-D). A more 
than 2-fold increase in neuronal FMRP expression is detected using this method, which 
represents an increase in FMRP up to the level of the control neurons (Figures 3.9D-F, Figure 
S3.6E). Taken together, these data demonstrate that targeting RANT in human neurons can 
correct FMRP deficits in the setting of a FXS full mutation. 
 
Discussion 
Simple tandem repeats make up a significant fraction of the human transcriptome and 
expansions in a subset of these repeats are a common cause of human disease (Gemayel et al., 
2010; Nelson et al., 2013). Despite this, we know very little about the native functions of 
transcribed repeats within the context of normal mammalian cellular physiology. Here we define 
a novel, conserved and biologically relevant function of the CGG repeat in the Fragile X gene. 
The repeat supports non-AUG initiated translation from specific near-cognate codons at normal 
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repeat sizes. This translation suppresses basal FMRP production and allows for activity-
dependent FMRP translation in neurons. These findings provide a framework for defining  
Figure 3.9 
RAN ASO increases FMRP expression in unmethylated Fragile X full mutation neurons. A) Control and 
TC43-97 iPSC derived neurons were differentiated for 5 weeks. ASO or vehicle was added to the media for 24 
hours. Cells were maintained for 5 additional days following treatment. B, C) Anti-FMRP western analysis from 
untreated and ASO treated neurons. +1 RAN ASO (150nM) treatment increases FMRP expression in control and 
TC43-97 neurons. Control neurons treated with the control ASO show no change in FMRP levels. n=3 for all control 
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neuron conditions, n=6 for TC43-97 neurons, **p<0.01, Student’s t-test. D) Immunocytochemistry to FMRP (green) 
in TUJ1 positive TC43-97 neurons demonstrates increase in endogenous FMRP in +1 RAN ASO treated cells. Blue 
is DAPI. Scale bar represents 50µm. (E) Zoomed in composite images show the FMRP increase in neuronal soma 
and processes. F) FMRP expression normalized to TUJ1 levels in the same neurons reveals correction of FMRP 
expression to control levels in +1 RAN ASO treated neurons. n=118 for the 0nM TC43-97 condition, n=100 for the 
150nM ASO TC43-97 condition, and n=95 for 0nM treated control neurons. One-way ANOVA with multiple 
comparisons, ****p<0.0001. Panel C represents mean +/- S.E.M. In panel F, bars represent the range of values with 
a line at the mean. 
 
physiological roles for repetitive elements in both translational control and neurobiology and 
answers a long-standing question as to why this disease causing repeat is present and conserved 
in mammals (Eichler et al., 1995). 
By mapping out a native function for RANT and CGG repeats, we identified a new 
therapeutic target in fragile X–associated disorders. To this end, we adopted a recent advance in 
ASO technology that allows targeting of AUG-initiated uORFs as a mechanism for enhancing 
translation from the main reading frame (Liang et al., 2016). Exactly how uORF ASOs function 
is unclear. They require RNA helicase activity and enhance recruitment of specific initiation 
factors (e.g. eIF2-alpha and eIF4A) to targeted transcripts (Liang et al., 2017) and based on the 
optimal target location for effect of these ASOs, they likely impede recognition of potential start 
sites during ribosomal scanning (Liang et al., 2016). This is consistent with our current 
knowledge of how RANT occurs at CGG repeats, where initiation is strongly cap-dependent and 
eIF4A-dependent (Kearse et al., 2016). However, too strong of a blockade by the ASOs may 
prevent continued scanning of the preinitiation complex. Consistent with this, when two ASOs 
that target the two potential +1 reading frame start sites are utilized, they inhibit rather than 
enhance FMRP synthesis despite enhancement when either is used separately (Figure S3.4E).  
Treatment of neurons with an ASO targeting the +1 RAN translation initiation site 
significantly suppresses neuronal toxicity elicited by premutation-sized CGG repeat expansions 
in a cellular model of FXTAS, correcting a gain of function phenotype and supporting a role for 
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RANT in FXTAS disease pathogenesis. In parallel, treatment of unmethylated full mutation 
iPSCs and neurons with this same ASO markedly enhanced endogenous FMRP production, 
correcting the fundamental loss of function defect in FXS. This ASO also acts at normal FMR1 
CGG repeat sizes, further demonstrating a native function for this process in FMR1 regulation. 
Thus, by selectively targeting a normal function at pathological expansions we were able to 
rescue multiple relevant disease states in cellular model systems.  
Our work identifies RANT initiation and CGG repeats as active modulators of neuronal 
FMRP translation, suggesting a new function for these elements in activity-dependent 
translation. Previous work described how CGG repeats act to enhance FMR1 transcription and 
reduce FMRP translation in a length-dependent fashion in both cell based and in vitro studies 
(Chen et al., 2003; Feng et al., 1995; Ofer et al., 2009; Tassone et al., 2007; Usdin and Kumari, 
2015). CGG repeats as DNA normally act as a large CpG island near the promoter of FMR1 to 
maintain an open chromatin state, and this effect is enhanced with repeat expansion (Usdin and 
Kumari, 2015). However, once the repeat size crosses a threshold, it triggers methylation and a 
closed chromatin state, perhaps through RNA-induced transcriptional silencing (Colak et al., 
2014; Zhou et al., 2016). Numerous modulatory factors for this process have now been identified 
(Usdin and Kumari, 2015). Thus we now have a relatively nuanced understanding of how repeats 
function transcriptionally. In contrast, our understanding of how CGG repeats influence 
translation have focused largely on a model where the repeat creates a steric hindrance on 
ribosomal scanning that is overcome in an unregulated fashion through the activity of RNA 
helicases (Ofer et al., 2009). The finding that this event is activity-dependent suggests a novel 
mechanism by which local mRNA translation in neurons could be regulated through selective 
uORF usage in the setting of repetitive or structured mRNA elements in the 5’ UTR.    
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How RANT and CGG repeats mediate this regulation is not clear, partially because how 
mGluR activation drives local protein synthesis is not entirely understood. mGluR1 activation 
stimulates a number of pathways in dendrites, including release of intracellular calcium stores, 
diacylglycerol and protein kinase C activation, ERK phosphorylation, mTOR signaling, and 
ubiquitin-proteasome activation (Bhakar et al., 2012; Hagerman et al., 2017). Neuronal  
 
Figure 3.10: 
Graphical Abstract: Expanded CGG repeats in FMR1 underlie both a common cause of autism (Fragile X 
Syndrome) and neurodegeneration (Fragile X-associated Tremor/Ataxia Syndrome). Repeat associated non-AUG 
(RAN) translation at this repeat initiates at near-cognate codons in the 5’ UTR of FMR1 mRNA. RAN translation 
and the CGG repeats normally function to suppress basal FMRP production while allowing for activity-dependent 
synthesis of FMRP in neurons, but both functions become problematic with repeat expansions due to toxic RAN 
proteins and loss of FMRP. An ASO targeting RAN initiation suppresses CGG repeat toxicity while simultaneously 
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enhancing FMRP synthesis in Fragile X patient derived neurons, suggesting a novel therapeutic approach to both 
Fragile X-associated disorders.  
 
activation by mGluRs drives synaptic alterations through cap-dependent protein synthesis (Huber 
et al., 2000) and additional work suggests specific roles for the cap complex protein eIF4E and 
the ternary complex component eIF2α in this process (Di Prisco et al., 2014; Gantois et al., 2017; 
Gkogkas et al., 2014). However, other studies suggest that at least the initial wave of translation 
that occurs in response to mGluR activation is derived from mRNAs bound to stalled 
polyribosomes, and cannot be precluded following incubation with a drug that binds and blocks 
ribosomes prior to their association with mRNA (Graber et al., 2013). Consistent with this, the 
eukaryotic elongation factor eEF2 appears to act as a sensor coupling synaptic activity to 
translational control. During particular patterns of synaptic activity, eEF2 phosphorylation is 
enhanced, negatively regulating protein synthesis (Sutton et al., 2007). Thus, both translation 
initiation and elongation regulation appear critical for controlling translation associated with 
synaptic plasticity.  
Our data demonstrate an increase in both native FMRP and FMRP reporter synthesis 
after mGluR activation. This mGluR-dependent increase requires RAN translation and the CGG 
repeat. One explanation for this is that ribosomes stall in translation of the CGG repeat with a 
build-up of 40S pre-initiation complexes that follow to eventually reach the AUG of FMRP. 
With DHPG stimulation, there is re-activation of translation from these stalled polyribosomes, 
and from loaded and scanning 40S subunits that have not yet initiated. Removing the repeat or 
altering the secondary structure and sequence upsets this balance, preventing upscaling of FMRP 
translation. Given that translating ribosomes and associated proteins are a potent RNA helicase, 
RANT itself may have repeat structure-destabilizing effects that could alleviate secondary 
structure and prime FMR1 for further translation (Todd et al., 2013). In this context, it is 
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interesting that RAN translation at CGG repeats is selectively and paradoxically enhanced by 
eIF2α phosphorylation, which typically suppresses translation initiation (Green et al, Nature 
Communications, in press). This suggests that RANT may bypass some canonical initiation 
pathways to serve specific regulatory roles in this synaptic context.  
Translational regulation elicited by the CGG repeat and RANT on the FMR1 transcript 
may be an exemplar for a broader class of regulatory events on eukaryotic mRNAs. Specific 
AUG-initiated regulatory uORFs in genes such as GCN2 and ATF4 are well characterized as 
serving to suppress translation from the main ORF normally but activate under stress 
conditions(Hinnebusch et al., 2016), and both GCN2 and ATF4 have been implicated as 
regulators of learning and memory in mouse behavioral studies (Costa-Mattioli et al., 2009). 
More recently, specific near cognate uORF sites were defined in transcripts encoding proteins 
critical for cancer and cellular responses to stress (Sendoel et al., 2017; Starck et al., 2016). 
Ribosome profiling studies suggest uORFs may be quite common, with some studies suggesting 
they are utilized on one third of all transcripts across a broad class of cell types and species 
(Brar, 2016; Ingolia et al., 2011). Moreover, some studies suggest that uORF usage shifts with 
changes in cell states, such as during mitosis in eukaryotic cells and across the life cycle of 
budding yeast (Brar et al., 2012). Studies in neurons suggest a select number of transcripts move 
to polysomes upon DHPG stimulation, and these are enriched for uORFs (Di Prisco et al., 2014). 
One transcript derived from a gene also implicated in X-linked intellectual disability, Ophn1, 
bears a uORF that is required for its regulation in response to DHPG. Translation of this 
transcript and other uORF containing transcripts is specifically regulated by phosphorylation of 
eIF2α, and this is in turn essential to learning in mice (Di Prisco et al., 2014). In this context, 
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perhaps RANT is acting as a regulatory uORF to impair basal FMRP, but in its absence proper 
scaling cannot be achieved in response to DHPG.  
In recent years, ASO therapies have moved from the research bench to the clinic. This 
was initially thought of as a strategy to target solely gain-of-function disorders, where 
knockdown of a toxic transcript or blocked expression of a toxic protein could potentially 
abrogate disease pathology. However, the recent success of nusinersen, which blocks binding of 
hnRNPs to SMN2 to increase production of the SMN protein in spinal muscular atrophy (Finkel 
et al., 2016; Rigo et al., 2012), speaks to the potential power of these molecules to treat loss-of-
function disorders in the nervous system. The exact abundance of FMRP required to correct 
phenotypes in FXS remains unknown, but even modest enhancement of this protein may be 
helpful in the disease state. To this end, the approaches described here represent an exciting 
opportunity to potentially leverage new disease insights towards effective therapeutic 
development.  
 
Methods 
Plasmid Construction 
Cloning of the pcDNA3.1(+) vectors expressing AUG-nLuc, +1 (CGG)n RAN-nLuc, +2 
(CGG)n RAN-nLuc, and +0 (CGG)n RAN-nLuc was described in (Kearse et al., 2016). All 
ligations were performed using Roche Rapid DNA Dephosphorylation and Ligation Kit 
according to manufacturer’s specification. PCR cloning was accomplished with Phusion High-
Fidelity DNA Polymerase (NEB) or Platinum Taq High-Fidelity (Thermo Fisher). All site-
directed mutagenesis was performed using Q5 Site-Directed Mutagenesis Kit (NEB) according 
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to manufacturer’s protocol. All vector sequences are listed in Table 3.1, and all primers used for 
cloning are listed in Table 3.2.  
To generate RAN translation reporters bearing out-of-frame mutants, the XhoI and XbaI 
fragment harboring the nLuc reporter in each particular reading frame was cloned back into the 
desired mutant background that contained CGG repeat (Kearse et al., 2016). +1 (CGG)100 GGG-
nLuc-3xFLAG-PEST was generated using a two-step Q5 site directed mutagenesis strategy 
using +1 (CGG)0 GGG-nLuc-3xFLAG (Kearse et al., 2016) as a template. The PEST containing 
GGG-nLuc coding sequence was cloned into the original plasmid using EcoRV and XbaI to 
obtain a full (CGG)100 repeat construct.  
For the (CGG)n FMRP-nLuc vector, the (CGG)100 repeat was moved from a separate 
pUAST vector using restriction enzymes EcoRI and XhoI. The 3’ end of the FMR1 5’ UTR and 
first coding exon was added by PCR cloning using XhoI and NotI. Nanoluciferase with a GGG 
in place of the AUG, GGG-nLuc-3xFLAG, was cloned in frame with the first FMRP exon using 
NotI and XbaI. The 3xSTOP (taattaattaa) was inserted 16 nucleotides downstream of the repeat 
by Q5 SDM using (CGG)0 FMRP GGG-nLuc as a template. The mutated sequence was then 
cloned via XhoI and XbaI back into the original (CGG)100 containing construct to obtain a full 
length repeat construct. The 3xSTOP upstream of the repeat was cloned using annealing primers 
via BlpI and NarI. 
The 3’ UTR was added to the FMRP reporters to produce the (CGG)n FMRP-nLuc-3’ 
UTR by PCR cloning from a separate pCRII-TOPO vector bearing the sequence using restriction 
enzymes XmaI and XbaI. The entire nLuc-3xFLAG-PEST tag was PCR cloned out of 
pcDNA3.1 +1 (CGG)100 nLuc-PEST and into the (CGG)n FMRP-nLuc-3’UTR vector using NotI 
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and XbaI. The +1 (CGG)100 nLuc-PEST vector was cut with XhoI and XbaI and ligated into the 
(CGG)n FMRP-nLuc-3’ UTR vectors to generate +1 (CGG)n nLuc-PEST-3’ UTR.  
The Venus open reading frame was cloned into pCRII-TOPO vector bearing the C-
terminal region of +1 FMRpolyG from XhoI to the first codon before the in-frame start site. This 
was PCR cloned in place of GFP in the +1 (CGG)100 GFP pcDNA3.1 plasmid (Todd et al., 2013) 
using XhoI and XbaI. Repeat size in all reporters was confirmed by digestion with BlpI and XhoI 
digestion and gel electrophoresis on a 2% (wt/vol) agarose gel, and by Sanger sequencing 
specific for structured DNA at the University of Michigan Sequencing Core.  
 
In Vitro Transcription 
pcDNA3.1(+) vectors were digested with PspOMI for linearization. pcDNA3.1(+) 
vectors with the 3’ UTR of FMR1 were digested with SmaI for linearization. HiScribe T7 Quick 
High Yield RNA Synthesis kit (NEB) was used to make capped RNA from our linearized 
plasmids, mRNA was then polyadenylated as in Kearse et al., 2016.  
 
In Vitro Translation and Luciferase Assay 
In vitro translation reactions using the Flexi Rabbit Reticulocyte Lysate (RRL) System 
(Promega), were programmed with nLuc reporter mRNAs and analyzed as in Kearse et al., 2016. 
Briefly, luciferase assays were performed using a 25µL:25µL reaction of prepared NanoGlo 
reagent (Promega) and diluted reactions in Glo Lysis Buffer (Promega), and quantified using a 
GloMax-96 plate reader (Promega). For western blot analysis, 10µL RRL reactions were 
performed with saturating mRNA levels, mixed with 40µL of SDS sample buffer and heated at 
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70° for 15 minutes, and then resolved using SDS-PAGE. nLuc-3xFLAG reporter proteins were 
detected by western blot using the anti-FLAG antibody(mouse, Sigma). 
 
Primary Hippocampal Neuron Culture and Luciferase Assay 
Hippocampi were dissected from P0-P3 rat pups of both sexes. Cells were papain 
dissociated as in Sutton et al., 2006. Hippocampal neurons were plated on poly-D-Lysine coated 
12-well culture plates at a density of 6.0x104 cells/plate. Hippocampal cultures were maintained 
for 11-12 DIV prior to transfection. On the day of transfection, cells were washed 1X with NGM 
supplemented with 0.0189% kynurenic acid (NGM-KY) [wt/vol], then placed in 1mL of NGM-
KY. A mixture of 510µL of Opti-MEM (Fisher), 10uL Lipofectamine 2000 (Fisher), and DNA 
was added to the neurons for 30 minutes. 2.5µg or 5µg nanoluciferase plasmid and pGL4.13 
(firefly luciferase) plasmid was added to each well for luciferase assays. 7.5µg of reporter 
plasmid and mCherry plasmid was transfected into cells for imaging assays. The 
OptiMEM/NGM-KY mixture was removed from cells followed by 2 washes in NGM-KY, and 
1mL of NGM was then added. Neurons were placed back in the 37°C incubator for 24 hours. 
Transfected neurons were lysed directly on plate for 10 minutes in 250µL of Glo Lysis 
Buffer. Luciferase assays were performed as described above in a 50µL:50µL reaction of 
prepared NanoGlo Reagent to lysate. For firefly luciferase quantification, 50µL of prepared 
ONE-Glo reagent (Promega) was used in place of NanoGlo. Nanoluciferase was normalized to 
firefly luciferase to control for transfection differences. All samples with firefly nanoluciferase 
values below 100 RLU were excluded due to viability and transfection concerns. 
 
Single-molecule microscopy and analysis 
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Single-molecule imaging of Venus constructs was performed as previously described 
(Barbarese et al., 2013; Ifrim et al., 2015; Tatavarty et al., 2012). Single-molecule imaging was 
performed with a modified Nikon (Tokyo, Japan) N-SIM microscope equipped with a Nikon 
Apo TIRF 100X, NA 1.49 microscope objective, and an iXon3 EMCCD camera (Andor 
Technology, Belfast, UK). For single-molecule imaging of translation in live cells, Venus protein 
was excited with a 488nm laser line (1.5mW laser power) from a continuous wave (CW) solid-
state laser (Coherent, Santa Clara, CA). The single-molecule imaging was done in 
epifluorescence mode. Following whole-cell photo-bleaching, single molecule time-lapse images 
of Venus protein were collected continuously at an exposure time of 150ms per frame. To 
minimize the effects of photo-damage on the cells an illumination area of ~25µm diameter was 
used.  
Data analysis of time-lapse images was done as previously described (Ifrim et al., 2015; 
Tatavarty et al., 2012; Yu et al., 2006). Briefly, the centroid coordinates of individual molecules 
in each frame were determined and linked in time to construct temporal trajectories, using a 
standard single-particle tracking algorithm. Each Venus molecule detected was tracked from 
appearance (maturation) to disappearance (bleaching). Preexisting Venus fluorescent signal was 
used to manually define an ROI that contained neuronal dendrites, but not soma, for each dataset. 
From each dataset, translation events situated inside the ROI were analyzed with MATLAB 
(MathWorks). The analysis software is available at http://www.ccam.uchc.edu/yu.  
 
Hybridization Chain Reaction 
Mouse embryonic Fibroblasts were seeded at 2.5 x104 cells/well for 24 hours on 0.01% 
poly-D-lysine-coated 8-well chamber slides, then transfected with 250 ng nLuc reporters (AUG-
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NL-3xF, +2(CGG)100-NL-3xF, and mock) and 2:1 jetPRIME® (VWR) for 24 hours. Cells were 
fixed according to Molecular Instruments protocol(Choi et al., 2016).  Following overnight 
incubation with 70% ethanol, cells were rehydrated in PBS for 1 hour, permeabilized with 0.1% 
Triton x-100 for 6 minutes, blocked with 2% BSA for 20 minutes at room temperature, and 
incubated overnight with mouse anti-FLAG primary antibody in 2% BSA at 4oC. Goat anti-
mouse Alexa 488 secondary antibody was applied the following morning for 1 hour at room 
temperature, in the dark. Following ICC, reporter RNA was detected in transfected cells using 
DNA probes with additional sequence complimentary to Cy5 labeled self-hybridizing hairpins 
(Choi et al., 2016; Choi et al., 2010; Huss et al., 2015). Probes against the nanoluciferase 
sequence (Table 3.3) were purchased from molecularinstruments.org and applied according to 
manufacturer’s protocol. Coverslips were then applied to slides with ProLong Gold Antifade 
Mountant with DAPI. 10-20 fields per condition were imaged at 20x1.6 magnification with 
Olympus IX71 fluorescent microscope and Slidebook 5.5 software. 
Rat hippocampal neurons plated on Mattek dishes were maintained to DIV 5 prior to 
transfection and incubation with plasmid for 24-hours. HCR was performed as above. mAPPLE 
protein was detected using a rabbit anti-dsRed antibody (Clonetech). Confocal imaging was 
performed as outlined below. 
 
RNA Quantification 
Total RNA was isolated from cells using Quick-RNA Miniprep Kit (Zymo Research). 
DNA was eliminated using 1µL Turbo DNase (Thermo Fisher) according to the manufacturer’s 
protocol. For cells transfected with plasmids, this process was repeated to ensure removal of 
contaminating DNA. cDNA was synthesized from equal amounts of total RNA using iScript 
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cDNA synthesis kit (Bio-Rad). qPCR reactions were performed using iQ SYBR® Green 
Supermix (Bio-Rad) and equal amounts of cDNA. qPCR was performed on a MyiQ 
thermocycler (Bio-Rad) using a two-step protocol. Biological triplicates were run in technical 
triplicate for all experiments. Standards were run alongside samples for each primer to calculate 
primer efficiencies. Relative abundance was calculated for each replicate using the efficiencies 
of each primer and Ct values from the transcript of interest relative to the housekeeping gene.  
 
Cell Culture and Transfection 
SH-SY5Y cells (ATCC) were plated on 6-well plates for nanoluciferase and RT-qPCR 
assays. Cells were maintained in DMEM:F12 (Fisher) and 1% Pen/Strep. Cells were transfected 
with 550ng of both nanoluciferase DNA and pGL4.13 using FuGENE® HD (Promega). Cells 
were maintained for 24 hours post-transfection before being either lysed for RNA isolation or 
nanoluciferase assay. 
HEK293 cells (ATCC) were maintained in DMEM with high glucose (Fisher), 10% fetal 
bovine serum (vol/vol), and 1% Pen/Strep (vol/vol; Fisher). 1.3x104 cells/well were plated on 96-
well plates for nanoluciferase assays, 24 hours prior to transfection. For ASO treatments, cells 
were transfected with 100ng nanoluciferase reporter RNA using Lipofectamine 2000. 7 hours 
later media was changed and ASOs were transfected with Lipofectamine RNAiMAX (Fisher) 
according to manufacturer’s specifications. After an additional 17 hours, cells were lysed in 
200µL of Glo Lysis buffer, and reporter levels were measured by luciferase assay as detailed 
above. All ASO sequences are listed in Table 3.4. 
For analysis of endogenous FMRP levels during ASO treatment, HEK293 cells were 
plated on 12-well plates, and transfected with a mixture of ASOs and 4.5µL of Lipofectamine® 
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RNAiMAX according to manufacturer’s specifications. After 24 hours, cells were lysed in 
250µL RIPA supplemented with mini cOmplete protease inhibitors (Sigma), boiled in 6X SDS 
sample buffer at 90°C for 5 minutes, and then were resolved on 8% polyacrylamide gels by SDS-
PAGE. FMRP was detected by subsequent western blotting using anti-FMRP antibody ab17722 
(Abcam). FMRP levels were quantified relative to GAPDH. 
For knockdown of +1 RAN reporters bearing large repeats, HEK293 cells were plated on 
a 96-well plate. After 24 hours of growth, cells were co-transfected with 100nM ASO and 50µg 
of reporter DNA and pGL4.13 using Lipofectamine® 2000. 24 hours later, nanoluciferase assays 
were performed (as above). For western blotting of the knockdown, HEK293 cells were plated 
on 24-well plates and transfected with 250ng of reporter DNA for 3 hours. Media was change 3 
hours later, and cells were re-transfected with 100nm control or +1 RAN ASO. Cells were 
incubated for 48 hours with a media change after 24 hours, then lysed in 200µL of RIPA buffer. 
Lysates were resolved on 12% SDS-PAGE gels with subsequent western blotting for detection of 
FLAG using anti-FLAG antibody (Sigma).  
 
Longitudinal fluorescence microscopy of primary neurons 
Mixed cortical neurons were dissected from E20 rat pups of both sexes, as previously 
described (Arrasate et al., 2004; Barmada et al., 2015). Cortical neurons were cultured at 0.6 x 
106 cells/mL on 96-well plates. Cultures were maintained at 37°C in neural growth media 
(NGM; Neurobasal A supplemented with 2% B-27 and 1% Glutamax-1 [vol/vol] (Fisher)). On 
DIV4, neurons were co-transfected with 0.1µg pGW1-mApple and either 0.1µg pGW1-GFP or 
pGW +1 (CGG)100 GFP DNA per well of a 96-well culture plate, using Lipofectamine 2000 
(Invitrogen). ASOs targeting the CGG repeat and control ASOs were applied to neurons at 1µM 
		
150	
immediately following transfection, the media with ASO remained on the neurons for the 
entirety of the experiment. Neurons were imaged at regular 24 h intervals beginning 24 h post-
transfection using an automated fluorescence microscopy platform detailed in prior studies 
(Arrasate et al., 2004; Barmada et al., 2015).  Image processing for each timepoint and survival 
analysis were achieved by custom code written in Python or the ImageJ macro language, and 
cumulative hazard plots were generated using the survival package in R. Statistical analyses for 
the comparison of survival between different conditions was also accomplished in R. 
 
iPSC Reprogramming 
Fibroblasts were cultured in DMEM, 10% FBS, 1X L-glutamax (Fisher), 1 mM MEM 
non-essential aminoacids (Fisher), at 37°C and 5% CO2. For episomal reprogramming, 1x 106 
fibroblasts were collected after Trypsin treatment and mixed with a set of plasmids pCXLE-
hOCT3/shP53, -hSK, -hUL (Addgene), then electroporated with Neon® device (condition:1650 
Volts, 10 mm width, and 3 pulses). Induced fibroblasts were plated onto 6 well plates at density 
of 0.5-1x104cells/well and switched 1 day later to a PSC medium mTeSR1 (StemCell 
Technologies). IPSC colonies appeared and were manually picked and passaged onto new 
matrigel coated 12-well plates, and continually grown with mTeSR1. IPSCs were passaged 
weekly using 0.5mM EDTA and culture medium supplemented with 10µM Y-27632 ROCK 
inhibitor (EMD Millipore) for 24 hours. After 5-10 passages the cells were evaluated for 
pluripotency by immunocytochemistry (ICC) and embryoid body differentiation. For embryoid 
body experiments, iPSC colonies were grown in suspension for 3-4 weeks, passaged onto 0.1% 
gelatin (Sigma) for another week and processed for ICC. iPSC reprogramming was confirmed by 
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staining with antibodies against Oct-3/4, NANOG, and SSEA4 (Santa Cruz Biotech, Abcam, 
DSHB). IPSC lines were karyotyped by Cell Line Genetics. 
 
iPSC Differentiation and ASO Treatment 
Undifferentiated iPSCs were cultured in TeSR-E8 media (Stem Cell Technology) on 
MatriGel-coated plates with daily media changes and were passaged at 1:5 to 1:10 using 1 mM 
EDTA. Neural induction was performed using a dual-SMAD inhibition (Shi et al., 2012) 
protocol with modifications. In brief, two wells of a 6-well plate were grown to approximately 
80% confluence, dissociated with EDTA, and plated into a single well of a MatriGel-coated 6-
well plate with TeSR-E8 containing 10 µM Rock Inhibitor (Y-27632). The cells were confluent 
the next day and neural differentiation was induced using neural maintenance media (referred 
here as 3N) containing 1 µM dorsomorphin and 10 µM SB431542. The cells were cultured for 
12-14 days with daily media changes. Neuroepithelial sheets were then combed into large 
clumps, passaged, and maintained on MatriGel-coated plates in rosette media (3N containing 20 
ng/ml FGF) with daily media changes until neural rosettes appeared. Rosettes were manually 
picked and dissociated into single cells using Accutase. Neural progenitors were plated onto 
MatriGel-coated plates, grown in neural expansion media (3N containing 20 ng/ml FGF and 20 
ng/ml EGF) with media changes every other day, and passaged as needed using Accutase. For 
differentiation into neurons, neural progenitors were plated at a density of approximately 1.5 x 
105 cells/mL in neural expansion media on PLO-laminin coated plates or coverslips, allowed to 
grow for 24 hours, and switched to neural maintenance media. Neurons were maintained for up 
to 6 weeks with half media changes every other day and a full media change supplemented with 
1 µg/ml laminin every 10 days.  
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For ASO treatments, undifferentiated iPSCs were plated as small colonies on MatriGel-
coated plates in TeSR-E8 containing 10 uM Rock Inhibitor and grown overnight. Media was 
replaced with TeSR-E8 the next day. Cells were allowed to recover for at least 4 hours and 
media was replaced again just prior to treatment. ASOs (0-100 nM) and RNAiMax (4.5 µl per 
100 µl of prepared complexes) were diluted in Opti-MEM reduced serum media, incubated 
together for 5 min at room temperature, and added to cells. Cells were harvested 24 hours after 
treatment. For iPSC-derived neurons, ASOs (0-100 nM) were diluted in neural maintenance 
media and added to 6-week old neurons one day after a full media change. Media was changed 
24 hours after treatment. Neurons were maintained as previously stated and harvested 6 days 
after treatment. Westerns were performed as described above. 
 
Immunocytochemistry 
Hippocampal and iPSC derived neurons were washed 2x in PBS containing 1mM MgCl2 
and 0.1 mM CaCl2 (PBS-MC). Cells were fixed for 15 minutes with a solution of 4% 
Paraformaldehyde/4% Sucrose in PBS-MC warmed to 37°C, washed 3x in PBS-MC, and 
permeabilized for 5 minutes in 0.1% Triton-X in PBS-MC. Cells were blocked in 2% BSA for an 
hour, then incubated in primary antibody for at least 2 hours at room temperature. Reporter 
protein was detected with an antibody for FLAG (mouse, Sigma) and mCherry or mApple was 
detected with an anti-dsRed antibody (rabbit, Clonetech). Cells were washed 3 times, followed 
by incubation in secondary antibody for 1 hour. Cells were subsequently washed and placed in 
ProLong Gold Antifade with DAPI (Thermo Fisher). 
 
Confocal Microscopy and Live Imaging 
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Fixed and live imaging was performed in an inverted Olympus FV1000 laser-scanning 
microscope. Directly prior to live cell imaging, NGM was removed and replaced with 1mL of 
warmed 1x HBSS. Plates were imaged for a maximum of 1 hour to prevent imaging hyper-
stressed or dying cells. For all experiments, acquisition parameters were identical between 
conditions within experiments. For all reporter quantification experiments, all co-transfected 
cells were imaged on >2 individual transfected plates. Imaging of transfected neurons was 
performed using a 60X objective. For human iPSC-derived neuron experiments, all cells in 3 
separate 40X–imaged fields were analyzed from each plate in regions of similar confluency and 
TUJ1 staining. Channels were imaged sequentially and optimized to eliminate bleed-through. 
Neurons were imaged in a series of Z-planes to resolve the entire soma and dendritic arbor. 
Images were analyzed in ImageJ. Average intensity composite images were derived from raw 
image files. For quantification of individual soma or dendrites, cell casts were made using 
threshold images as a guide. The ROI was applied to the individual channels, and intensities 
were measured and normalized as specified. 
 
Statistical Analysis Software and Selection of Statistical Analyses 
Statistical analyses were performed in GraphPad Prism7, with the exception of the 
cumulative risk of death calculation, which was performed in R. An unpaired Student’s t-test 
(two-tailed) with a 95%-CI was performed for all assays comparing two experimental conditions. 
A two-way ANOVA with a 95%-CI was performed for the neuron experiments comparing start 
site mutants to the controls run in parallel from 3-4 individual experiments run in triplicate, 
individually transfected wells of neurons. A one-way ANOVA with multiple comparisons was 
performed for all other experiments with more than two experimental conditions. A one-way 
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ANOVA with a Fisher’s LSD test was performed on all ASO dose-response experiments. 
Survival measures were calculated according to Cox proportional hazard analysis.  All bar 
graphs show the mean +/- S.E.M. unless otherwise stated. 
 
Supplemental Figures 
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Figure S3.1:  
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RAN translation modulates synthesis from FMRP reporters in vitro. A) Left: NLuc assay in HEK293 cells 
shows the relative levels of FMRP, +1 RAN, and 0-frame RAN at 25 and 100 repeats in transfected cells. Values 
were normalized to control nLuc vector without an AUG start codon, serving as a negative control. Right: Western 
blot with equivalent amounts of each reporter transfected into HEK293 cells. The decrease in abundance of the +1 
product (FMRpolyG) relative to FMRP is comparable to nLuc assay derived values. The 0-frame product is almost 
undetectable in cells by western blot at this exposure. The greater expression of FMRP reporter at expanded repeat 
sizes is derived largely from enhanced reporter transcript abundance. B) Left: In vitro translation assay and western 
blot for FLAG of (CGG)0 FMRP-nLuc reporters (see Figure 1 for schematic) with indicated near-cognate RAN 
initiation codons mutated. Right: Western blot to FLAG tag from nLuc reporters in RRL. In the absence of a repeat, 
there is significant signal derived from both the N-terminal extension (‡) and AUG initiation codon for FMRP (‡‡). 
A second N-terminal extension band derives from an alternative codon 3’ to the repeat site. This is largely lost at 
larger repeat sizes and in transfected cells (Kearse et al, 2016, data not shown). C) NLuc assay in RRL using FMRP 
reporters with 0, 25, and 100 repeat lengths were mutated to include AUG codons in +1 (glycine) frame (+1-AUG) 
or +2(alanine) frame (+2-AUG) upstream of the repeat. Driving out of frame translation impedes FMRP reporter 
synthesis, with greater effects in the +1 frame and at larger repeat sizes. D) Schematic of STOP codon inserted 
FMRP Reporters with 100 repeats. Mutant 1 has a stop codon just 5’ to the repeat in all 3 reading frames, and 
Mutant 2 has a stop codon inserted 3’ to the repeat in all three reading frames. E) Left: In vitro nLuc assay on STOP 
mutants in RRL. Stop codons 5’ of the repeat (All STOP up) enhanced FMRP reporter signal, while stop codons 3’ 
of the repeat (All STOP down) had a modest (~10% decrease) but significant inhibitory effect. Right: Western blot 
analysis of in vitro assay. White bar in blot represents lanes removed post-hoc that were from a separate experiment 
not included in this analysis. All lanes shown were on the same blot at the same exposures for both FLAG and 
loading control. F) Western blot showing impact of 0- and +1 reading frame RAN initiation sites on +2 
(FMRpolyA) RANT. All RRL nLuc assays were performed in triplicate. A one-way ANOVA was performed for 
each repeat group separately, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. All graphs represent mean +/- S.E.M.  
 
 
Figure S3.2: 
Impact of RAN translation on FMRP reporter expression in neurons. A) NLuc assay in mature hippocampal rat 
neurons transfected with reporters containing no CGG repeats show that the 0/+1-AAA mutation significantly 
increases FMRP-nLuc signal. n=3 for each reporter, one-way ANOVA was performed with multiple comparisons, 
***p<0.001. B) In neurons, FMRP nLuc reporters bearing 0, 25, and 100 repeats exhibit decreased signal when an 
AUG start codon replaces the ACG in the +1 frame utilized for RANT. C) RT-qPCR performed on transfected SH-
SY5Y cells shows relative difference in basal mRNA expression between reporters bearing 25 and 100 repeats, 
consistent with previous reports. n=3 for all experiments. Student’s t-test, **p<0.01, ***p<0.001. All graphs 
represent mean +/- S.E.M. 
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Figure S3.3: 
Hybridization chain reaction to detect nanoluciferase reporter RNA. A) Replacing the (CGG)25 repeat with a 
(GAA)25 repeat in vitro results in an increase in basal nLuc signal from FMRP reporters. n=3. Student’s t-test, 
***p<0.001. Graph represents mean +/- S.E.M. B) Mouse embryonic fibroblasts were transfected with +1 CGG100 
RAN-nLuc reporters or mock transfected were probed for nLuc RNA by HCR and co-stained for FLAG expression. 
The specificity of the probes for nLuc is illustrated by the presence of signal (red) in transfected cells only. Mock 
transfected cells do not exhibit probe binding. 
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Figure S3.4: 
Characterization of all tested RAN-targeting ASOs. A) Schematic of all tested non-cleaving RANT blocking 
ASOs. Colored bars overlap the corresponding FMR1 5’ UTR sequence and start sites; 0 frame ACG(orange), +1 
frame ACG (purple), and +1 frame GUG (green). B) +1 RAN ASO was transfected into human fibroblasts for 24 
hours, producing a significant increase in FMRP at 75nM. C-F) Effect of ASOs targeting the indicated start sites as 
well as 18 nucleotide “non-targeting” control ASO in HEK293 cells at increasing doses. Combinatorial approaches 
using multiple ASOs either had no significant impacts beyond the single best ASO used or led to a paradoxical 
decrease in FMRP in transfected cells. n=3 for all conditions. One-way ANOVA with a Fisher’s LSD test for dose 
dependency, *p<0.05, **p<0.01. All graphs represent mean +/- S.E.M.  
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Figure S3.5: 
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Characterization of unmethylated Fragile X full mutation iPSC line. A) Detection of three pluripotency 
markers—OCT-3/4, Nanog, and SSEA4—in the TC43-97 line confirms successful reprogramming of the fibroblast 
line. The three markers show proper subcellular localization. B) Karyotyping was performed by Cell Line 
Genetics® on the TC43-97 iPSC line. Cytogenetic analysis of cells in metaphase revealed an apparently normal 
male karyotype. C) TC43-97 and control iPSCs show no significant difference in Fmr1 mRNA as determined by 
RT-qPCR. Fmr1 mRNA levels are normalized to 18S in each respective replicate. D) Western blotting of TC43-97 
iPSC line shows a decrease in FMRP verses the unaffected control iPSC line. E) Methylation sensitive qPCR of 
FMR1 promoter demonstrates lack of DNA methylation in TC43-97. n=3 for each condition. Student’s t-test, 
**p<0.01. All graphs represent mean +/- S.E.M. 
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Figure S3.6:  
+1 RAN ASO specifically increases FMRP levels in iPSC-derived neurons. A) RT-qPCR was performed on ASO 
treated TC43-97 iPSCs. No significant change in Fmr1 mRNA is detected in response to ASO treatment. n=3. 
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Student’s t-test, n.s.=not significant. B) Immunocytochemistry performed on iPSC derived neurons confirms a 
neuronal cell-type with NeuN positive nuclei in the Control and TC43-97 cell line. C) Soma and processes of 
differentiated iPSCs are TUJ1 positive in both cell lines. D) TUJ1 immunofluorescence calculated as mean intensity 
for Control untreated neurons and TC43-97 ASO treated and untreated neurons. There was no difference induced by 
ASO treatment in TC43-97 derived neurons. There was a ~10% difference in TUJ1 immunofluorescence between 
control and treated TC43-97 neurons that was insufficient to explain the observed differences in FMRP expression 
(see Panel E, this figure). E) Average intensity of cellular FMRP levels show a significant decrease in the untreated 
TC43-97 neurons compared to control neurons and +1 RAN ASO treated TC43-97 neurons independent of 
normalization to TUJ1. n=118 for the untreated TC43-97 condition, n=100 for the treated TC43-97 condition, and 
n=95 for untreated control neurons. One-way ANOVA with multiple comparisons, ****p<0.0001. All graphs 
represent mean +/- S.E.M. 
 
 
Supplemental Tables 
Table 3.1 Vectors used in this study 
5’ UTR 
of 
FMR1 
up to 
XhoI 
site 
 
 
ACTTCCGGTGGAGGGCCGCCTCTGAGCGGGCGGCGGGCCGACGGCGAGCGCGGGCGG 
CGGCGGTGACGGAGGCGCCGCTGCCAGGGGGCGTGCGGCAGCGCGGCGGCGGCGGC 
GGCGGCGGCGGAGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCG 
GCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC 
GGCTGGGCCTCGAG 
Mutations: 
0-AAA; +1 AAA or +1 AUG(at ACG); 0/+1 AAA 
 
Reporter 
Name 
Full Reporter 
Description 
Reports for: Sequence downstream of CGG repeat, starting at 
XhoI restriction site  
Mutations 
CGGn 
FMRP-
nLuc 
5’ UTR FMR1-1st 
coding exon of 
FMRP-
Nanoluciferase-
3xFLAG 
FMRP-nLuc-
3xFlag 
CTCGAGCGCCCGCAGCCCACCTCTCGG 
GGGCGGGCTCCCGGCACTAGCAGGGC 
TGAAGAGAAGATGGAGGAGCTGGTGG 
TGGAAGTGCGGGGCTCCAATGGCGCTT 
TCTACAAGGCATTTGAAAGCGGCCGCG 
GGGTCTTCACACTCGAAGATTTCGTTG 
GGGACTGGCGACAGACAGCCGGCTACA 
ACCTGGACCAAGTCCTTGAACAGGGAG 
GTGTGTCCAGTTTGTTTCAGAATCTCGG 
GGTGTCCGTAACTCCGATCCAAAGGATT 
GTCCTGAGCGGTGAAAATGGGCTGAAG 
ATCGACATCCATGTCATCATCCCGTATGA 
AGGTCTGAGCGGCGACCAAATGGGCCA 
GATCGAAAAAATTTTTAAGGTGGTGTAC 
CCTGTGGATGATCATCACTTTAAGGTGA 
TCCTGCACTATGGCACACTGGTAATCGA 
CGGGGTTACGCCGAACATGATCGACTAT 
TTCGGACGGCCGTATGAAGGCATCGCCG 
TGTTCGACGGCAAAAAGATCACTGTAAC 
AGGGACCCTGTGGAACGGCAACAAAATT 
ATCGACGAGCGCCTGATCAACCCCGACG 
GCTCCCTGCTGTTCCGAGTAACCATCAAC 
GGAGTGACCGGCTGGCGGCTGTGCGAA 
CGCATTCTGGCGGACTACAAAGACCATG 
ACGGTGATTATAAAGATCATGACATCGA 
TTACAAGGATGACGATGACAAGCGATCG 
TAA 
 
0-AAA 
+1 AAA 
+1 AUG 
0/+1 
AAA 
 
+1 
CGGn 
RAN-
5’ UTR FMR1 in the 
+1 frame to XhoI site-
Nanoluciferase-
FMRpolyG-
nLuc-3xFlag 
CTCGAGGATATCAAGATCTGGCCTCGG 
CGGCCAAGCTTGGCAATCCGGTACTGT 
TGGTAAAGCCACCGGGGTCTTCACACT 
0-AAA 
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nLuc 3xFLAG CGAAGATTTCGTTG 
GGGACTGGCGACAGACAGCCGGCTACA 
ACCTGGACCAAGTCCTTGAACAGGGAG 
GTGTGTCCAGTTTGTTTCAGAATCTCGG 
GGTGTCCGTAACTCCGATCCAAAGGATT 
GTCCTGAGCGGTGAAAATGGGCTGAAG 
ATCGACATCCATGTCATCATCCCGTATGA 
AGGTCTGAGCGGCGACCAAATGGGCCA 
GATCGAAAAAATTTTTAAGGTGGTGTAC 
CCTGTGGATGATCATCACTTTAAGGTGA 
TCCTGCACTATGGCACACTGGTAATCGA 
CGGGGTTACGCCGAACATGATCGACTAT 
TTCGGACGGCCGTATGAAGGCATCGCCG 
TGTTCGACGGCAAAAAGATCACTGTAAC 
AGGGACCCTGTGGAACGGCAACAAAATT 
ATCGACGAGCGCCTGATCAACCCCGACG 
GCTCCCTGCTGTTCCGAGTAACCATCAAC 
GGAGTGACCGGCTGGCGGCTGTGCGAA 
CGCATTCTGGCGGACTACAAAGACCATG 
ACGGTGATTATAAAGATCATGACATCGA 
TTACAAGGATGACGATGACAAGCGATCG 
TAA 
 
+2 
CGGn 
RAN-
nLuc 
5’ UTR FMR1 in the 
+2 frame to first stop 
codon after the repeat-
Nanoluciferase-
3xFLAG 
FMRpolyA-
nLuc-3xFlag 
CTCGAGCGCCCGCAGCCCACCTCTCG 
GGGGCGGGCTCCCGGCGCGGCCGCG 
GGGTCTTCACACTCGAAGATTTCGTTG 
GGGACTGGCGACAGACAGCCGGCTAC 
AACCTGGACCAAGTCCTTGAACAGGG 
AGGTGTGTCCAGTTTGTTTCAGAATCT 
CGGGGTGTCCGTAACTCCGATCCAAA 
GGATTGTCCTGAGCGGTGAAAATGGG 
CTGAAGATCGACATCCATGTCATCATC 
CCGTATGAAGGTCTGAGCGGCGACCA 
AATGGGCCAGATCGAAAAAATTTTTA 
AGGTGGTGTACCCTGTGGATGATCAT 
CACTTTAAGGTGATCCTGCACTATGGC 
ACACTGGTAATCGACGGGGTTACGCC 
GAACATGATCGACTATTTCGGACGGC 
CGTATGAAGGCATCGCCGTGTTCGAC 
GGCAAAAAGATCACTGTAACAGGGA 
CCCTGTGGAACGGCAACAAAATTATC 
GACGAGCGCCTGATCAACCCCGACGG 
CTCCCTGCTGTTCCGAGTAACCATCAA 
CGGAGTGACCGGCTGGCGGCTGTGC 
GAACGCATTCTGGCGGACTACAAAG 
ACCATGACGGTGATTATAAAGATCAT 
GACATCGATTACAAGGATGACGATGA 
CAAGCGATCGTAA 
 
0-AAA  
+1 AAA 
0/+1 
AAA 
+1 AUG 
+0 
CGGn 
RAN-
nLuc 
5’ UTR FMR1 in the 
0-frame to XhoI site 
after repeat-
Nanoluciferase-
3xFLAG 
FMRpolyR-
nLuc-3xFlag 
CTCGAGGGGGTCTTCACACTCGAAGATTT 
CGTTGGGGACTGGCGACAGACAGCCGGC 
TACAACCTGGACCAAGTCCTTGAACAGGG 
AGGTGTGTCCAGTTTGTTTCAGAATCTCG 
GGGTGTCCGTAACTCCGATCCAAAGGATT 
GTCCTGAGCGGTGAAAATGGGCTGAAG 
ATCGACATCCATGTCATCATCCCGTATGA 
AGGTCTGAGCGGCGACCAAATGGGCCA 
GATCGAAAAAATTTTTAAGGTGGTGTAC 
CCTGTGGATGATCATCACTTTAAGGTGA 
TCCTGCACTATGGCACACTGGTAATCGA 
CGGGGTTACGCCGAACATGATCGACTAT 
TTCGGACGGCCGTATGAAGGCATCGCCG 
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TGTTCGACGGCAAAAAGATCACTGTAAC 
AGGGACCCTGTGGAACGGCAACAAAATT 
ATCGACGAGCGCCTGATCAACCCCGACG 
GCTCCCTGCTGTTCCGAGTAACCATCAAC 
GGAGTGACCGGCTGGCGGCTGTGCGAA 
CGCATTCTGGCGGACTACAAAGACCATG 
ACGGTGATTATAAAGATCATGACATCGA 
TTACAAGGATGACGATGACAAGCGATCG 
TAA 
 
+1 
CGGn 
RAN-
Venus 
5’ UTR FMR1-+1 
frame of first FMRP 
exon to first stop 
codon-Venus 
FMRpolyG-
Venus 
CTCGAGCGCCCGCAGCCCACCTCTCGG 
GGGCGGGCTCCCGGCGCTAGCAGGGC 
TGAAGAGAAGATGGAGGAGCTGGTG 
GTGGAAGTGCGGGGCTCCACCGCGGA 
GCAAGGGCGAGGAGCTGTTCACCGGG 
GTGGTGCCCATCCTGGTCGAGCTGGAC 
GGCGACGTAAACGGCCACAAGTTCAGC 
GTGTCCGGCGAGGGCGAGGGCGATGC 
CACCTACGGCAAGCTGACCCTGAAGCT 
GATCTGCACCACCGGCAAGCTGCCCGT 
GCCCTGGCCCACCCTCGTGACCACCCTG 
GGCTACGGCCTGCAGTGCTTCGCCCGC 
TACCCCGACCACATGAAGCAGCACGAC 
TTCTTCAAGTCCGCCATGCCCGAAGGCT 
ACGTCCAGGAGCGCACCATCTTCTTCAA 
GGACGACGGCAACTACAAGACCCGCGC 
CGAGGTGAAGTTCGAGGGCGACACCCT 
GGTGAACCGCATCGAGCTGAAGGGCA 
TCGACTTCAAGGAGGACGGCAACATCC 
TGGGGCACAAGCTGGAGTACAACTAC 
AACAGCCACAACGTCTATATCACCGCC 
GACAAGCAGAAGAACGGCATCAAGGC 
CAACTTCAAGATCCGCCACAACATCGA 
GGACGGCGGCGTGCAGCTCGCCGACC 
ACTACCAGCAGAACACCCCCATCGGCG 
ACGGCCCCGTGCTGCTGCCCGACAACC 
ACTACCTGAGCTACCAGTCCGCCCTGA 
GCAAAGACCCCAACGAGAAGCGCGAT 
CACATGGTCCTGCTGGAGTTCGTGACC 
GCCGCCGGGATCACTCTCGGCATGGA 
CGAGCTGTACAAGCCCTGCAGGAACT 
GCATAATTCTGAAGTCTAGAGGGCCC 
GTTTAA 
 
 
CGGn 
FMRP-
nLuc-
3’UTR 
5’ UTR FMR1-1st 
coding exon of 
FMRP-
Nanoluciferase-
3xFLAG-Pest tag-3’ 
UTR FMR1 
FMRP-nLuc-
Pest-3xFlag 
CTCGAGCGCCCGCAGCCC 
ACCTCTCGGGGGCGGGCTCCCGGCGC 
TAGCAGGGCTGAAGAGAAGATGGAG 
GAGCTGGTGGTGGAAGTGCGGGGCT 
CCAATGGCGCTTTCTACAAGGCATTT 
GAAAGCGGCCGCGATTTCGTTGGGG 
ACTGGCGACAGACAGCCGGCTACAA 
CCTGGACCAAGTCCTTGAACAGGGA 
GGTGTGTCCAGTTTGTTTCAGAATCTC 
GGGGTGTCCGTAACTCCGATCCAAAG 
GATTGTCCTGAGCGGTGAAAATGGG 
CTGAAGATCGACATCCATGTCATCAT 
CCCGTATGAAGGTCTGAGCGGCGACC 
AAATGGGCCAGATCGAAAAAATTTTT 
AAGGTGGTGTACCCTGTGGATGATCA 
TCACTTTAAGGTGATCCTGCACTATG 
GCACACTGGTAATCGACGGGGTTAC 
GCCGAACATGATCGACTATTTCGGAC 
-0/+1 
AAA 
-GAA in 
place of 
CGG 
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GGCCGTATGAAGGCATCGCCGTGTTC 
GACGGCAAAAAGATCACTGTAACAG 
GGACCCTGTGGAACGGCAACAAAAT 
TATCGACGAGCGCCTGATCAACCCCG 
ACGGCTCCCTGCTGTTCCGAGTAACC 
ATCAACGGAGTGACCGGCTGGCGGC 
TGTGCGAACGCATTCTGGCGGACTAC 
AAAGACGATGACGGTGATTATAAAGA 
TCATGACATCGATTACAAGGATGACG 
ATGACAAGCGATCGAATTCTCACGGC 
TTTCCGCCTGAGGTTGAAGAGCAAGC 
CGCCGGTACATTGCCTATGTCCTGCG 
CACAAGAAAGCGGTATGGACCGGCA 
CCCAGCCGCTTGTGCTTCAGCTCGCAT 
CAACGTCTTAATCTAGAACTGCATAA 
TTCTGAAGTTATATTTCCTATACCATTT 
CCGTAATTCTTATTCCATATTAGAAAA 
CTTTGTTAGGCCAAAGACAAATAGTA 
GGCAAGATGGCACAGGGCATGAAAT 
GAACACAAATTATGCTAAGAATTTTTT 
ATTTTTTGGTATTGGCCATAAGCAACA 
ATTTTCAGATTTGCACAAAAAGATACC 
TTAAAATTTGAAACATTGCT…(FMR1  
3’ UTR) 
 
+1 
CGGn 
RAN-
nLuc-
3’UTR 
5’ UTR FMR1 in the 
+1 frame to XhoI site 
-Nanoluciferase-
3xFLAG-Pest tag-3’ 
UTR FMR1 
FMRpolyG-
nLuc-Pest-
3xFlag 
CTCGAGGATATCAAGATCTGGCCT 
CGGCGGCCAAGCTTGGCAATCCG 
GTACTGTTGGTAAAGCCACCGGGGTC 
TTCACACTCGAAGATTTCGTTGGG 
GACTGGCGACAGACAGCCGGCTACAA 
CCTGGACCAAGTCCTTGAACAGGGA 
GGTGTGTCCAGTTTGTTTCAGAATCTC 
GGGGTGTCCGTAACTCCGATCCAAAG 
GATTGTCCTGAGCGGTGAAAATGGG 
CTGAAGATCGACATCCATGTCATCAT 
CCCGTATGAAGGTCTGAGCGGCGACC 
AAATGGGCCAGATCGAAAAAATTTTT 
AAGGTGGTGTACCCTGTGGATGATCA 
TCACTTTAAGGTGATCCTGCACTATG 
GCACACTGGTAATCGACGGGGTTAC 
GCCGAACATGATCGACTATTTCGGAC 
GGCCGTATGAAGGCATCGCCGTGTTC 
GACGGCAAAAAGATCACTGTAACAG 
GGACCCTGTGGAACGGCAACAAAAT 
TATCGACGAGCGCCTGATCAACCCCG 
ACGGCTCCCTGCTGTTCCGAGTAACC 
ATCAACGGAGTGACCGGCTGGCGGC 
TGTGCGAACGCATTCTGGCGGACTAC 
AAAGACGATGACGGTGATTATAAAGA 
TCATGACATCGATTACAAGGATGACG 
ATGACAAGCGATCGAATTCTCACGGC 
TTTCCGCCTGAGGTTGAAGAGCAAGC 
CGCCGGTACATTGCCTATGTCCTGCG 
CACAAGAAAGCGGTATGGACCGGCA 
CCCAGCCGCTTGTGCTTCAGCTCGCAT 
CAACGTCTTAATCTAGAACTGCATAA 
TTCTGAAGTTATATTTCCTATACCATTT 
CCGTAATTCTTATTCCATATTAGAAAA 
CTTTGTTAGGCCAAAGACAAATAGTA 
GGCAAGATGGCACAGGGCATGAAAT 
GAACACAAATTATGCTAAGAATTTTTT 
ATTTTTTGGTATTGGCCATAAGCAACA 
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ATTTTCAGATTTGCACAAAAAGATACC 
TTAAAATTTGAAACATTGCT…(FMR1 3’UTR) 
 
pGW +1 
CGG100 
GFP 
 FMRpolyG-
GFP 
CTCGAGCGCCCGCAGCCCACCTCTCGG 
GGGCGGGCTCCCGGCGCTAGCAGGGC 
TGAAGAGAAGATGGAGGAGCTGGTGG 
TGGAAGTGCGGGGCTCCAATGGCGCTT 
TCTACAAGGCATTTGAAAGCGGCCGC 
ACCGGTCGCCACCATGGT 
GAGCAAGGGCGAGGAGCTGTTCACC 
GGGGTGGTGCCCATCCTGGTCGAGCT 
GGACGGCGACGTAAACGGCCACAAG 
TTCAGCGTGTCCGGCGAGGGCGAGG 
GCGATGCCACCTACGGCAAGCTGACC 
CTGAAGTTCATCTGCACCACCGGCAA 
GCTGCCCGTGCCCTGGCCCACCCTCG 
TGACCACCCTGACCTACGGCGTGCAG 
TGCTTCAGCCGCTACCCCGACCACATG 
AAGCAGCACGACTTCTTCAAGTCCGCC 
ATGCCCGAAGGCTACGTCCAGGAGCG 
CACCATCTTCTTCAAGGACGACGGCA 
ACTACAAGACCCGCGCCGAGGTGAAG 
TTCGAGGGCGACACCCTGGTGAACCG 
CATCGAGCTGAAGGGCATCGACTTCA 
AGGAGGACGGCAACATCCTGGGGCA 
CAAGCTGGAGTACAACTACAACAGCC 
ACAACGTCTATATCATGGCCGACAAG 
CAGAAGAACGGCATCAAGGTGAACTT 
CAAGATCCGCCACAACATCGAGGACG 
GCAGCGTGCAGCTCGCCGACCACTAC 
CAGCAGAACACCCCCATCGGCGACGG 
CCCCGTGCTGCTGCCCGACAACCACTA 
CCTGAGCACCCAGTCCGCCCTGAGCAA 
AGACCCCAACGAGAAGCGCGATCACA 
TGGTCCTGCTGGAGTTCGTGACCGCCG 
CCGGGATCACTCTCGGCATGGACGAG 
CTGTACAAGTAA 
 
 
 
 
Table 3.2 Primers used in this study 
 
Mutation Forward Primer (5’ to 3’) Reverse Primer (3’ to 5’) 
PEST tag Q5 SDM (step 1) aagccgccggtacattgcctatgtc 
ctgcgcacaTAAGGCCGCGACTCTAGA 
Gctcttcaacctcaggcggaaagccgtg 
agaattCTTGTCATCGTCATCCTTGTAATC 
PEST tag Q5 SDM (step 2) gcttgtgcttcagctcgcatcaacgt 
cTAAGGCCGCGACTCTAGAG 
ggctgggtgccggtccataccgctttctTG 
TGCGCAGGACATAGGC 
3X Stop downstream of 
repeat Q5 SDM 
attaaCCGCAGCCCACCTCTCGG taattaGCGCTCGAGGCCCAGCCG 
3X Stop upstream of repeat TCAGCTCCGTTTCGGTTTCACTTC 
CGGTGGAGGGCCGCCTCTGAGCG 
GGCGGCGGGCCGACGGCGAGCG 
CGGGCGGCGGCGGTGACGTAAT 
TAATTAAGAGG 
CGCCTCTTAATTAATTACGTCAC 
CGCCGCCGCCCGCGCTCGCCGT 
CGGCCCGCCGCCCGCTCAGAGG 
CGGCCCTCCACCGGAAGTGAAA 
CCGAAACGGAGC 
PCR cloning FMR1 3’ 
UTR 
actgcattaCCCCGGGCATCATGACTTTG 
AACTGAAAAACATACA 
actgcattaCTCTAGAACTGCATAATT 
CTGAAGTTATATTTCCTATACC 
Full nLuc-3xFlag-PEST 
XmaI/XbaI 
cataattttaGCGGCCGCGATTTCGTTG 
GGGAC 
cataattttaTCTAGATTAAGACGTTGA 
TGCGAGCTGAAG 
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Cloning Venus into CGG 
vector 
attaattaCTCGAGCGCCCGCAGC tttaactatTCTAGACTTCAGAATTAT 
GCAGTTCCTGCAGGGC 
 Forward Primer (5’ to 3’) Reverse Primer (3’ to 5’) 
Fmr1 qPCR CATGAAGATTCAATAACAGTTGC CACTTTAGCTAACCACCAACA 
Bisulfite qPCR for FMR1 
promoter (methylated) 
GGTCGAAAGATAGACGCGC AAACAATGCGACCTATCACCG 
Bisulfite qPCR for FMR1 
promoter (universal) 
TGTTGGTTTGTTGTTTGTTTAGA AACATAATTTCAATATTTACACCC 
18S qPCR GGCCCTGTAATTGGAATGAGTC CAAGATCCAACTACGAGCTT 
NL qPCR CAGCCGGCTACAACCTGGAC GCCCATTTTCACCGCTCAG 
FF qPCR GCAGTACCGGATTGCCCAAG GTCGGGGATGATCTGGTTGC 
 
 
Table 3.3 Hybridization Chain Reaction Probe sequences 
 
HCR_DNA_nLuc DNA Probe_1 GAGGAGGGCAGCAAACGGGAAGAGTCTTCCTTTACGATATT  
TTGTAGCCGGCTGTCTGTCGCCAGTCCCCAACGAAATCTTCGAGTGTGAA 
ATATA GCATTCTTTCTTGAGGAGGGCAGCAAACGGGAAGAG 
HCR_DNA_nLuc DNA Probe_2 GAGGAGGGCAGCAAACGGGAAGAGTCTTCCTTTACGATATT  
TTGGATCGGAGTTACGGACACCCCGAGATTCTGAAACAAACTGGACACAC 
ATATA GCATTCTTTCTTGAGGAGGGCAGCAAACGGGAAGAG 
HCR_DNA_nLuc DNA Probe_3 GAGGAGGGCAGCAAACGGGAAGAGTCTTCCTTTACGATATT  
AAATTTTTTCGATCTGGCCCATTTGGTCGCCGCTCAGACCTTCATACGGG 
ATATA GCATTCTTTCTTGAGGAGGGCAGCAAACGGGAAGAG 
HCR_DNA_nLuc DNA Probe_4 GAGGAGGGCAGCAAACGGGAAGAGTCTTCCTTTACGATATT  
CGTAACCCCGTCGATTACCAGTGTGCCATAGTGCAGGATCACCTTAAAGT 
ATATA GCATTCTTTCTTGAGGAGGGCAGCAAACGGGAAGAG 
 
 
Table 3.4 ASOs used in this study 
 
Name Sequence Length Chemistry 
0-frame ASO CGTCGGCCCGCCGCCCGC  
 
18 nucleotides 2'-OMe, PS 
 
0 16nt CGTCGGCCCGCCGCCC  
 
16 nucleotides 2'-OMe, PS 
 
+1 RAN ASO CGTCACCGCCGCCGCCCG  
 
18 nucleotides 2'-OMe, PS 
 
1-1 16nt CGTCACCGCCGCCGCC  
 
16 nucleotides 2'-OMe, PS 
 
+1 RAN 
ASO-2 
CACGCCCCCTGGCAGCGG  
 
18 nucleotides 2'-OMe, PS 
 
1-2 16nt CACGCCCCCTGGCAGC  
 
16 nucleotides 2'-OMe, PS 
 
Control ASO CATTGTTTTTTGTCTTCC 18 nucleotides 2'-OMe, PS 
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CHAPTER IV 
Future Directions and General Discussion 
 
Introduction 
The process of mRNA translation is central to cellular life and its regulation plays critical 
roles in neuronal function, differentiation, and plasticity. This thesis explored two specific areas 
of translational regulation in the context of neurons: upstream open reading frames (uORFs) and 
translational initiation. It provides evidence that two widely accepted doctrines are principally 
outdated: 1) mammalian transcripts are monocistronic, with few exceptions, and 2) robust 
translation initiation must begin at an AUG start codon in vivo. Instead, I find that uORFs are—
consistent with work in yeast and mice—very common in the human neuroblastoma 
transcriptome and that their initiation commonly occurs at a codon other than AUG. In the 
second half of my thesis I define how one specific type of uORF event, RAN translation at CGG 
repeats in FMR1, acts to regulate translation of the Fragile X protein in neurons—a finding with 
significant clinical implications. Below, I discuss the repercussions of this new understanding of 
post-transcriptional gene regulation 
 
uORFs translated in neuronal differentiation may be a significant source of post-
transcriptional regulation 
Translation of uORFs in transcripts such as ATF4 are known to impact the level at which 
the CDS is synthesized, and are generally inhibitory. How applicable this model is beyond the 
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handful of well characterized transcripts is an open question. My work reveals that among 
thousands of identified uORFs, only a relatively small subset are actively inhibitory to the 
synthesis of the main coding sequence (CDS) in which they arise; this regulatory group includes 
both uORFs fully contained in the 5’ leader (cORFs) and uORFs that overlap the CDS (oORFs) 
and uORFs initiated at AUG codons (such as ATF4) and those initiating at non-AUG near 
cognate codons. These principles, illustrated globally in Chapter 2 of my thesis, both support 
findings from previous studies utilizing ribosome profiling and extend them in important ways.  
 
The dichotomous effect of AUG and non-AUG uORFs 
Ribosome profiling utilizes RNase protection of ribosome associated mRNA fragments to 
generate a cDNA library for deep sequencing. Evidence from the first reports using this 
technique showed enrichment of ribosome footprints in 5’ leaders (Ingolia, Lareau et al. 2011, 
Brar, Yassour et al. 2012). The power of this technique was shown in studies looking at 
conditional fluctuations in protein synthesis(Ingolia, Lareau et al. 2011, Brar, Yassour et al. 
2012). Based on this previous work, I hypothesized that during neuronal differentiation 
translation of a set of mRNA transcripts would be regulated by translation events in their 5’ 
leaders. By tracking their 3-nucleotide periodicity as a mark of active translation (Ingolia, 
Ghaemmaghami et al. 2009, Chun, Rodriguez et al. 2016), I identified ~3500 uORFs in human 
SH-SY5Y cells, the majority of which utilize a non-AUG initiation site. The translation of these 
uORFs cluster based on both SPECtre score and translational efficiency (TE) across conditions, 
suggesting that they are regulated events. However, on a global scale their relative translation is 
not inversely predictive of directional CDS changes (Figure 2.5). Instead, uORF TE and CDS TE 
positively correlate in this large set of transcripts.  
	 179	
It is tempting to attribute this positive correlation to the inclusion of near-cognate 
initiated uORFs in our dataset. These could potentially create more noise in the analysis if they 
are not “real”. However, a few points suggest this is not the case. First, I experimentally 
validated a number of uORF events based identified by RP, including multiple non-AUG 
initiation events, using reporter constructs. Second, this positive correlation has been reported in 
ribosome profiling analyses that restricted their analysis to AUG-initiated uORFs, as well (Chew, 
Pauli et al. 2016, Johnstone, Bazzini et al. 2016). Instead, this effect is most likely explained by 
the fact that both AUG and near-cognate initiated uORFs are suboptimal initiation events relative 
to modes of regulation that act upstream such as increased pre-initiation complex and mRNA 
interaction. Thus, CDS translation on a transcript with a uORF is going to change in the same 
direction. For this reason, we limited our analysis to uORFs above a stricter translational 
threshold.  
In doing so, we detect that AUG initiated uORFs are generally associated with repressed 
CDS translation, while near-cognate initiated uORFs show a dichotomous effect based on their 
relative sequence conservation. When investigating non-AUG uORFs from the highest quartile 
of sequence conservation, we see that these are generally associated with a mildly translationally 
repressed CDS. However, transcripts bearing lowly conserved non-AUG uORFs show higher 
CDS translation. The reason for this is not clear, although I suspect that this is due to the level of 
noise introduced to our analysis when including near-cognate initiated uORFs. This finding 
suggests that highly translated transcripts support a level of uORF translation, likely due to the 
increased presence of initiating ribosomes. Taken together, this suggests that uORFs may impart 
a regulatory role dependent on sequence conservation. Interestingly, we do see a higher GC 
content in the conserved non-AUG uORFs relative to the lowly conserved non-AUG uORFs. 
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Translation through these structured regions may be inefficient, thus impairing further scanning 
of pre-initiation complexes, and preventing them from reaching the main CDS. Additionally, the 
GC content within the uORF may be an indicator of the secondary structure present across the 
entire 5’ leader, which could be the source of repression.  
 
Conditional CDS fluctuations are tied to oppositional uORF translation 
The most interesting findings came when the dataset was constrained to uORFs that were 
detected above a strict translational threshold in both conditions. This filtering was key to the 
results that followed because it allowed us to look specifically at translation changes in uORFs 
with no or low input from alternative levels of regulation, like transcriptional changes, 
alternative transcript leaders, or alternative splicing. The most compelling evidence that the 
regulatory role of uORFs is largely imparted through scaled translation of these 5’ elements 
came when we investigated the conditional translation of uORFs. To illustrate this point, we 
investigated transcripts bearing cORFs or oORFs in the constrained dataset that show the 
greatest decrease in CDS TE in either Non-Diff and RA-Diff condition (Figure 2.6). Analysis of 
the absolute TE changes of the cORFs and oORFs revealed significant directionality, with the 
majority of cORFs and oORFs showing an increased level of translation in the condition where 
the CDS TE is lowest. These data illustrate that conditional increases in uORF translation 
accompany a decrease in CDS translation, in a subset of highly expressed uORFs. This suggests 
an oppositional relationship between these two regions that may be important for uORFs to limit 
the synthesis of the main CDS product.  
 
Future avenues of interest: uORFs in neuronal differentiation 
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One surprising finding from my work is the potential role of uORFs in regulating 
expression of ribosomal transcripts. Recent studies suggest that ribosomal heterogeneity is more 
widespread than previously appreciated(Xue and Barna 2012). I am intrigued by the idea that 
ribosomal heterogeneity might contribute to translational changes in neuronal differentiation. In 
this sense, RPL38 and RPS25 are two very interesting ribosomal proteins. Both are thought to 
exist in sub-stoichiometric amounts in ribosomes, and may be integral to the concept of 
heterologous ribosomes (Shi, Fujii et al. 2017). Though these two examples do not show an 
inverse relationship between uORF and CDS translation, they do bare oORFs, which are 
generally repressive and may still exert differentiation-specific inhibition of downstream 
translation. To investigate this further, I would specifically like to mutate these oORFs by 
CRISPR/Cas9 genome editing, and investigate translational changes in SH-SY5Y cells 
undergoing differentiation similar to what was done for PTCH1 (Fujii, Shi et al. 2017). I would 
also look at the same differentiation markers, and see if the overall process is somehow affected.  
Another avenue of research to follow-up this work would be to investigate alternative 
transcript leaders. The state dependent SPECtre clusters we observe (Figure 2.5) may largely be 
due to changes at the transcriptional level, which would significantly alter the landscape of 
uORFs translated. Lastly, because of continued concerns over the validity of RP as a tool for 
detecting rare translation events, I would utilize mass spectrometry with enrichment for small 
peptides to detect uORF-derived peptides in the cell. Recent work by other groups in comparable 
systems suggests that some of these uORF do produce at least transiently stable small proteins 
which can be detected by mass spectrometry (Bazzini, Johnstone et al. 2014, Na, Barbhuiya et al. 
2018). Using the technique TAILS, terminal amine isotopic labeling of substrates, to enrich for 
the N-termini of peptides has yielded the highest number of 5’ leader-derived, novel peptides 
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(Na, Barbhuiya et al. 2018). Two-thirds of these aligned with ribosome profiling data, and over 
90% of these initiated at a near-cognate codon. After identifying stable peptides by this 
technique, I would then tag the peptides we detect with a fluorescent marker to investigate 
potential cellular roles. To discern the role of two proteins generated by two distinct cistrons on a 
single transcript would be a very novel occurrence for a mammalian transcript.  
 
CGG RAN translation acts as a uORF to modulate basal and activity-dependent FMRP 
synthesis 
In Chapter 3, I investigated translation within the 5’ leader of FMR1. FMR1 is interesting 
because its 5’ leader supports translation that is influenced by the presence of a repetitive CGG 
trinucleotide element which forms a stable hairpin structure. This form of translation is termed 
Repeat Associated Non-AUG translation, or RAN translation. Expansions of this repeat leads to 
neurodegeneration in Fragile-X Associated Tremor/Ataxia Syndrome. RAN translation of 
expanded CGG repeats is linked to toxicity in animal models of FXTAS, and the main protein 
synthesized from this region, FMRpolyG, forms aggregates in patients (Todd, Oh et al. 2013, 
Krans, Kearse et al. 2016, Sellier, Buijsen et al. 2017). Until now, RAN translation at CGG 
repeats and elsewhere has been investigated solely as a pathogenic process(Todd, Oh et al. 2013, 
Sellier, Buijsen et al. 2017). However, I was intrigued by the fact that FMRpolyG was highly 
translated at normal repeat lengths in our in vitro and cell assays. Upon this, I wondered how 
RAN translation in the 5’ leader of FMR1 affected translation of FMRP, the main protein 
product of this gene. 
 
The interplay between the RAN translation reading frames and FMRP 
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The finding that both the 0- and +1 frame RAN events work together to impede FMRP 
synthesis in vitro and in neurons (Figure 3.2) was the first piece of evidence that CGG RAN 
translation can work as a uORF. This was exciting for two reasons: 1) this occurred at normal 
repeats, suggesting that these two reading frames may work to regulate FMRP in unaffected 
cells, and 2) RAN translation may have a role in decreasing the translational efficiency of FMRP 
in individuals with expanded repeats. In terms of the latter point, we do see more de-repression 
of FMRP levels when we mutate the two reading frames in the expanded repeat reporters than 
when it is done in reporters with a normal repeat size (Figure 3.2, 3.3). This is important because 
it suggests that there is an element to RAN translation acting as a uORF that may be 
dysfunctional in the setting of an expanded repeat. This may contribute to the overall decrease in 
FMRP seen in FXTAS and mosaic Fragile X patients. 
 
RAN translation and the CGG repeat maintain the balance of FMRP translation, which is key to 
further scaling 
The next intriguing finding pointing to a functional role for RAN translation is the data 
showing that removal of the RAN initiation sites prevents the DHPG-induced increase in FMRP 
reporter translation with normal and expanded repeats. Additionally, FMRP reporters without a 
CGG repeat showed the same lack of increase. These findings suggest that these two elements—
RAN translation and the repeat—are required for the proper translational response of FMRP. 
This is interesting because it illustrates the nuances of translational regulation conferred by the 5’ 
leader of FMR1. My interpretation of this data is that both elements likely limit scanning of the 
preinitiation complex to reach the AUG of FMRP, and in their absence translation at the main 
AUG is at full capacity preventing any further upscaling by DHPG-induced signaling. This is 
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also likely the case for the GAA reporter. This is an unstructured repeat, and likely does not 
impede preinitiation complex scanning like the CGG repeat. The finding that we see a selective 
increase in our wild-type FMRP reporters and not the RAN reporters adds to this model; it shows 
that RAN and FMRP translation do not function in concert in response to DHPG. Instead, RAN 
translation acts as a roadblock that can be overcome to allow for more downstream initiation.  
This raises two questions that would inform us about how the FMR1 transcript interacts 
with the translation machinery, and may provide a better understanding about how translation is 
regulated in response to external stimuli. First, does CGG RAN translation halt completely in 
response to DHPG? Or does it continue at a normal rate? Either way, translation initiation on the 
FMR1 transcript is increased in response to the stimulus, so the efficiency of RAN translation as 
a proportion of translation on the whole transcript is decreased. Second, how is RAN translation 
selectively bypassed in the wake of this upscaling? One potential mechanism by which this can 
occur is by reactivation of stalled, initiating ribosomes. This has been suggested to occur on 
transcripts selectively translated in response to DHPG (Graber, Hebert-Seropian et al. 2013). It is 
possible that these ribosomes stall because of RAN translation and the presence of the CGG 
repeat, and in their absence stalling cannot occur neither can the increase in FMRP. 
Alternatively, RAN translation could be selectively bypassed through changes in start codon 
stringency. Alterations in synaptic eIF1 and eIF5 levels can potentially drive the balance of start 
site selection away from suboptimal start sites, and promote initiation at the AUG of FMRP. 
However, there is no direct evidence to support this in prior research or in our own.  
An alternative mechanism for activity dependent RAN bypass is similar to what occurs in 
ATF4 and GCN4 in response to stress. In fact, some groups have suggested that DHPG induces 
eIF2α phosphorylation (Di Prisco, Huang et al. 2014, Trinh, Ma et al. 2014). If ternary 
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complexes are limiting, this may lead to the bypassing of the 0- and +1 frame start sites by 
scanning ribosomes, leading to more downstream initiation at the AUG of FMRP.  
This proposed mechanism can also bring the +2 RAN frame into play. The +2 frame 
terminates 16 nucleotides from the AUG of FMRP, leaving a possibility for re-initiation. No start 
site has been located for the +2 frame, leading us to conclude that initiation occurs within the 
repeat. The best way to study the +2 frame is through manipulation of its termination site. The 
+2 frame does not appear to function normally to impede FMRP synthesis since when the 
termination site for the +2 frame is moved after the AUG of FMRP to create an overlapping 
uORF, FMRP translation is unaffected (Figure A.1). However, when the 0/+1 AAA mutations 
are introduced to an FMRP reporter with that same +2 termination site mutation, there is a slight 
decrease in the FMRP reporter (Figure A.1). This shows that only under conditions when these 
two frames are bypassed, the +2 frame affects FMRP levels. Even more, when the 0/+1-AAA 
mutations were introduced to the +2 frame RAN reporters, there was an increase in 
nanoluciferase activity (Figure 3.2) suggesting that there is indeed interplay between these 
events.  
In summary, the final proposed mechanism may occur as follows: If eIF2α is 
phosphorylated during DHPG treatment, this can lead to bypassing of the start sites for the 0- 
and +1 frames due to limitation of available ternary complexes. Initiation may then occur in the 
+2 RAN reading frame, and reinitiation may then occur downstream at FMRP. One experiment 
left to do to clarify this point is to perform a DHPG-treated nanoluciferase assay on neurons 
transfected with two reporters: 1) the +2 stop site mutant, FMRP reporter and 2) the 0/+1-
AAA/+2 stop site mutant, FMRP reporter. If this last proposed mechanism is correct, we should 
still see a DHPG-induced increase in the first condition but not in the latter condition.  
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Future avenues of interest: RAN translation and FMRP regulation in response to stress 
It would be interesting to further investigate the role for prolonged eIF2α phosphorylation 
in regulating FMRP synthesis. FMRP is a key component of stress granules which are 
ribonucleoprotein aggregates that form following cellular stress and contain mRNA associated 
with ribosomes stalled during initiation (Protter and Parker 2016). Importantly, +1 and +2 CGG 
RAN translation of reporters with large repeats is increased in response to several hours of cell 
stress and eIF2α phosphorylation(Green, Glineburg et al. 2017, Cheng, Wang et al. 2018). 
However, this has not been investigated in reporters with normal repeat sizes. If this is seen at 
normal repeat sizes this may be a way by which FMRP translation is regulated in response to 
extended periods of eIF2α phosphorylation. At peak eIF2α phosphorylation, CGG RAN is 
increased and there is a global decrease in translation. This may be different for what is proposed 
to occur during DHPG stimulation, because eIF2α phosphorylation levels are prolonged and at 
their peak. Additionally, there may be an element of compartmentalization to the fluctuations 
that occur in eIF2α phosphorylation levels specific to neurons. Since it is unclear as to how an 
increase in the translation of both the +1 and +2 frames might impact FMRP, it would be 
interesting to look into further.  
There are two potential outcomes I can see potentially happening in response to stress: 1) 
a decrease in FMRP and 2) maintenance of consistent FMRP levels during translational arrest. A 
decrease in FMRP would mirror the state of global translation in the cell. However, this is 
different than other uORF-bearing transcripts which usually show protection from translational 
arrest(Hinnebusch, Ivanov et al. 2016). FMR1 could be different as its uORFs (RAN translation) 
are synthesized at a greater rate in response to stress. A decrease in FMRP may be an adaptive 
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response to cell stress as FMRP constitutes stress granules and is a negative regulator of 
translation. Decreasing FMRP levels might be a way to help cells to end the translational arrest 
alongside the increase in eIF2α dephosphorylation. Mutation of the RAN start sites in our FMRP 
reporters and investigation into whether we see a change in FMRP levels in response to stress is 
necessary to determine this relationship. Alternatively, the increase in +2 frame RAN translation 
may counter the increase in the +1 frame RAN translation, leading to a neutral effect on FMRP, 
and maintenance of FMRP levels. Based on my data, when translation is increased in the +2 
frame, reinitiation is necessary to maintain FMRP levels. Thus, this might be a means by which 
FMRP escapes the translation arrest associated with cell stress, thus leading to an outcome much 
like other uORF-bearing transcripts. This may be necessary for the prolonged formation of stress 
granules. Either way, it would be interesting to investigate the role of RAN translation in 
regulating FMRP translation under various cell states known to impact RAN translation.  
 
Using ASOs to impede RAN translation and increase in FMRP translation 
The mechanistic studies above allowed for the rational generation of ASOs aimed at 
blocking RAN translation and increasing FMRP synthesis. These ASOs provide direct evidence 
that RAN translation acts endogenously to impede FMRP translation. Because they lack their 
native gene context, reporter constructs and assays always run the risk of providing misleading 
findings in relation to the biology they are attempting to characterize. In the absence of making 
mutations to the 5’ leader, sterically blocking initiation at the first and second +1 start site 
increases endogenous FMRP. I confirmed that the ASO was acting in the expected manner by 
ASO treating cells transfected with the +1 RAN reporter, and performing nanoluciferase assays. 
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This expands on the first reports where ASOs were used with this strategy because it was never 
shown that the ASOs were, in fact, precluding translation of the uORFs that were targeted.  
Using the ASOs in HEK cells confirmed that blocking RAN can increase FMRP derived 
from transcripts with normal repeat sizes. This was taken further into iPSCs and neurons derived 
from a patient with an expanded repeat where the effect of the ASO on FMRP was observed as 
well. In addition to the proof of principle that steric hindrance of RAN can increase FMRP 
endogenously, these data provide exciting evidence that ASOs targeting RAN start sites might be 
a viable therapeutic target in patients with a deficit in FMRP. 
 
Future avenues of interest: The endogenous effect of RAN translation on FMR1 
One experiment to complete moving forward is to mutate the RAN start sites 
endogenously by CRISPR/Cas9 genome editing. If done in iPSCs or human neural progenitors, 
we could further investigate the endogenous role of RAN translation in a neuronal setting. 
Additionally, the +1 RAN ASO could be applied to iPSC-derived neurons prior to DHPG 
stimulation. This is complicated by the developmental state of these neurons, and a potential lack 
of proper surface receptor expression. However, if an increase in FMRP in response to DHPG is 
observed in these cells, we would expect this effect to be blocked in the presence of the ASO. 
The would lend more confidence to the endogenous role of +1 RAN translation in modulating 
activity-dependent FMRP synthesis.  
Additional research should apply the +1 RAN ASO in a mouse model of FXTAS to 
further elucidate the benefits of precluding RAN translation. There are caveats to this as the 
mouse FMR1 transcript does not have complete sequence alignment with the human region 
targeted by the ASO. One way to get around this would be to virally infect reporters for RAN 
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translation into the brains of mice. It would be interesting to investigate the ASO’s potential to 
knock-down this reporter. Subsequently, investigation of cell health and aggregate formation 
would provide insight into the cellular effects of the ASO. Behavioral assays of mice treated with 
the ASO would be necessary for investigating the overall benefit of an ASO treatment to knock-
down RAN as a therapeutic approach to treat FXTAS.  
 
Conclusions 
My thesis both describes the universal role of uORFs in a neuronal setting and focuses on 
how RAN translation can act as a uORF to the key neuronal transcript, FMR1. The results I have 
gathered through my work on FMR1 have pointed to a nuanced but important role for RAN 
translation in modulating the basal and activity-dependent synthesis of FMRP. While the CGG 
repeat and RAN translation may seem like an exceptional case, ribosome profiling of SH-SY5Y 
cells suggests that it is not. The CGG repeat is a significant structural barrier, but structured 5’ 
leaders are common (Pickering and Willis 2005). Also, while upstream AUGs are largely 
selected against, there are thousands of transcripts that not only have one AUG but many, and 
near-cognate codons are even more prevalent (Chew, Pauli et al. 2016, Johnstone, Bazzini et al. 
2016). Upon this, careful inspection and experimentation of the 5’ leaders of individual 
transcripts may yield an abundance of insight about how translation is regulated. Whereas the 
continued use of ribosome profiling will reveal overarching themes and attributes of 5’ leader 
regulation and its implications across diverse cell states.  
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APPENDIX A 
A role for reinitiation after RAN translation in regulating FMRP synthesis 
 
 In this set of experiments, I wondered if the +2 frame RAN event affected FMRP levels. 
It is believed that initiation in the +2 frame occurs in the repeat, thus we cannot prevent initiation 
in this frame. Thus, I mutated the termination site in our FMRP reporters, which is about 16 
nucleotides upstream of the AUG for FMRP. This mutation (+2 Mut) removes the termination 
site so that the next +2 frame termination site is downstream of the start codon for FMRP, 
turning +2 RAN into an overlapping uORF. In doing so, we see no effect on FMRP reporter 
levels with a wild-type 5’ leader (Figure A.1). However, in the combined 0/+1 AAA, +2 Mut 
reporter with a large repeat, we do observe a decrease in reporter levels relative to the 0/+1 AAA 
reporter of the same repeat size. In Figure 3.2E, we do observe an increase in +2 RAN translation 
when the 0/+1 AAA mutations are made. These data suggest that the +2 RAN event may not be 
inhibitory under wild-type conditions, until it is upregulated. Under conditions where +2 RAN is 
increased, reinitiation after translation may be necessary to maintain FMRP translation levels.  
 
 
 
 
 
 
	 194	
 
 
Figure A.1:  
Reinitiation after +2 CGG RAN occurs in the absence of 0- and +1-frame RAN translation. SH-SY5Y cells 
were transfected for 24 hours with nLuc reporter. nLuc activity was normalized to FFluc, which was co-transfected. 
0/+1 AAA reporters recapitulate the increase relative to WT, as previously mention. However, the +2 Mut alone 
does not affect FMRP reporter levels. However, in the 90 repeat reporters, we do observe a modest decrease in nLuc 
levels in the 0/+1 AAA, +2 Mut reporter relative to the 0/+1 AAA mutant reporter alone. n=3, one-way ANOVA 
with multiple comparisons within repeat size, *p<0.05, ***p<0.001, ****p<0.0001
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APPENDIX B 
Repeat length-dependent protein turnover of FMRpolyG 
 
In this set of experiments, I sought to discern differences in turnover of FMRpolyG with 
varying lengths in the homopolymeric glycine stretch. To do this, I utilized Dendra2. This is a 
photoconvertable protein that emits green fluorescence in its unconverted state, and upon UV 
application the Dendra2 molecule emits red fluorescence. This allows for the tracking of proteins 
present in the cell at the time of photoconversion. I made a series of reporters for the +1 RAN 
products, FMRpolyG. These reporters had the full 5’ UTR sequence for FMRpolyG (with 54 or 
100 repeats) with a Dendra2 tag. The Dendra2 tag does not have the first 3 amino acids to 
preclude initiation and synthesis of Dendra2 without the FMRpolyG sequence upstream. To 
track protein degradation, photoconverted Dendra2 was imaged serially in the red channel. Green 
fluorescence was tracked when imaging aggregates to detect the rate at which new protein was 
added. Aggregate turnover was monitored in hippocampal neurons, which were transfected at 
DIV10 and imaged 24 hours later (Figure B.1A). Green and red protein was monitored directly 
after photobleach (0 minutes), and 20 and 40 minutes after photobleach. Interestingly, we see an 
increase in accumulation of green protein in the 54 repeat reporter relative to the 100 repeat 
reporter (Figure B.1B). This was unexpected. We hypothesized that larger repeat proteins would 
be more rapidly drawn to aggregate. We noticed that there are two populations of aggregates in 
the 54 repeat group: those that are dropping in green fluorescence (like the 100 repeat group) and 
those that are increasing in green fluorescence. We did not detect this in the 100 repeat group. 
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However, we believe this is due to expression differences over the 24 hours of 
transfection. The 100 repeat aggregates might form earlier within that span due to higher 
expression levels early on. Thus, we have a higher likelihood of imaging an aggregate that has 
been present for several hours. The 54 repeat proteins may aggregate later on within the 24 hour 
span, thus we are imaging aggregates as they are forming. In fact, when imaging the red channel 
in these forming aggregates, we also see accumulation. This is likely due to the high level of 
attraction for all FMRpolyG present in the cell at the time, thus even diffuse, spuriously 
photoconverted protein is added to the aggregate. For this reason, we only included aggregates 
from the 54 repeat condition that were not “forming”; these were not increasing in red 
fluorescence, we call this select group the “formed” group. Thus, we compared the red 
fluorescence of only the formed aggregates with 54 and 100 repeats. In doing so, we see no 
difference between the repeat sizes (Figure B.1C). Taken together, these data show that there is 
no difference between repeat sizes in turnover of the protein present in aggregates, but repeat 
size does appear to influence the formation dynamics of aggregates.  
Next, we hypothesized that FMRpolyG turnover could be better assessed through 
imaging whole cells. I switched to SH-SY5Y cells so that I could capture multiple cells in one 
frame. Cells were transfected for 24 hours. Cells were imaged every 10 minutes post 
photobleaching for 60 minutes. This strategy revealed a difference in turnover of FMRpolyG 
with 54 and 100 repeats, with the larger repeat showing more stability as we hypothesized. The 
increase in stability of the larger repeat may lend some insight into what occurs in patients. In 
FXTAS patients we detect FMRpolyG aggregates, these are not present in control tissue. An 
element of this may be due to the increase in stability of FMRpolyG with a larger repeat. 
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Figure B.1:  
FMRpolyG aggregate formation is repeat-dependent. A) Individual aggregates were imaged at 0, 20, and 40 
minutes after photobleaching. B) Aggregated green protein was tracked revealing, revealing a relative increase in 
active aggregation in the +1 CGG54 Dendra2 relative to +1 CGG100 Dendra2. C) Imaging already formed aggregates 
for photoconverted protein (red), revealed no difference in turnover based on repeat size. A) n=11, 54 repeats, n=8, 
100 repeats. B) n=4, 54 repeats, n=8, 100 repeats. Two-way ANOVA with multiple comparisons, **p>0.01. 
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Figure B.2:  
FMRpolyG turnover is repeat-dependent. Whole-cell imaging of SH-SY5Y cells transfected with +1 CGGn 
Dendra2 plasmids. The larger repeat reporter is significantly more stable at 30-60minutes of imaging. n=7 cells for 
each condition, two-way ANOVA with multiple comparisons, *p>0.05, **p>0.01. 
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APPENDIX C 
ASO targeting CGG RAN increases FMRP in Fragile X hESC-derived neurons 
 
In this set of experiments, I hypothesized that the +1 RAN ASO would increase FMRP 
levels in human embryonic stem cell (hESC)-derived neurons. A line of control (unaffected) 
cells were treated, along with a line of cells with a full repeat. This line does make FMR1 RNA 
at early passage numbers, so we reasoned that in these early passage cells, there should be FMR1 
mRNA for the ASO to bind. Neurons were treated at 5 weeks with ASO for 24-hours, then 
maintained for 6 days. Western blotting was performed (Figure C.1). 
 
Figure C.1:  
+1 RAN ASO increases FMRP in control and FXS hESC-derived neurons. A) hESC-derived neurons with a 
normal, unmethylated repeat (~30) were treated as described above. A 71.3% increase was detected by western blot 
in the +1 RAN ASO treated cells relative to the Control ASO treated cells. n=3, Student’s t-test, **p>0.01. B) The 
western blot is shown for the FXS neurons treated with both ASO conditions, leading ~3-fold increase. n=1, Control 
ASO, n=2, +1 RAN ASO.
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